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Bacteriophage therapy has been exploited for the control of bacterial diseases in fauna, flora and 
humans. However, the advent of antibiotic therapy lead to a cessation of most phage research. 
Recently, the problem of antibiotic resistance has rendered many commonly used antibiotics 
ineffective, thereby renewing interest in phage therapy as an alternative source of control. This is 
particularly relevant in the case of bovine mastitis, an inflammatory disease of bovine mammary 
glands, caused by strains such as Staphylococcus aureus subsp. aureus Rosenbach 1884. 
Antibiotic resistance (primarily towards penicillin and methicillin) by staphylococcal strains 
causing mastitis is regularly reported. Phage therapy can provide a stable, effective and 
affordable system of mastitis control with little to no deleterious effect on the surrounding 
environment or the affected animal itself. Several studies have delved into the field of biocontrol 
of bovine mastitis using phages. Results are variable. While some phage-based products have 
been commercialized for the treatment of S. aureus-associated infections in humans, no products 
have yet been formulated specifically for the strains responsible for bovine mastitis. If the 
reliability of phage therapy can be resolved, then phages may become a primary form of control 
for bovine mastitis and other bacterial diseases.  
This study investigated the presence of S. aureus and its phages in a dairy environment, 
as well as the lytic ability of phage isolates against antibiotic-resistant strains of mastitic S. 
aureus. The primary goals of the thesis were to review the available literature on bovine mastitis 
and its associated control, and then to link this information to the use of phages as potential 
control agents for the disease, to conduct in vitro bioassays on the selected phages, to conduct 
phage sensitivity assays to assess phage activity against different chemical and environmental 
stresses, to morphologically classify the selected phages using transmission electron microscopy, 
to characterize the phage proteins using one-dimensional electrophoresis, and lastly, to 
characterize phage genomes, using both electrophoresis as well as full genome sequencing.  
Twenty-eight phages were isolated and screened against four strains of S. aureus. Only 
six phages showed potential for further testing, based on their wide host range, high titres and 
common growth requirements. Optimal growth conditions for the host S. aureus strain was 37°C 











 dilution of phage stock), these phages were able to reduce live bacterial 
cell counts by 64-95%. In addition, all six phages showed pathogenicity towards another 18 S. 
aureus strains that were isolated from different milk-producing regions during a farm survey. 
These six phages were named Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6.  
Sensitivity bioassays, towards simulated environmental and formulation stresses were 
conducted on six identified phages. Phages Sabp-P1, Sabp-P2 and Sabp-P3 showed the most 
stable replication rates at increasing temperatures (45-70°C), in comparison to phages Sabp-P4, 
Sabp-P5 and Sabp-P6. The effect of temperature on storage of phages showed that 4ºC was the 
minimum temperature at which phages could be stored without a significant reduction in their 
lytic and replication abilities. Furthermore, all phages showed varying levels of sensitivity to 
chloroform exposure, with Sabp-P5 exhibiting the highest level of reduction in activity (74.23%) 
in comparison to the other phages. All six phages showed optimal lytic ability at pH 6.0-7.0 and 
reduced activity at any pH above or below pH 6.0-7.0. Exposure of phages to varying glycerol 
concentrations (5-100%) produced variable results. All six phages were most stable at a glycerol 
concentration of 10-15%. Three of the six isolated phages, Sabp-P1, Sabp-P2 and Sabp-P3, 
performed optimally during the in vitro assays and were used for the remainder of the study.  
Morphological classification of phages Sabp-P1, Sabp-P2 and Sabp-P3 was carried out 
using transmission electron microscopy. All three phages appeared structurally similar. Each 
possessed an icosahedral head separated from a striated, contractile tail region by a constricted 
neck region. The head capsules ranged in diameter between 90-110nm with the tail length 
ranging from 150-200nm in the non-contractile state and 100-130nm in the contractile state. 
Rigid tail fibres were also visible below the striated tail. The major steps in the virus replicative 
cycle were also documented as electron micrographs. Ultra-thin sections through phage plaques 
were prepared through a modification of traditional methods to speed up the process, with no 
negative effects on sample integrity. The major steps that were captured in the phage replicative 
cycle were (1) attachment to host cells, (2) replication within host cells, and, (3) release from 
cells. Overall results suggested that all three phages are strains from the order Caudovirales and 
are part of the Myoviridae family.  
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A wealth of information can be derived about an organism based on analysis of its 
proteomic data. In the current study, one-dimensional electrophoretic methods, sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and ultra-thin layer isoelectric focusing 
(UTLIEF), were used to analyse the proteins of three phages, Sabp-P1, Sabp-P2 and Sabp-P3, in 
order to determine whether these strains differed from each other. SDS-PAGE analysis produced 
unique protein profiles for each phage, with band fragments ranging in size from 8.86-
171.66kDa. Combined similarity matrices showed an 84.62% similarity between Sabp-P1 and 
Sabp-P2 and a 73.33% similarity between Sabp-P1 and Sabp-P3. Sabp-P2 showed a 69.23% 
similarity to Sabp-P3. UTLIEF analysis showed protein isoelectric charges in the range of pI 
4.21-8.13, for all three phages. The isoelectric profiles for each phage were distinct from each 
other. A combined similarity matrix of both SDS-PAGE and UTLIEF data showed an 80.00% 
similarity between phages Sabp-P1 and Sabp-P2, and a 68.29% similarity between Sabp-P1 and 
Sabp-P3. Sabp-P2 showed a 70.59% similarity to Sabp-P3. Although the current results are 
based on putative protein fragments analysis, it can be confirmed that phages Sabp-P1, Sabp-P2 
and Sabp-P3 are three distinct phages.  
This was further confirmed through genomic characterization of the three staphylococcal 
phages, Sabp-P1, Sabp-P2 and Sabp-P3, using restriction fragment length analysis and whole 
genome sequencing. Results showed that the genomes of phages Sabp-P1, Sabp-P2 and Sabp-P3 
were all different from each other. Phages Sabp-P1 and Sabp-P3 showed sequence homology to 
a particular form of Pseudomonas phages, called ―giant‖ phages. Phage Sabp-P3 showed 
sequence homology to a Clostridium perfringens phage. Major phage functional proteins (the tail 
tape measure protein, virion structural proteins, head morphogenesis proteins, and capsid 
proteins) were identified in all three phages. However, although the level of sequence similarity 
between the screened phages and those already found on the databases, enabled preliminary 
classification of the phages into the order Caudovirales, family Myoviridae, the level of 
homology was not sufficient enough to assign each phage to a particular type species. These 
results suggest that phage Sabp-P1 might be a new species of phage within the Myoviridae 
family. One longer-term objective of the study is to carry out complete assembly and annotation 
of all the contigs for each phage. This will provide definitive conclusions in terms of phage 
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Bovine mastitis is an infectious inflammation of the mammary glands that interferes with the 
normal flow and quality of milk (Blowey and Edmondson, 2010). This disease is a major cause 
of economic losses in the dairy industry worldwide. Direct costs can be incurred through 
discarded milk, and drug and veterinary costs, while indirect costs can be incurred through milk 
price penalties as a result of increased somatic cell counts (SCC), decreased milk yield due to 
udder damage, additional labour requirements for treating infected cows, and higher culling and 
replacement costs (Blowey and Edmondson, 2010; Mubarack et al., 2011). In the United States 
alone, annual losses are estimated to be 2 billion USD, and worldwide, mastitis is associated with 
economic losses of up to 35 billion USD annually (Jones and Bailey, 2009; Van den Borne, 
2010; Mubarack et al., 2011).  
The wide range of organisms that can cause the disease, and the ubiquity of these causal 
agents, makes complete eradication of the disease from a dairy system virtually impossible. 
Traditional methods of disease control revolved around the use of antibiotic treatment of infected 
cows. However, the development of resistance by the major causal organisms, against those 
antibiotics commonly used to treat the disease, has reinforced the importance of integrated 
control measures. This scenario is particularly relevant to bovine mastitis induced by 
Staphylococcus aureus subsp. aureus Rosenbach 1884. Numerous strains have developed 
antibiotic resistance. Resistance was noted to have first developed against penicillin, after which 
methicillin became the treatment of choice (Vanderhaeghen et al., 2010). However, the 
development of resistance to methicillin shifted treatment to the use of vancomycin, and, as 
anticipated, some strains of S. aureus have now developed resistance towards vancomycin 
(Vanderhaeghen et al., 2010). As a result, interest has shifted from the more conventional 
antibiotic therapies towards the field of biological control of the disease.  
 One such biocontrol option involves the use of lytic bacterial viruses (bacteriophages) 
that are specific to S. aureus. Phage therapy has been applied to different disciplines, ranging 
from human and veterinary medicine to agricultural settings. There have been increased 
applications of phages in the food industry to control major food pathogens such as Listeria 
monocytogenes (Murray et al. 1926), Salmonella, Campylobacter and pathogenic Escherichia 
coli (Hagens and Offerhaus, 2008); in human medicine, to treat burns, contaminated wounds, 
viii 
 
diarrheal diseases (Soothill, 1994) and for use against methicillin-resistant Staphylococcus 
aureus (Rosenbach) (MRSA) (Capparelli et al., 2007). In the United States, in the past two years 
alone, several phage applications have been approved for use. The most prominent include 
Listex (an organic anti-Listeria phage) (Hagens and Offerhaus, 2008), an anti-Escherichia coli 
wash, and an anti-Salmonella wash for the treatment of live animals prior to slaughter 
(www.omnilytics.com). In addition to phage therapy, phage use can be extended to the field of 
phage display, vaccine delivery and pathogen detection. There has been significant progress, 
using animal models, in the field of control of S. aureus using phages. However, no single 
phage-based product has yet been commercialized for use against bovine mastitis, despite the 
clear need for a more sustainable control option to manage the disease. Phages are specific for 
their target bacterium and hence create no negative effects on the surrounding mammary tissues 
or the environment. This, coupled with their ability to multiply up to 1000-fold within a host cell, 
makes the phage an ideal candidate for the biocontrol of bovine mastitis (Blowey and 
Edmondson, 2010).  
 With this background in mind, the long-term objective of the current project was to use 
phages as a supplementary treatment against bovine mastitis. However, prior to any in vivo 
applications, in vitro biological and molecular classification of isolated phages was essential in 
order to understand the organism before field application.  The objectives of the current study 
were therefore as follows:  
1. Review available literature, firstly on bovine mastitis, in order to properly understand the 
course of infection, treatment protocols and associated drawbacks, and secondly, to link this 
information to the use of phages as potential biological control agents for the disease.  
2. Conduct biological activity assays on phages isolated from the dairy environment, in order to 
assess their in vitro ability to control South African strains of S. aureus.  
3. Investigation of phage sensitivity, in vitro, towards simulated environmental and chemical 
stresses. This study aimed to contribute to phage formulations for eventual in vivo application.  
4. Classification of three phages with activity against South African strains of S. aureus, 
according to their morphology and replicative cycle, using transmission electron microscopy. 
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5. Characterisation of phage proteins using one-dimensional electrophoretic methods, sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and ultra-thin layer isoelectric 
focusing (UTLIEF), in order to determine whether the selected strains differed from each other. 
6. Characterization of phage genomes, using both electrophoresis as well as full genome 
sequencing, in order to verify whether or not each selected strain is indeed different from the 
others.  
This dissertation is comprised of six discreet chapters; one being a review of literature, 
followed by five research chapters, each covering a specific aspect of phage classification and 
characterization. Each research chapter has been compiled in the form of a discreet, scientific 
paper. As a result, there has been some repetition of references between chapters. This is the 
standard format adopted for dissertations by the University of KwaZulu-Natal. All references 
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Review of Literature 
1.1 Introduction  
Bovine mastitis is an infectious inflammation or irritation of the mammary glands that interferes 
with the normal flow and quality of milk (Blowey and Edmondson, 2010). Although a range of 
control measures are used, this disease remains a major cause of economic losses in the dairy 
industry worldwide. While some diseases, such as foot-and-mouth, can be completely eliminated 
from a system using culling and vaccination protocols, bovine mastitis is an endemic disease that 
cannot be completely eradicated. The wide range of microorganisms that can cause this disease, 
and the ubiquity of these organisms, make complete eradication unlikely. Optimum control 
therefore lies in first understanding the epidemiology of the disease and the causal agents, and 
then implementing an integrated control strategy. 
In recent years, the use of integrated control measures has become paramount, due to the 
onset of resistance against the antibiotics commonly used to treat the disease. This is particularly 
relevant to the primary causal bacterium of bovine mastitis, Staphylococcus aureus subsp. aureus 
Rosenbach 1884. Numerous strains have developed antibiotic resistance. Resistance was noted to 
have first developed against penicillin (both β-lactam and non- β-lactam), after which methicillin 
became the treatment of choice (Vanderhaeghen et al. 2010). However, the development of 
resistance to methicillin shifted treatment to the use of vancomycin, but some strains of S. aureus 
have now developed resistance towards vancomycin. The financial implications of such 
resistance within a herd of infected cows can be substantial. Losses can exceed 200USD per cow 
because culling of infected animals serves as the final control measure (Borm et al. 2006). As a 
result, interest has shifted from the more conventional antibiotic therapies towards the field of 
biological control of the disease.  
 One such biocontrol option involves the use of lytic bacterial viruses (bacteriophages) 
that are specific to S. aureus. Phage therapy has been applied to different disciplines, ranging 
from human and veterinary medicine to agricultural settings. There have been increased 
applications of phages in the food industry to control major food pathogens such as Listeria 
monocytogenes (E. Murray et al. 1926), Salmonella enterica (ex. Kaufmann and Edwards 1952), 
Campylobacter Sebald and Véron 1963 and pathogenic Escherichia coli Castellani and Chalmers 
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1919 (Hagens and Offerhaus, 2008); in human medicine, to treat burns, contaminated wounds, 
diarrheal diseases (Soothill, 1994) and for use against methicillin-resistant S. aureus (MRSA) 
(Capparelli et al. 2007). In the United States, in the past two years alone, several phage 
applications have been approved for use. The most prominent include Listex (an organic anti-
Listeria phage) (Hagens and Offerhaus, 2008), an anti-E. coli wash, and an anti-Salmonella wash 
for the treatment of live animals prior to slaughter (www.omnilytics.com). Phage use can be 
extended to the field of phage display, vaccine delivery and pathogen detection (Chanishvilli et 
al. 2001). In addition, there has been significant progress, using animal models, in the field of 
control of S. aureus using phages (Soothill, 1992; Kelly et al. 2011). However, no single phage-
based product has yet been commercialized for use against bovine mastitis, despite the clear need 
for a more sustainable control option to manage the disease.  
This review covers the biology and current control of bovine mastitis and assesses the use 
of phages as an alternative or supplementary therapy for the disease.  
 
1.2 Types of mastitis 
Due to the more than 200 recorded organisms that are able to cause mastitis (Ranjan et al. 2006) 
and the varying levels of infection associated with each, there exists a complete lexicon to 
describe the disease and classify it according to specific organisms. A simple classification 
method recognizes two distinct forms of the disease, contagious and environmental (Blowey and 
Edmondson, 2010). It must be understood however, that proper identification of the disease using 
bacteriological analysis of causal agents must be undertaken in order to definitively classify the 
type of mastitis that the animal is afflicted with. 
 
1.2.1 Contagious mastitis 
Pathogens that are spread from cow to cow primarily during milking are referred to as contagious  
pathogens (Tyler and Ensminger, 1993). The mammary glands and teat skin serve as reservoirs 
of infections with colonies establishing at the teat end and slowly growing into the teat canal over 
1-3 days (Blowey and Edmondson, 2010). Commonly used control measures include postmilking 
teat dipping, dry cow therapy, milking hygiene and culling. Among the contagious organisms, S. 
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aureus, Streptococcus agalactiae Rosenbach 1884 and Streptococcus dysgalactiae Rosenbach 
1884 have been identified as the major causes of bovine mastitis in many countries (Rebhun, 
1995; Sandgren et al. 2008; Nickerson, 2009).  
S. aureus organisms are haemolytic, Gram-positive cocci that appear as cream-white to 
yellow colonies on solid growth media (Madigan et al. 2012). The primary reservoir for the 
bacterium is within the mammary gland itself. Staphylococci are exceptionally difficult to 
eliminate once infection is established within a system. Trials have shown that a cow releasing S. 
aureus in her milk may contaminate the teats of the next 6 to 8 cows to be milked (Blowey and 
Edmondson, 2010). It therefore makes sense that if it is present in a herd, certain mandatory 
precautions should be applied: postmilking teat disinfection is vital; infected cows should be 
milked last and in a separate group using separate machinery; and teat skin should be maintained 
in an optimum condition to prevent entry of bacteria through broken/chapped surfaces. Under 
certain circumstances, S. aureus can also cause an acute gangrenous mastitis (Blowey and 
Edmondson, 2010). This form of mastitis is not caused by a specific acute strain of the bacterium 
but rather by a change in the immune system of the cow as a result of a chronic S. aureus 
infection (Blowey and Edmondson, 2010). The clinical appearance of gangrenous mastitis is 
characterized by a blue/black discolouration of teat and udder skin (Rebhun, 1995; Blowey and 
Edmondson, 2010). The teats and udder also feel cold and sticky to the touch and can develop 
small blisters (Rebhun, 1995; Blowey and Edmondson, 2010).  
Strep. agalactiae is a Gram-positive alpha-haemolytic coccus that appears as very small 
colonies that exhibit a blue hue on Edwards medium (Madigan et al. 2012). Its primary reservoir 
of infection is in the udder, however, it has been found to colonise the teat canal and even the teat 
skin, particularly if these surfaces are chapped (Rebhun, 1995; Nickerson, 2009; Petzer et al. 
2009). These organisms do not cause overt abscesses or fibrosis but will permanently decrease 
productivity in infected glands (Rebhun, 1995; Nickerson, 2009).  
Strep. dysgalactiae is also a Gram-positive haemolytic coccus with very small colonies 
that cause a green discolouration of Edwards medium (Madigan et al. 2012). While this organism 
does share many of the properties applicable to S. aureus and Strep. agalactiae, a few distinct 
differences do exist. Strep. dysgalactiae survives well in the environment and may be considered 
to be halfway between contagious and environmental organisms. It is commonly found on teat 
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skin, particularly when the surface integrity is compromised by chaps, cuts or bruises (Rebhun, 
1995; Nickerson, 2009). Strep. dysgalactiae is also present on the tonsils of the cow and hence 
licking could also transmit infection to the teats (Rebhun, 1995; Nickerson, 2009). Conditions 
such as teat irritation associated with flies or chapping due to cold weather might encourage an 
animal to lick its teats and hence transfer infection which gradually colonises the teat canal until 
clinical mastitis occurs (Rebhun, 1995; Nickerson, 2009). 
Contagious mastitis can be divided into three major groups: (a) Clinical mastitis is 
commonly characterized by gross inflammation of the udder, e.g., swelling, redness, heat, and 
also by anomalies in the appearance of milk, e.g., clots and changes in the colour and smell of the 
milk (Rebhun, 1995; Blowey and Edmondson, 2010).  Clinical mastitis can be further divided 
into peracute mastitis which is characterized by gross inflammation, disrupted functions 
(reduction in milk yields, changes in milk composition) and systemic signs (fever, depression, 
loss of appetite, shivering, loss of weight) (Figure 1.1); acute mastitis which is similar to the 
peracute form, but with lesser systemic symptoms (fever and mild depression); sub-acute mastitis 
where the mammary gland infection is minimal and there are no visible systemic symptoms 
(Blowey and Edmondson, 2010); (b) Sub-clinical mastitis is commonly characterized by a 
change in milk composition with no signs of gross inflammation or milk abnormalities (Rebhun, 
1995; Blowey and Edmondson, 2010). The changes in milk composition have to be detected 
using special diagnostic tests such as somatic somatic cell counts (SCC), electrical conductivity 
tests, culture and pH tests and enzymatic analyses (Viguier et al. 2009; Reyher and Dohoo, 
2011); (c) Chronic mastitis refers to a form of the disease where inflammation exists for months, 
and may continue from one lactation to another (Rebhun, 1995; Blowey and Edmondson, 2010). 
Chronic mastitis, for the most part, exists in a sub-clinical form but may exhibit periodic flare-
ups into the acute or sub-acute forms for short periods of time (Rebhun, 1995).  
1.2.2 Environmental mastitis 
This type of mastitis is caused by organisms that do not normally live on the surface of the skin 
or in the udder, but which enter the teat canal when the cow comes into contact with a 
contaminated environment (Blowey and Edmondson, 2010). These pathogens can normally be 
found in faeces, bedding material,  farmyard and feed. They are usually transferred from the 
reservoir to the teats between milking (Blowey and Edmondson, 2010). Control of environmental 
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mastitis is usually achieved far more successfully than with the contagious form of the disease by 
implementing proper environmental hygiene, predipping teats and applying dry period teat 
sealants. Among the environmental organisms, coliforms (especially E. coli) and Streptococcus 










Figure 1.1 Healthy udder (a) alongside a mastitic udder (b); (a) www.indiamart.com; (b) 
www.valleyveterinarygroup.com.  
 
E. coli is a Gram-negative rod-shaped bacterium which produces grey mucoid colonies in 
blood agar, with strains that are both haemolytic and non-haemolytic (Madigan et al. 2012).  E. 
coli is present in high numbers in faeces and hence infection occurs primarily when animal 
housing conditions are wet, and when hygiene is poor. During lactation, E. coli is thought to 
enter the teat canal by propulsion and hence increased mastitis is seen with dirty teats, 
suboptimal machinery function or techniques that lead to teat-end impacts (Blowey and 
Edmondson, 2010). E. coli penetration of the teat canal though, does not always result in chronic 
infection, with a high percentage (80-90%) of infections undergoing self-cure (Blowey and 
Edmondson, 2010). Typical symptoms include slight damage to the endothelial lining of the teat 
wall that manifests as flaky clots in milk, and a hard, hot swollen quarter with a watery discharge 
(Nickerson, 2009; Blowey and Edmondson, 2010). The toxic effects of E. coli mastitis are due to 
the release of an endotoxin (typically lipopolysaccharide) that is derived from the bacterial cell 
wall. The accumulation of this toxin results in intense haemorrhaging of the endothelial lining of 




that serum ooze can be seen on the surface of the udder and teat. Such cases can lead to 
endotoxaemia, extensive gangrene and eventual sloughing of the udder tissue (Nickerson, 2009; 
Blowey and Edmondson, 2010).   
Strep.uberis is a Gram-positive coccus that is non-haemolytic and produces brown 
colonies on Edwards medium (Madigan et al. 2012). A typical case of Strep. uberis mastitis is 
often sudden in onset, and produces a hard, swollen udder, very high body temperatures and milk 
with large white clots (Nickerson, 2009; Blowey and Edmondson, 2010). It is particularly 
associated with straw yards where as much as 10
6
 organisms per gram of straw have been 
reported (Blowey and Edmondson, 2010). In addition to being found in the environment, Strep. 
uberis can also be found on a wide range of sites on the animal itself, e.g., mouth, vulva, groin 
and axilla (Nickerson, 2009; Blowey and Edmondson, 2010). Although present in faeces, levels 
are not significantly high, and in this respect Strep. uberis differs from E. coli. Following 
infection, Strep. uberis has been found to remain persistent in the udder for an average of 1.5 
months after treatment (Nickerson, 2009). This poor response to treatment and the long 
refractory period within the udder are possibly due to its resistance to phagocytosis, its ability to 
survive within animal cells where it is protected from antibiotics and its ability to move into the 
lymph node from where it maintains a reservoir of infection (Nickerson, 2009).  
 
1.3 The effects of mastitis on milk synthesis and milk proteins  
The effects of mastitis on milk yield and composition are of significant economic importance to 
the dairy farmer. Direct costs can be incurred through discarded milk and drug and veterinary 
costs, while indirect costs can be incurred through penalties as a result of increased SCC, 
decreased milk yields due to udder damage, additional labour requirements for treating infected 
cows, and higher culling and replacement costs (Blowey and Edmondson, 2010; Mubarack et al. 
2011). In the United States alone, animal losses are estimated to approach 2 billion USD. 
Worldwide, it is associated with economic losses of up to 35 billion USD annually (Jones and 
Bailey, 2009; Van den Borne, 2010; Mubarack et al. 2011). On average, a quarter infected with a 
major pathogen will yield approximately 30% less milk than an equivalent uninfected quarter of 
the same cow (Kudi et al. 2009; Blowey and Edmondson, 2010). Infected cows are also culled 
more quickly either because of repeated clinical infections or reduced milk yields.  
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In addition, mastitis has a major effect on the taste and quality of milk mainly as a result of 
its effects on the lactose, protein and fat content of milk; typically affected milk is rancid and 
slightly salty/bitter to the taste (Table 1.1) (Mubarack et al. 2011). As a result of diminished milk 
quality, overall income is reduced as the farmer receives a lower price (up to 20% less per litre) 
for such milk (Mubarack et al. 2011). 
 
Table 1.1 Effects of mastitis on milk quality (adapted from Hardy, 1995a, b; Batavani et al. 











Calcium 126.29 90.45 
Phosphorous 30.59 24.40 
Potassium 167.74 15.56 
   
Total proteins (%)   
α-lactalbumin  28.72 22.25 
β-lactoglobulin 57.08 34.21 
Albumin 6.99 17.21 
Pre-albumin 0.18 0.09 
   
Undesirable components    
Plasmin (degrades casein Low High 
Lipase (breaks down fat) Low High 
Sodium Low High 
Immunoglobulin Low High 
 
Lactose 
Glucose, produced in the cow liver as a result of rumen fermentation, is transferred to the udder 
where part of it is converted to the simple sugar, galactose (Walstra et al. 2006; Blowey and 
Edmondson, 2010). Then one molecule of glucose combines with one molecule of galactose to 
form the disaccharide, lactose. Lactose is the main osmotic determinant of milk (Blowey and 
Edmondson, 2010). Lactose concentration increases and decreases as the concentration of the 
other milk components varies, in order to maintain milk at the same concentration as blood 
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(Harding, 1995a; Walstra et al. 2006; Blowey and Edmondson, 2010). However, the pH of milk 
is slightly lower than that of blood, i.e. 6.7 and 7.4, respectively (Blowey and Edmondson, 2010). 
This difference has been used to attract drugs such as erythromycin, trimethoprim and 
penethamate into the mammary gland (Walstra et al. 2006; Blowey and Edmondson, 2010). 
If lactose concentrations within the udder drop, then sodium and chloride levels increase 
to maintain osmotic potential of the milk (Walstra et al. 2006; Blowey and Edmondson, 2010). 
This is one of the reasons for the bitter and slightly salty taste of mastitic milk. These changes 
can also be used to assess mastitis status by measuring the electrical conductivity of the milk as 
sodium and chloride are much better conductors of electricity than lactose is (Harding, 1995a, b; 
Walstra et al. 2006; Blowey and Edmondson, 2010).  
 
Protein 
The majority of protein in milk is in the form of casein (Walstra et al. 2006; Blowey and 
Edmondson, 2010). Amino acids are transported to the udder via the bloodstream and 
transformed into casein by the mammary alveolar cells (Harding 1995a; Blowey and 
Edmondson, 2010). Other proteins present in milk but in smaller quantities than casein, are 
albumin and globulins (Harmon, 1995; Ogola et al. 2007). These are transferred straight from the 
blood stream into milk. Mastitic milk on the other hand, contains reduced levels of casein and 
increased levels of albumin and globulin (Blowey and Edmondson, 2010).  
Hence, while the total protein content may remain unchanged, the milk is of poor quality 
particularly, for manufacturing processes such as cheese and yoghurt production where casein 
coagulation serves as one of the major starting processes (Harmon, 1995). In addition, mastitic 
milk contains high levels of the enzyme plasmin, which degrades casein in stored milk. This 
enzyme is not destroyed during pasteurisation and remains active in milk even at 4°C implying 
that milk will continue to be degraded even while it is on supermarket shelves (Harmon, 1995).  
 
Milk fat  
Milk fat is formed in the udder secretory cells in the alveoli when fatty acids combine with 
glycerol to form a neutral form of fat called a triglyceride (Walstra et al. 2006; Blowey and 
Edmondson, 2010). Fatty acids are derived from three main sources, i.e., body fat (50% of total 
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fatty acids), dietary fat and fatty acids synthesized in the udder from acetate (which is absorbed 
as a product of rumen fermentation) (Ogola et al. 2007; Walstra et al. 2006; Blowey and 
Edmondson, 2010). Aside from the enzyme plasmin, mastitic milk also has an increased level of 
the enzyme lipase (Harding, 1995b). This leads to degradation of milk fat into its fatty acid 
components and thus imparts a rancid flavour to the milk. Increased levels of fatty acids can also 
inhibit starter cultures in cheese and yoghurt manufacture and impart an adverse flavour to these 
products (Harding, 1995b). 
 
1.4 Disease cycle and epidemiology 
A sound knowledge of the disease cycle is required as a basis for the implementation of control 
measures to ensure that the most appropriate options are applied to treat specific phases of the 
disease. Mastitis occurs in the following sequence: (i) arrival of a reservoir of infection, (ii) 
transfer of infection from the reservoir to the teat end of the animal, (iii) penetration of the teat 
canal by the microbe, (iv) colonization of host tissues within the teat and udder (Blowey and 
Edmondson, 2010).  
 
1.4.1 Arrival of a reservoir of infection 
Bovine mastitis has been characterised according to the primary source of organisms that lead to 
infection. The facilities in which dairy cows are maintained serves as one such reservoir with 
microbes such as E. coli, Strep. uberis, certain Bacillus spp., fungi and yeasts always being 
present (Madigan et al. 2012). These organisms can inhabit the environment without causing 
harm to the animals. However, a problem arises when there is a sudden change in environmental 
conditions which promotes the rapid reproduction of any single species of microbe. This results 
in an increased challenge of infection on the teat end, especially if the teat is soiled or damaged. 
Typical environmental reservoirs include dairy workers, housing and bedding quarters, 
farmyards and milking machines.  
Other infections are normally only present in the udder of infected cows (Blowey and 
Edmondson, 2010). The arrival of a reservoir in this instance indicates either the purchase of a 
new cow or also an infected cow calving down into a herd. This infection is therefore regarded as 
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‗contagious‘ as it passes from one cow to the next and includes organisms such as S. aureus, 
Strep. agalactiae and Strep. dysgalactiae (Blowey and Edmondson, 2010).  
 
1.4.2 Transfer of infection from reservoir to teat end  
This generally occurs between milkings for environmental organisms, as the first stage in the 
establishment of new infection is the transfer of microbes from the environment to the teat end 
(Blowey and Edmondson, 2010). For contagious mastitis however, transfer occurs during the 
milking process and vectors (such as udder cloths, milkers‘ hands, and milking machines that are 
not properly sanitised) which are needed to carry the bacteria from the infected cow (or quarter) 
to a non-infected cow (or quarter). Furthermore, after milking, the teat canal remains dilated for 
1-2 hours while the canal of a damaged teat may remain partially open (Blowey and Edmondson, 
2010). This facilitates movement of organisms from either the environment or 
surrounding/injured skin into the teat canal.  
 
1.4.3 Penetration of the teat canal 
There are two ways in which bacteria commonly penetrate the teat canal. Contagious organisms 
such as S. aureus and Strep. agalactiae have strong adhesive factors that enable them to grow 
into the teat canal by attaching to the teat end (Blowey and Edmondson, 2010; Madigan et al. 
2012). Here they multiply and colonise the teat-end and then literally grow up through the teat 
canal and enter the teat sinus. The second method of entry is propulsion through the canal 
(Blowey and Edmondson, 2010; Madigan et al. 2012). Environmental pathogens such as E. coli 
commonly use this method because they lack adhesive properties (Madigan et al. 2012). They 
are, therefore, forced through the canal, usually with a reverse flow of milk. This typically occurs 
with teat-end impacts which are forces that result in milk particles being propelled from the milk-
tubes attached to the cow teats up against the teat-end (Blowey and Edmondson, 2010; Madigan 
et al. 2012). Teat-end impacts usually occur when air enters between the teat and lining of the 
milking machine, leading to an imbalance of pressure between the teat-end and the milking unit 
(Blowey and Edmondson, 2010). These two modes of bacterial entry to the teat canal are by no 
means as distinctive as this. It must be noted that a reverse flow of milk will also assist the 
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movement of contagious pathogens into the teat canal and that high teat-end challenge 
immediately after milking could facilitate movement of environmental organisms into the teat 
canal without the need for reverse flow of milk (Blowey and Edmondson, 2010).   
 
1.4.4 Colonisation of host tissues 
Once bacterial infection is established, bacteria multiply rapidly. As they multiply, they enter the 
glandular tissues and compete with milk-secreting alveolar cells for nourishment (Tyler and 
Ensminger, 1993). Toxins produced through bacterial metabolism eventually causes death of the 
mammary alveoli (toxaemia) (Tyler and Ensminger, 1993; Blowey and Edmondson, 2010). In 
addition, they may mechanically block normal circulation and change the filtering ability of 
membranes. In chronic infections, the teat duct can become so inflamed that it becomes 
completely blocked off (Tyler and Ensminger, 1993). If prompt treatment is not implemented at 
this stage, scar tissue develops and the ducts become permanently blocked. In acute mastitis, 
blood vessels become greatly dilated, causing stagnation (Tyler and Ensminger, 1993; Blowey 
and Edmondson, 2010). Milk ducts become compressed so that little or no milk is formed, and 
the milk that is formed cannot be withdrawn (Tyler and Ensminger, 1993; Blowey and 
Edmondson, 2010). As a result of these changes, medication cannot be effectively delivered into 
the gland. Essentially, the longer the mastitis is allowed to persist, the more alveolar cells will be 
damaged followed by further blockages in the teat ducts and hence significant decreases in milk 
production potential.   
 
1.5 Teat and udder defences  
Although bacteria may penetrate the teat canal and enter the udder, the cow is by no means 
completely defenceless. There are a variety of ways in which the teats and udder are able to 
overcome infection.  
1.5.1 Teat defences 
Teat skin has a thick covering of stratified squamous epithelium, the surface of which consists of 
dead cells filled with keratin (Tyler and Ensminger, 1993; Walstra et al. 2006; Blowey and 
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Edmondson, 2010). When intact, this provides a hostile environment for bacteria, hence 
preventing their growth. In addition, there are bacteriostatic fatty acids present on skin that also 
prevent bacterial growth (Tyler and Ensminger, 1993; Walstra et al. 2006; Blowey and 
Edmondson, 2010). These bacteriostatic properties can be reduced by continual washing of teats 
after milking, especially with detergents.    
The teat canal ranges from 5-13mm long and is lined with keratinised skin epidermis 
covered in a thin film of lipid keratin (Tyler and Ensminger, 1993; Walstra et al. 2006). This 
lipid has similar bacteriostatic properties to the teat skin. These properties are most effective 
when contraction of the sphincter muscle leads to canal closure (Tyler and Ensminger, 1993; 
Walstra et al. 2006). At teat closure, the sphincter muscles contract, the folds interdigitate to 
form a tight seal and the hydrophobic lipid lining ensures that no residual continuous column of 
milk persists within the canal (Tyler and Ensminger, 1993; Walstra et al. 2006; Blowey and 
Edmondson, 2010). Damage to the canal lining and lipid seal could result in a persistent residual 
column of milk, which can act as a ‗wick‘ for bacterial entry (Blowey and Edmondson, 2010). 
The teat canal also contains specialised cells called the Rosette of Furstenberg (Blowey and 
Edmondson, 2010). This is on the inner side of the teat canal and is formed by a ring of 
lymphocyte cells that detect invading bacteria and initiate an immune response (Blowey and 
Edmondson, 2010).  
Many bacteria entering the teat between milkings become trapped by the layer of keratin and 
lipid that lines the teat canal. They are then flushed out at the start of the next milking by the first 
flow of milk, as this removes the superficial layers of keratin lining the teat canal (Tyler and 
Ensminger, 1993; Blowey and Edmondson, 2010). This process is known as the ‗keratin flush‘.  
It is very important to ensure that udder preparation and unit attachment are such that 
milk flows out of the teat when the milking cluster is applied and that there is no reverse flow of 
milk which could carry infection back into the udder (Tyler and Ensminger, 1993; Blowey and 
Edmondson, 2010). In addition, during the dry period (i.e., when lactogenesis is stopped), a 
mixture of wax and keratin accumulates in the teat canal to form a physical plug (Tyler and 
Ensminger, 1993; Blowey and Edmondson, 2010). This mechanism is important in preventing 
new infection. However, the plug begins to dissolve as calving approaches (Tyler and 
Ensminger, 1993), making the udder susceptible to infection once again.    
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1.5.2 Udder defences 
Even if bacteria are able to breach the teat canal and enter the udder, there are several highly 
efficient systems that exist within the udder that are able to assist in the removal of such bacteria 
and hence facilitate the reduction of infection. These can be categorised as intrinsic defence 
mechanisms, which are mechanisms that are continuously present in the udder, and inducible 
systems, which are only activated in response to bacterial infection (Walstra et al. 2006; Blowey 
and Edmondson, 2010).  
a. Intrinsic defence mechanisms 
Lactoferrin 
Iron is required for bacterial growth (especially that of E. coli). In the dry, non-lactating udder, 
lactoferrin removes iron from udder secretions and in so doing, minimises bacterial 
multiplication (Walstra et al. 2006; Blowey and Edmondson, 2010). Although the risk of new 
infection by E. coli during the dry period is four times greater than in lactation, the presence of 
lactoferrin ensures that clinical disease onset is minimised (particularly by contagious organisms) 
(Blowey and Edmondson, 2010). Because it is only present in low concentrations, the 
bacteriostatic effects of lactoferrin are lost during lactation. This is mainly as a result of high 
citrate levels in milk which competes with lactoferrin for iron in order to produce iron citrate, 
which in turn is utilised during bacterial metabolism (Blowey and Edmondson, 2010).  
 
Lactoperoxidase 
All milk contains the enzyme lactoperoxidase (LP) (Walstra et al. 2006; Blowey and 
Edmondson, 2010). In the presence of thiocyanate (SCN) and hydrogen peroxide (H2O2), LP can 
inhibit the growth of some bacteria (Gram-positive organisms such as S. aureus and 
Streptococcus spp.) and kill others (Gram-negative bacteria such as E. coli) (Walstra et al. 2006; 
Blowey and Edmondson, 2010). The level of SCN in milk varies with diet, with levels being 
particularly high when cows are fed brassicas or legumes (Walstra et al. 2006). Hydrogen 
peroxide can be produced by bacteria themselves. Gram-negative bacteria produce very little 
H2O2 and hence the LP system is not very effective in their control (Walstra et al. 2006; Blowey 
and Edmondson, 2010). However, there is some evidence that Gram-positive bacteria produce 
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sufficient amounts of H2O2 during their metabolism to support the LP system and hence impose 
partial control (Walstra et al. 2006; Blowey and Edmondson, 2010). 
 
Antibodies (immunoglobulins) 
It is unlikely that antibodies have a primary effect on mastitis control (Leitner et al. 2003; Barrio 
et al. 2003; Blowey and Edmondson, 2010). It is known that colostrum contains very high levels 
of antibodies, yet freshly calved cows can develop peracute mastitis and frequently get severe 
mastitis several days after calving (Blowey and Edmondson, 2010). The role of specific 
antibodies against mastitic bacteria is, to date, not fully understood. It has been postulated that 
their main role is in the opsonisation of bacterial cells before they are phagocytosed by 
leukocytes and macrophages (O‘Brien et al. 2000; Barrio et al. 2003). During opsonisation, a 
portion of the antibody molecule (Fab arm) attaches to the bacteria, leaving the second antibody 
arm (the Fc fragment) exposed. Leukocytes are activated by the exposed Fc arm and attach to it. 
Phagocytosis of the bacteria then proceeds more rapidly (Barrio et al. 2003).   
 
Cellular response  
There are a variety of somatic cell types present in milk, with leukocytes constituting the 
majority. These leukocytes can be counted and are expressed as the SCC of milk. There are 
disputes over which cell types are actually present in milk, and their various proportions at 
different stages of lactation (Table 1.2) (Blowey and Edmondson, 2010). These proportions vary 
with factors such as level of milk yield, stage of lactation and the presence of infection.  
The primary function of macrophages and lymphocytes is to recognise bacteria and then 
trigger ‗alarm‘ systems that induce a more vigorous host response, eventually leading to huge 
numbers of polymorphonuclear leukocytes (PMN) (mainly neutrophils) entering the milk. These 








Table 1.2 Ratio of cell types in milk and colostrum as a percentage (adapted from Blowey and 
Edmondson, 2010). 
Type of cell Stage present 
 Mid-lactation (%) Colostrum (%) 
Polymorphonuclear leukocytes 3 61 
Vacuolated macrophages 65 8 
Non-vacuolated macrophages 14 25 
Lymphocytes 16 3 
Duct cells 2 3 
b. Inducible defence mechanisms 
The inducible mechanisms of defence serve as the final control option when all other pathways 
have been breached by bacteria. Alarm signals are sent to the body of the cow, which results in a 
sequence of immunity events, in an attempt to curb infection.  
 
The chemotaxin alarm 
The macrophages and PMNs already present in the milk recognise and engulf fragments of dead 
bacteria and their toxins during phagocytosis (Sordillo et al. 1989; Walstra et al. 2006). 
Phagocytosis in turn, leads to the release of various chemotaxins such as interleukin 8 and 
tumour necrosis factor (TNF) (Walstra et al. 2006; Blowey and Edmondson, 2010). These 
chemotaxins, together with the toxins produced by the bacterial cells themselves that are 
multiplying within the udder, that act as the inducers of the defence system triggered to control 
the bacteria (Blowey and Edmondson, 2010).  
 
The inflammatory response 
The principal response to chemotaxins is a massive inflow of PMNs from the capillaries in the 
teat wall and udder into the udder cisterns and ducts (Sordillo et al. 1989; Ali-Vehmas et al. 
1997; Blowey and Edmondson, 2010). The severity of the inflammation is often such that it 
persists well after the bacteria have been destroyed. The increase in the somatic cell count of 











 in just a few hours (Blowey and Edmondson, 
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2012). Bacteria are killed, and concurrently, so many PMNs may have entered the udder that the 
white cell count of the blood falls to almost zero (Blowey and Edmondson, 2012). This occurs 
through a variety of processes: 
Increased blood flow: blood vessels in the teat wall dilate, increasing the blood flow and 
supply, and the number of PMNs to the infected quarter/s. Hence a quarter with an acute mastitis 
infection becomes palpably swollen, hot and painful (Sordillo et al. 1989; Ali-Vehmas et al. 
1997).   
Margination: small carbohydrate projections (selectins) appear on the inner surface of 
cells lining the capillary walls. These attract PMNs out towards the sides of the capillaries and 
help force them between the capillary cells and out through the wall (Sordillo et al. 1989; 
Blowey and Edmondson, 2010).  
Loosening of endothelial cell junctions: under the influence of specific chemotaxins, the 
endothelial cells lining the capillaries, and teat and udder cisterns move apart to facilitate more 
rapid passage of PMNs into the infected milk. Once the PMNs have passed through, the cells 
come together once again (Sordillo et al. 1989; Ali-Vehmas et al. 1997; Walstra et al. 2006; 
Blowey and Edmondson, 2010). 
Diapedesis: in this process, PMNs squeeze through the walls of the capillaries, across the 
tissue of the teat wall and udder, through the endothelial lining and into the milk, where 
phagocytosis takes place (Sordillo et al. 1989; Smits et al. 1998).  
Serum ooze from blood vessels: as a result of the opening of the junctions between 
endothelial cells in the capillary walls to allow for the passage of PMNs, serum can also flow 
into the tissues (Sordillo et al. 1989). Udder tissues are therefore stretched and dilated by fluid 
and appear swollen. This phenomenon is particularly apparent with acute E. coli infections, 
where leakage of serum is so pronounced that it flows directly into the milk and produces a 
yellow, watery secretion. Occasionally serum ooze may even be seen on the skin surface as small 
reddish-brown droplets (Sordillo et al. 1989; Jackson et al. 1990). 
Phagocytosis: once they have passed into the milk, the PMNs released in response to the 
chemotaxin alarm, start to engulf whole bacteria (Jackson et al. 1990). Inside the PMN, the 
bacteria are destroyed by a process of oxidative metabolism that is induced by the PMNs. This 
results in the production of several microbicidal agents within the PMNs such as hydrogen 
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peroxide, hydroxyl radical and singlet oxygen, which oxidise lipids in the bacterial membranes 
and causes lysis of the bacteria (Jackson et al. 1990).   
 
1.6 Mastitis and its control through the ages 
1.6.1 Antibiotic therapy 
Under optimal conditions, the natural defence mechanisms (self-cure) discussed above, in 
conjunction with cultural control measures such as clean bedding, proper milking sanitation and 
vigilant inspection of lactating cows, may prove effective in curbing disease onset and severity. 
However, the real problem arises when these intrinsic defences and cultural measures are 
compromised by infection. Antibiotic therapy has traditionally served as the next option to 
achieve effective control of the disease. Overall benefits of antibiotic therapy include a more 
rapid elimination of bacterial pathogens than self-cure, a reduced probability of chronic recurrent 
infections, a reduced depression in milk yield, and a more rapid return to an acceptable SCC and 
hence to saleable milk (Barkema et al. 2006; Nickerson, 2009).  
 Antibiotic treatments can be administered both during lactation (lactation cow therapy) and the 
period during which the cow is dried off (dry cow therapy), via intramammary or parenteral 
means (Blowey and Edmondson, 2010). However, despite much success with antibiotics, it 
remains debatable as to whether this therapy is indeed worthwhile. There are several conflicting 
views on this (Murchan et al. 2004; Borm et al. 2006; Sandgren et al. 2008; Nickerson, 2009; 
Blowey and Edmondson, 2010; Vanderhaeghen et al. 2010), many of which revolve around S. 
aureus and its ability to develop antibiotic resistance. Of the large number of organisms that are 
able to cause bovine mastitis, S. aureus is the etiological agent most commonly associated with 
the disease (clinical, subclinical and chronic forms) (Pereira et al. 2011). However, the cure rate 
of antibiotic treatments against this pathogen is low and, therefore, the disease cannot be 
effectively eliminated and/or controlled in infected herds by using antibiotics (Sutra et al. 1993; 
Carter et al. 2003; Murchan et al. 2004; Shi et al. 2010).  
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1.6.2 Antibiotic resistance and S. aureus 
Antibiotic resistance can be attributed to several factors. S. aureus forms abscesses within the 
udder that are surrounded by a thick fibrous capsule (Almeida et al. 1996; Villar et al. 2011). 
This prevents sufficient concentrations of antibiotic from entering the abscess itself and hence 
blocks the effective destruction of viable bacteria. Some strains of S. aureus can live within cells 
such as macrophages. Most antibiotics are only able to circulate in the body fluids surrounding 
cells and cannot penetrate within cells themselves, hence these staphylococci are protected from 
the majority of antibiotics (Herbert et al. 2000; Villar et al. 2011). Many strains of S. aureus 
produce beta-lactamase, rendering them resistant to certain formulations of penicillin, in addition 
to other antibiotics that have been deemed to be more effective (such as certain aminoglycosides, 
cephalosporins and tetracyclines) (Herbert et al. 2000; Blowey and Edmondson, 2010; Cabrera et 
al. 2011).  Some strains of S. aureus can persist in a state of bacterial dormancy within a mucoid 
capsule and completely cease all replication (Blowey and Edmondson, 2010; Cabrera et al. 
2011). In this state, they are not killed by antibiotics and are able to reactivate once favourable 
conditions prevail.  
 The spread of virulent methicillin-resistant S. aureus (MRSA) (Goñi et al. 2004; Murchan et 
al. 2004; Nickerson, 2009; Shi et al. 2010; Vanderhaeghen et al. 2010), coupled with the 
development of resistance to two new antibiotics (daptomycin and linezolid) recently approved 
for clinical use against Gram-positive bacteria (Mangili et al. 2005), has shown that S. aureus is 
indeed a formidable pathogen. Antibiotic resistance is however, not exclusive to S. aureus. In the 
past three decades, we have witnessed a rise in the populations of bacteria carrying extended 
spectrum β-lactamases, which are mutants of enzymes that previously could only inactivate 
penicillins but now have gained activity against many cephalosporins too (Wright, 2010); 
plasmid-mediated (and hence horizontally transmitted) resistance to fluoroquinolone antibiotics 
(Silver, 1993); the rise of multi-drug resistant Neisseria gonorrhoeae Zopf 1885 (Tapsall, 2009); 
the emergence and global dissemination of multi-drug resistant Acinetobacter baumannii Bouvet 
and Grimont 1986, Pseudomonas aeruginosa Schröter 1872, Klebsiella pneumonia Schroeter 
1886 and Enterobacteriaceae Rahn 1937(Kumarasamy et al. 2010; Wright, 2010); and, the 
spread of extensively drug-resistant Mycobacterium tuberculosis Zopf 1883 (Wright, 2010). This 
being said however, the development of new antibiotics is still ongoing. Tigecycline, a third-
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generation, semi-synthetic tetracycline antibiotic approved in 2005, has been shown to have 
activity against MRSA when used in conjunction with rifampin (Raad et al. 2007). In addition, 
ceftobiprole, a fifth-generation cephalosporin, has shown in clinical trials, to provide significant 
control over MRSA (Zhanel et al. 2008). The core problem is that the rate of development of 
new antibiotics is unable to keep up with the pace of microbial evolution and hence resistance 
easily develops against common antibiotics. As a result, the latest antibiotics being used are 
themselves the source of the evolutionary pressure that will render them obsolete.  
 
1.6.3 Alternative therapies for mastitis 
Due to these treatment limitations, research on the control of bovine mastitis has shifted to 
alternative therapies, such as the development of vaccines (Sutra, 1993; Herbert et al. 2000; 
Pereira et al. 2011) and biological control options such as the use of botanical extracts 
(Akinyemi et al. 2005; Fawole, 2009). Vaccines for S. aureus have produced varied levels of 
success. This has been a result of the type of vaccine used, adjuvants and other factors such as 
age of the cow and environmental conditions (Hoedemaker et al. 2001, Pereira et al. 2011). A 
recent study has shown that a commercial bacterin (vaccine developed from killed bacteria) did 
not result in effective protection from new infections of S. aureus (Middleton et al. 2009). Better 
results have been obtained with a toxoid produced from three bacterial strains (with each strain 
demonstrating a different haemolysis pattern) added to the bacterin, which resulted in greater 
than 50% protection in the experimental challenge (Leitner et al. 2006; Pereira et al. 2011). 
Besides the conventional bacterins, new technologies are currently being used in the 
development of S. aureus vaccines. DNA and recombinant protein vaccines have been tested for 
the main factors of S. aureus virulence that are related to infections in the mammary gland 
(Middleton, 2008). A DNA vaccine with a booster dose of recombinant protein has proven to 
significantly increase humoral and cellular immune response and has achieved promising results 
in protecting mammary glands from new S. aureus infections (Shkreta et al. 2004). However, 
due to the wide variety of vaccines available against S. aureus and the variable clinical results 
associated with each, there remains no general consensus on which immunotherapeutic protocol 




1.7 Bacteriophages and disease control  
There remains however, a biological resource for the control of S. aureus that has not been 
thoroughly tapped. This involves the use of bacterial viruses (bacteriophages) for the biological 
control of S. aureus. Phages are ubiquitous in the environment - from the oceans, soil, deep sea 
vents, hot-springs, the water we consume and the food we eat (Kutter and Sulakvelidze, 2005; 
Miedzybrodski et al. 2005). The discovery of these organisms dates back to the early part of the 
twentieth century (Jones et al. 2007). The discoveries by Twort and d‘Herelle (1915) allowed for 
phage research to develop, such that phage therapy has been applied to different disciplines 
ranging from human and veterinary medicine to plant pathology (Sulakvelidze and Barrow, 
2005). It was initially used successfully to treat a variety of diseases ranging from dysentery, 
typhoid and paratyphoid fevers, cholera and pyogenic urinary tract infections (Hagens and 
Offerhaus, 2008).  A further facet of phage technology is that appropriate phages can control 
plant bacterial pathogens, which antibiotics do not do well. Circumstances in which phage 
therapy of plants or plant products has been attempted include control of Salmonella associated 
with fresh-cut fruit (Leverentz et al. 2001), to disinfest Streptomyces scabies Rosenbach 1884-
infected potato seed tubers (McKenna et al. 2001), against bacterial spot of mungbeans caused 
by Xanthomonas axonopodis pv. vignaeradiatae (Borah et al. 2000), against Xanthomonas pruni 
(Smith) Dowson associated with bacterial soft rot of peaches (Randhawa and Civerolo, 1986), 
against X. campestris pv. pruni (Smith) Dye infections on peach trees, cabbage and pepper 
diseases (Randhawa and Civerolo, 1986), to control Ralstonia solanacearum Smith 1896 (causal 
organism of bacterial wilt) (Fujiwara et al. 2011) and to control soft rot and fire blight associated 
with Erwinia spp. Winslow et al. 1920 (Gill and Abedon, 2009). These findings have all 
supported the further development of phage therapeutics (Table 1.3; 
http://www.phageinternational.com).  
 
1.7.1 Bacteriophage classification 
Phages have been found to infect more than 140 bacterial genera including (1) aerobes and 
anaerobes; (2) exospore and exospore formers; (3) cyanobacteria, spirochetes, mycoplasmas, 
chlamydias; (4) budding, gliding, ramified, stalked and sheathed bacteria; (5) extreme halophiles 
and methanogens; and (6) hyperthermophilic Archaea (Ackermann, 2005). Phages have been 
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found to be extremely heterogeneous in their structural, physicochemical and biological 
properties, which could suggest that they are polyphyletic in nature (Ackermann, 2005). 
However, their primary mode of action is similar. Virions differ significantly as well; occurring 
as tailed, polyhedral, filamentous or pleomorphic structures with genomic make-ups ranging 
dsDNA, ssDNA, dsRNA and ssRNA (Ackermann, 2005; 2007). By 2007, at least 5568 phages 
had been examined through electron microscopy (Table 1.4) (Ackermann, 2007). Results derived 
from genomic and morphological studies have been used to categorise phages into 1 order, 13 
families and 31 genera (Ackermann, 2005; 2007).  
 
Table 1.3 Commercial phage-based products and companies (adapted from Monk et al. (2010)). 
Product Target organism Company Country 
AgriPhage™ Xanthomonas campestris pv. vesicatoria 




BioTector Salmonella spp. in poultry CheiIJdang Corporation 
http://eng.cjcheiljedang.com/ 
China 

















ListShield™ Listeria monocytogenes in foods and 




LISTEX™ P100 Targets L. monocytogenes strains on 
food products 





blood culture test 













Differentiation of methicillin resistant 
(MRSA) and methicillin-susceptible 




Tailed phages of the order Caudovirales constitute the most extensive group of bacterial 
viruses, comprising 96% of phages identified so far (Table 1.4; Figure 1.2) (Ackermann, 2007; 
Gutiérrez et al. 2011). These phages consist of a protein shell and linear dsDNA, and lack any 
type of envelope (Ackermann, 2005; 2007). Phage heads are icosahedral and tails are true helices 
that consist of stacked discs. These tails usually possess terminal adsorption structures such as 
base plates, spikes or tail fibres (Ackermann, 2005). Although these phages constitute a 
monophyletic group possessing related properties (morphological, physicochemical, 
physiological) and have been classified into as a single order, Caudovirales, their individual 
properties are rather varied. Typically, they differ in terms of dimension and fine structure, DNA 
content and composition, nature of constitutive proteins, serology and host range (Table 1.4; 
Figure 1.2) (Ackermann, 2005). Ackermann (2005) has devised helpful criteria by which to 
distinguish between these phages:  
Myoviridae: contractile tails consisting of a sheath and central tube; approximately 25% of tailed 
phages; 
Siphoviridae: long, non-contractile tails; approximately 61% of tailed phages; and, 
Podoviridae: short, non-contractile tails; approximately 14% of tailed phages.  
The DNA composition of tailed phages generally resembles that of their specific host 
bacteria (Ackermann, 2005). Phage genomes are large, complex and usually organized into 
interchangeable modules, with genes for related functions clustered together (Ackermann, 2005; 
2007). Replicating DNA tends to form large, branched concatemers, which are then cut into unit 
lengths and inserted into preformed capsids (Ackermann, 2005). Virion assembly of individual 
components (heads, tails, tail fibres) takes places via separate pathways that form the last stage of 
the maturation process (Ackermann, 2005). Newly assembled phage particles are then liberated 
into the surrounding environment via lysis of the host bacteria (Ackermann, 2005).  
 While tailed phages do comprise the majority of bacterial viruses, tailless phages also 
occur (Table 1.4; Figure 1.2). These include only about 190 known viruses, corresponding to less 
than 4% of the currently recognised bacterial viruses (Ackermann, 2005). They are classified into 
10 small families, occur enveloped or non-enveloped, and are of three types: polyhedral phages 
that are icosahedral with cubic symmetry and either DNA or RNA constituted, filamentous 
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phages with helical symmetry that are DNA constituted, and, a few pleomorphic types without 
obvious symmetry axes that are also DNA constituted (Ackermann, 2005). 
 
Table 1.4 Overview of phage families (Ackermann, 2007). 
Shape Nucleic acid Virus group Particulars Example  









Polyhedral DNA, 1, C 
           2, C, S 
           2, L 
           2, L 
           2, C 
RNA, 1, L 









complex capsids, lipids 
inner lipid vesicle, 
pseudotail 











Filamentous DNA, 1, C 
           2, L 












Pleomorphic DNA, 2, C, S 
           2, C, S 
           2, L, S 
           2, C, S 
           2, L         
           2, C 








envelope, lipids, no capsid 
















































Figure 1.2 Morphotypes of phages (Ackermann, 2007).  
 
1.7.2. Genomic studies on S. aureus bacteriophages 
Phages have been found to play a fundamental role in the evolution of their host. Whole genome 
sequencing of bacteria has shown that phage elements contribute significantly to sequence 
diversity and can potentially influence pathogenicity (Monk et al. 2010). To date, there are 
approximately 967 phage genome sequences available in the NCBI phage database, with 
genomes ranging from 15-500kbp in size (http://www.ncbi.nlm.nih.gov). Generally, phage 
genomes are organized in modular structures with each set of modules containing a set of genes 
which carry out a biological function (O‘Flaherty et al. 2004). Phage evolution can occur by the 
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exchange of modules between phages that have access to the same gene pool (O‘Flaherty et al. 
2004).  
To date, the genomes of more than 50 S. aureus phages are currently available in public 
databases (García et al. 2009). The number of known, strictly lytic phages is limited to the close-
knit Myoviridae genus of the SPO1-like viruses which also contains phages K, Twort and G1 
(O‘Flaherty et al. 2004; García et al. 2009). Apart from this group, a large number of genomes 
from unclassified Siphoviridae in lysogenic S. aureus strains are available (Kwan et al. 2005). 
Some lysogenic phages may play an important role in the pathogenicity of S. aureus by carrying 
virulence factors, mediating lateral gene transfer and possibly facilitating adaptation of the 
pathogen during infection (Górski et al. 2009). Kwan et al. (2005) sequenced the complete 
genomes and proteomes of 27 S. aureus phages. Comparative nucleotide and protein sequence 
analysis was used to group these phages into three classes: <20kbp, ~40kbp and >125kbp. García 
et al. (2009) also presented a detailed genomic and molecular characterisation of two S. aureus 
lytic phages. Other studies conducted by various researchers also on sequence analysis of S. 
aureus phages (O‘Flaherty et al. 2004; Rashel et al. 2008; Vandersteegen et al. 2011; Gu et al. 
2012; Kwiatek et al. 2012) have provided a solid background for future comparative studies.  
 
1.7.3 Bacteriophages and their mode of action 
Phages can display one of two types of life cycle: lytic or temperate. Lytic phages bring about 
rapid lysis and death of the host bacterium whereas the temperate forms spend part of their life 
cycle in a quiescent state (prophage) (Monk et al. 2010). In this lysogenic cycle, viral DNA is 
integrated into host cell DNA. Prophage DNA will then be replicated when the host cell genome 
replicates and hence daughter cells will inherit the viral DNA (Fischetti, 2005). This temperate 
form however, has very little value in terms of phage therapy applications. During a typical lytic 
cycle, the virus attaches to the host cell via specific receptor sites that may be one of a variety of 
cell surface components including protein, oligosaccharide, teichoic acid, peptidoglycan and 
lipopolysaccharide (Monk et al. 2010). Phage genetic material is then transferred into the host 
cell and usually occurs via contraction of the virus tail and formation of a hole within the 
bacterial cell wall (Fischetti, 2005; Monk et al. 2010). The viral genome is then transcribed by 
host cell RNA polymerase, producing early mRNA that has the effect of taking over the 
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metabolic machinery of the bacterium (Monk et al. 2010). In so doing, the metabolic processes 
within the host cell are redirected towards the manufacture of new viral components which are 
then assembled into new virions (Monk et al. 2010). Following construction and assembly of the 
new virions, there remains the matter of release from the host cell. Nearly all dsDNA phages 
have developed enzymes that attack bacterial peptidoglycans (Fischetti, 2005; Monk et al. 2010). 
These muralytic enzymes (or endolysins) are produced within the cytoplasm and require another 
enzyme to enable them to cross the cytoplasmic membrane to reach their substrate. This enzyme 
is a holin that disrupts the membrane, allowing the lysin to degrade the peptidoglycan (Fischetti, 
2005). In this way, the holin controls the timing of cell lysis and the release of viral progeny.  
  This intricate cascade of events was not well understood during the early period of phage 
discovery. This lack of in-depth knowledge, coupled with the advent of antibiotics, lead to the 
early demise of phage therapy. However, the surge in antibiotic resistance and the wide pool of 
information now available on phage biology has proven pivotal in re-establishment of interest in 
phage therapy. It is easy to see why there is an increased trend towards phages as therapeutic 
agents because they offer several advantages over the use of antibiotics. Phages target only the 
pathogens of interest and the normal microflora of a system remains unaffected (Monk et al. 
2010). Their mechanism of action is completely different from all available antibiotics and they 
are effective against bacterial strains exhibiting resistance towards multiple antibiotics (Monk et 
al. 2010). As a result, even if they are not used as the first line of defence, phages represent a 
very useful last line of defence (Monk et al. 2010). Furthermore, work presented in the early 
1980‘s by Smith and Huggins (1982), demonstrated the superiority of phage treatments against 
E. coli infections in mice in comparison to antibiotics. This provided further support for the 
renewed interest in phage therapy.  
  The effects of phage therapy are all localised at the infection site whereas antibiotics do 
not necessarily concentrate at the initial site of infection (Veiga-Crespo et al. 2010). The 
pharmokinetics of phage therapy is such that the initial dose increases exponentially as the virus 
multiplies within the susceptible bacterial host and is subsequently released (Monk et al. 2010). 
Often all that is required thereafter is a ‗booster‘ dose of phage to ensure elimination of any 
residual bacterial cells. In addition, there is evidence that phages are able to penetrate poorly 
vascularised tissues and can even cross the blood-brain barrier (Alisky et al. 1998). Extensive 
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clinical experience in the former Soviet Union and Eastern Europe has revealed very few cases 
of side-effects or allergic reactions (Deresinski et al. 2008; Monk et al. 2010). It is less certain 
however, what immunological effects might arise upon multiple dosages (Deresinski et al. 2008; 
Monk et al. 2010). In spite of these positive factors however, part of the evolutionary capability 
of the target bacteria is to develop resistance to specific phages. The solution is to recognise this 
as a normal process and to put into place a phage discovery and screening system to constantly 
supply more strains of phages to replace the newly ineffective strains. This has been put into 
practise in spin-off companies from the world renowned George Eliava Institute of 
Bacteriophage, Microbiology and Virology in Georgian Republic (www.eliava-institute.org). 
Furthermore, production costs of phages are significantly lower than those associated with 
antibiotic manufacture (Veiga-Crespo et al. 2010).  
 
1.8 Bacteriophage therapy and bovine mastitis 
Considering the wealth of information at our disposal, phage therapy appears to be one of the 
most sustainable measures for control of bovine mastitis. It is essential when looking at the 
treatment of bovine mastitis with phages that one has a full grasp of the disease cycle and where 
phages occur within this cycle (Figure 1.3).  
A limited number of studies have identified various phages with lytic capabilities towards 
S. aureus (O‘Flaherty et al. 2005b; Gill et al. 2006a; García et al. 2007; García et al. 2008; 
Synott et al. 2009). In studies by Gill et al. (2006a), the effectiveness of phage therapy was 
evaluated for the control of mastitis during lactation. The study was designed to treat already 
established intramammary infections in cows housed in a commercial production environment. 
Infected cows were treated with a 5-day course of intramammary infusions with either the lytic 
phage (called Phage K) or a saline placebo. The effects of phage infusion into healthy quarters 
were also examined in order to assess the pharmacokinetics of infused phages and its impact on 
milk quality. Phage infusion was able to elicit a heightened immune response as exhibited by an 
increase in the SCC of treated udders and resulted in a cure rate of 16.7%. In addition, phages 
were detectable in milk for up to 36hrs post-infusion but at significantly lower rates, indicating 
that degradation or inactivation of the infused phage occurred within the gland. While this study 
proved that Phage K was able to control S. aureus in infected udders, several limiting factors 
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were also detected. Phage inactivation in the udder could have taken place as a result of the 























Figure 1.3 Disease cycle of bovine mastitis indicating phage occurrence. 
 
 
It has been found that whey proteins attach to S. aureus cell surfaces which inhibit phage 
binding (O‘Flaherty et al. 2005a; Gill et al. 2006b). In addition, S. aureus has been shown to 
aggregate when it is grown in milk or milk whey, which could also confer some protection for 
bacteria against phage attack (O‘Flaherty et al. 2005b). However, another study by O‘Flaherty et 
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 into live cow teats 
resulted in no detectable increase in SCC, indicating that there was no localised immune response 
to high numbers of phage. This is in stark contrast to the study by Gill et al. (2006a) where 
inflammation of the udder as a result of a high SCC was noted. In vivo studies by Wills et al. 
(2005) in rabbits, showed increased recovery of viable phage from treated animals than was 
initially administered, implying that phage multiplication occurred successfully within animal 
tissues. Capparelli et al. (2007) also tested phage against S. aureus in mice. Findings included a 
97% recovery of infected animals over a 10-day period. In addition, phage delivery into 
macrophages by S. aureus, was found to kill intracellular staphylococci both in vivo and in vitro.  
 
1.9 Conclusions and future prospects 
Phages are specific for their target bacterium and hence create no negative effects on the 
surrounding mammary tissues or the environment. This, coupled with their ability to multiply up 
to 1000-fold within a host cell, makes the phage an ideal candidate for the biocontrol of bovine 
mastitis (Blowey and Edmondson, 2010). While phages do provide solutions to bacterial 
diseases, there are still several areas of research that require further investigation. Studies into the 
detailed effects of whey proteins on bacterial activity and aggregation, proper administration of 
phage cocktails into animal tissues and the development of phage formulations to facilitate 
optimal delivery and activity within intramammary tissues, are ongoing. Further studies also 
need to be conducted on the pharmacokinetics and pharmacodynamics of these organisms in 
order to properly understand lytic events and to exploit them to their full potential. While some 
are of the opinion that phage therapy for bovine mastitis has limited potential (Johnson et al. 
2008), the advances made thus far, and the global occurrence of antibiotic resistance, has re-
opened the doorway for phage therapy.  
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Biological and pathogenicity assays of bacteriophages specific for Staphylococcus aureus 
strains, associated with bovine mastitis 
 
Abstract  
Bovine mastitis is an infectious disease of the mammary glands of dairy cattle. One of the 
primary causal agents for the disease is the bacterium, Staphylococcus aureus subsp. aureus 
Rosenbach1884. Traditional control of this organism was through the use of antibiotics. 
However, S. aureus is developing resistance towards these chemotherapeutic agents faster than 
they are being developed. Bacteriophages can serve as an alternative control measure for the 
disease. This study investigated the prevalence of phages and S. aureus in the dairy environment, 
as well as pathogenicity of phage isolates against antibiotic-resistant S. aureus. Twenty-eight 
phages were isolated and screened against four strains of antibiotic-resistant S. aureus. Only six 
phages showed potential for further testing based on their wide host range, high titres and 
common growth requirements. Optimal growth conditions for the host S. aureus strain was 37°C 









 dilution of phage stock), these phages were able to reduce live bacterial 
cell counts between 64-95%. In addition, these six phages showed further pathogenicity towards 
18 S. aureus strains that were isolated from a different milk-producing region during a farm 
survey. The phages isolated in this study show great potential for in vivo applications. However, 
lytic ability must be evaluated when the phages are exposed to elements that will be involved in 
their mass production and formulation, prior to such application.  
 
2.1 Introduction 
Bovine mastitis is an infectious inflammation or irritation of the mammary glands that interferes 
with the normal flow and quality of milk (Blowey and Edmondson, 2010). Although a range of 
control measures are used, this disease remains a major cause of economic losses in the dairy 
industry worldwide. Direct costs can be incurred through discarded milk, and drug and 
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veterinary costs, while indirect costs can be incurred through penalties as a result of increased 
somatic cell counts (SCC), decreased milk yield due to udder damage, additional labour 
requirements for treating infected cows, and higher culling and replacement costs (Blowey and 
Edmondson, 2010; Mubarack et al. 2011). In the United States alone, losses are estimated to 
approach 2 billion USD and worldwide, mastitis is associated with economic losses of up to 35 
billion USD annually (Jones and Bailey, 2009; Van den Borne, 2010; Mubarack et al. 2011).  
On average, a quarter of an udder infected with a major pathogen will yield 
approximately 30% less milk than an equivalent uninfected quarter of the same cow (Kudi et al. 
2009; Blowey and Edmondson, 2010). Infected cows are also culled more quickly, either 
because of repeated clinical infections, or reduced milk yields. In addition, mastitis has a major 
effect on the taste and quality of milk, mainly as a result of its effects on the lactose, protein and 
fat content of milk; typically affected milk is rancid and slightly salty/bitter to the taste 
(Mubarack et al. 2011). As a result of diminished milk quality, overall profitability is reduced as 
the farmer receives a lower price (up to 20% less per litre) for such milk (Mubarack et al. 2011). 
In recent years, the use of integrated control measures for the control of bovine mastitis 
has become paramount due to the onset of resistance against the antibiotics commonly used to 
treat the disease. This is particularly relevant to the primary causal bacterium of bovine mastitis, 
Staphylococcus aureus subsp. aureus Rosenbach 1884. Numerous strains have developed 
antibiotic resistance (Smith and Huggins, 1982; Borm et al. 2006; Vanderhaeghen et al. 2010), 
with the result that interest has shifted from antibiotic therapies towards the field of biological 
control of the disease.  
One such biocontrol option involves the use of lytic bacterial viruses (bacteriophages) 
that are specific to S. aureus. Phage therapy has been applied to different disciplines, ranging 
from human and veterinary medicine to agricultural settings (Soothill, 1994; Capparelli et al. 
2007; Hagens and Offerhaus, 2008). However, no single phage-based product has yet been 
commercialized for use against bovine mastitis. This is despite the clear need for a more 
sustainable control option to manage the disease. Phages have several associated benefits. They 
are specific for their target bacterium and hence create no negative effects on the surrounding 
mammary tissues or the environment. This, coupled with their ability to multiply up to 1000-fold 
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within a host cell (Blowey and Edmondson, 2010), makes the phage an ideal candidate for the 
biocontrol of bovine mastitis.  
 This study looked at the isolation of lytic anti-staphylococcal phages that were isolated 
from the local dairy environment in the province of KwaZulu-Natal (Republic of South Africa). 
These phages were further investigated for their in vitro ability to control South African strains 
of S. aureus. It is envisaged that these results will contribute towards a final goal of creating a 
phage-based biological control product to supplement current control methods for bovine 
mastitis in dairy cows.   
 
2.2 Materials and Methods 
2.2.1 Bacterial host strains and their isolation 
Four S. aureus strains were used for phage isolation and propagation, i.e., SaB1, SaB2, SaB3 and 
SaB4. Three strains (SaB1, SaB2 and SaB3) were isolated from raw bovine milk collected from 
dairy farms in the province of KwaZulu-Natal, RSA (Republic of South Africa). One strain 
(SaB4) was from the American Type Culture Collection (ATCC Strain 6538; S. aureus subsp. 
aureus Rosenbach). The milk samples from which S. aureus was isolated were selected at 
random from mastitis-affected dairy cows.   
S. aureus was initially isolated on blood agar. Cultures required for phage propagation 
were maintained on tryptone soy agar (TSA) or typtone soy broth (TSB). Identity of each 
bacterial isolate as a S. aureus strain was confirmed by hemolysis on blood agar, catalase 
reaction, Gram reaction and arrangement of bacterial cells upon Gram staining, reaction on Baird 
Parker agar (augmented with egg yellow tellurite) (www.merck.com) and coagulase reaction 
using EDTA-rabbit plasma (www.merck.com). All four strains of S. aureus were used for phage 





2.2.2 Antibiotic resistance assay of S. aureus 
The Kirby-Bauer disc diffusion method (Jorgensen and Turnidge, 2007), was used to screen the 
four S. aureus strains for resistance against a range of antibiotics applied against bovine mastitis. 
Antibiotics were selected from six major groups: β-lactam (ampicillin, penicillin G, methicillin 
and amoxycillin), macrolides (erythromycin), aminoglycosides (streptomycin), tetracyclines 
(tetracycline, oxytetracycline), glycopeptides (vancomycin), and non-β-lactam (trimethoprim). 
Antibiotic discs were used for all screening, and all assays were run on Mueller-Hinton agar 
(4mm agar thickness; pH 7.2). Four discs were used per plate and all assays were carried out in 
triplicate. Plates were incubated for 12hrs at 37ºC for all antibiotics, excluding vancomycin. 
Vancomycin plates were incubated for 24hr at 37ºC. Zones of inhibition (mm) were recorded 
after incubation. All assays were done in triplicate and standard deviations were determined 
where zones of inhibition did develop.    
 
2.2.3 Phage isolation, propagation and purification 
Raw bovine milk samples collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa) served as the initial material from which to isolate phages. These 
milk samples were chosen at random and included milk with both high (>400,000cells.ml
-1
) and 
low somatic cell counts (SCC). All milk samples were stored on ice during transit, or at 4ºC in 
the laboratory.  
Phages were isolated using the spot-test method on double-layer agar (Sambrook et al. 
1989; Harley and Prescott, 1993). Overnight S. aureus cultures, SaB1 to SaB4,  




, were incorporated into 7% top agar that was supplemented with 1M CaCl2. 
Raw milk samples were filtered through a 0.45μm syringe filter. Filtered samples were then 
spotted onto the surface of solidified top agar at 10μl per spot. Plates were allowed to dry for 2hr, 
followed by incubation for 12hr at 37ºC. Zones of clearing (plaques) were indicative of phage 
activity. Plaques were removed from top agar and soaked in phage buffer (Appendix 1) for 12hr 
with gentle agitation (150rpm) at 4ºC. The resulting suspension was centrifuged using an Avanti 
J-26 XPI (www.beckmancoulter.com) at 10,000g x 10min at 4ºC. The supernatant was filtered 
using a 0.45μm syringe filter and stored as phage stock at 4ºC. Subsequent phage was grown 
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from this stock in liquid broth culture or using the double-layer agar method (Sambrook et al. 
1989).   
Isolated phages were purified through a modification of standard methods (Sambrook et 
al. 1989; Harley and Prescott, 1993). Filter-sterilised phage stock isolated from either liquid 
broth culture or double-layer agar method, were subjected to centrifugation using an Avanti J-26 
XPI (Beckman-Coulter)
1
 at 75,600g x 3hrs x 10ºC. Resulting phage pellets were re-suspended in 
fresh phage buffer and a second centrifugation was conducted (Avanti J-26 XPI (Beckman-
Coulter) at 75,600g x 3hrs x 10ºC). The phage pellets were then re-suspended in fresh phage 
buffer at 1/10 of the original volume that was processed. All stocks were stored at 4ºC.  
A total 28 phages were isolated however, only six showed consistency with regard to host 
cell lysis and growth requirements. These six phages were used for subsequent screening and 
were named Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6. Multiplicity of 
infection (MOI) was calculated for each phage.  
 
2.2.4 Phage titre 




) was made up for each of Sabp-P1-Sabp-P6. The standard double-
layer plating method as described by Sambrook et al. (1989) was followed. All six phages were 
titred against all four bacterial cultures. Plates were incubated for 12hr at 37ºC. Plaques were 





) = number of plaques x reciprocal of dilution x dilution factor (Sambrook et 
al. 1989).   
 
2.2.5 Phage host range analysis 
Host range analysis was carried out using the spot-test method (Harley and Prescott, 1993). An 
overnight culture of each S. aureus (SaB1 to SaB4) was made up on TSA plates. Colonies were 
scraped off the TSA and re-suspended in 0.9% saline. Bacterial suspension (+ 1M CaCl2) was 
incorporated into pre-warmed top agar (0.7%). Top agar was immediately poured into previously 
prepared bottom layer agar. Plates were left to dry for 1hr. Undiluted phage stock of Sabp-P1 to 
Sabp-P6, were screened against SaB1-SaB4 by spotting 10µl droplets of each phage onto the 
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surface of a prepared double-layer plate inoculated with S. aureus. All plating was carried out in 
triplicate. The plates were left to dry for 2hr followed by incubation for 12hr at 37ºC. The control 
treatments consisted of sterile phage buffer that was spotted onto individual lawns of SaB1 to 
SaB4. After overnight incubation, any plates exhibiting zones of clearing were regarded as a 
positive result.   
 





 dilution of each phage was used to determine the single step growth curve as 
this dilution produced the most distinctive number of plaques without ―webbing‖ of the plaques.    
Only S. aureus, SaB1, was used for this assay. The protocol was carried out according to Harley 
and Prescott (1993). Phage starting solution (10
-5
) was made up in 9.9ml TSB. Then 100µl of 
overnight SaB1 (+ 1M CaCl2) was added to the phage dilution and the mixture was incubated at 
37ºC with gentle agitation (150rpm). This was recorded as Time Zero. When 19 minutes had 
elapsed, 100µl phage suspension was aliquoted onto pre-warmed top-layer agar. This was 
followed by the addition of 100µl overnight SaB1 culture to the same top-layer agar. The top-
layer agar was immediately poured onto previously prepared bottom-layer agar. The plate was 
left to dry for 2hr, followed by incubation for 12hr at 37ºC. This process was repeated for the 
following intervals: 25min, 30min, 35min, 40min, 45min, 50min, 55min and 60min. The control 
treatment consisted of 100µl SaB1 + 100µl phage buffer (+ 1M CaCl2). Plaques were counted on 
each plate after 12hr incubation.   
 
2.2.7 Lethal dose assay 




 dilution. SaB1 
cultures were grown in six different batches in TSB with 12hr incubation at 37ºC. Bacterial cell 
counts were determined after overnight incubation using dilution plating. Thereafter, each batch 
was inoculated with each phage. Final reaction mixtures each consisted of 50ml SaB1 + 5ml 
phage (+ 1M CaCl2). Inoculated cultures were incubated for 12hr at 37ºC. After 12hr incubation, 




2.2.8 Farm survey 
A preliminary survey looking at the prevalence of S. aureus and its associated phages within a 
commercial dairy setting was carried out. This survey was primarily conducted in order to assess 
the bacteria: phage dynamics in an in vivo system, and to investigate the prevalence of phages, 
even if the host bacterium is absent. The dairy was located in the Karkloof Valley, KwaZulu-
Natal, Republic of South Africa. Sampling was carried out twice. Composite milk samples were 
drawn from cows with a high somatic cell count (>400,000cells.ml
-1
). Milk samples were 
screened for the presence of S. aureus using hemolysis plating, catalase testing and Gram 
reaction. Milk was screened for phages using the spot-test method. S. aureus, SaB1, was used as 
the host organism. In addition, phages Sabp-P1 to Sabp-P6 were screened for virulence against 
the fresh S. aureus cultures that were isolated from the raw milk. The spot-test method was used 
to determine susceptibility of each S. aureus strain to each phage isolate.     
 
2.2.9 Statistical analyses 
Differences between treatments were determined by analysis of variance (ANOVA) using 
Genstat 14
th
 Edition. Fisher‘s least significant difference test (LSD), F-value and coefficient of 




2.3.1 S. aureus isolation and screening 
Hemolysis patterns on blood agar, catalase reactions using hydrogen peroxide (5%),  Gram 
reaction, coagulase tests and colony formation on Baird-Parker agar (amended with egg yellow 
tellurite) were sufficient to distinguish S. aureus cultures from other bacteria in milk samples 




2.3.2 Phage isolation  
Of the 28 phages that were isolated, only six showed consistency with regard to lysis of all four 
strains of S. aureus (SaB1 to SaB4), and under similar growth conditions, i.e., 10-12hr incubation 
period at 37ºC. Of the 22 phages that were not selected, 13 showed variable lytic ability towards 
the bacterial hosts; this was in terms of time to lyse cells and efficiency of lysis. Furthermore, the 
remaining 9 phages became lysogenic after multiple culturing. The six phages that showed 
enhanced activity in comparison to the other 22, were used for subsequent screening: phage titre, 
host range analysis, single step growth curves, lethal dose assay and the farm survey. These six 
phages were named: Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6 
 
2.3.3 Phage titre 
Phages Sabp-P1, Sabp-P2 and Sabp-P3 appeared to be highly virulent and produced higher 
plaque counts than Sabp-P4, Sabp-P5 or Sabp-P6.  Plaque counts were most accurate when 




. At this dilution, plaques were 
distinct and there was no ―webbing‖ or adjoining of neighbouring plaques (Figure 2, 
Appendix1). This dilution was used for all subsequent screening. Phages Sabp-P1, Sabp-P2 and 








, respectively. Phages Sabp-









Phage MOI was determined for each phage: Sabp-P1=3, Sabp-P2=3, Sabp-P3=3, Sabp-P4=0.2, 
Sabp-P5=0.1 and Sabp-P6=0.2. 
 
2.3.4 Phage host range analysis and antibiotic resistance 
SaB1, SaB2 and SaB3 isolated from different regions of the major milk-producing areas in 
KwaZulu-Natal showed susceptibility to lysis by all 28 phages that were isolated. The 
commercial S. aureus strain (SaB4), ATCC 6538, showed susceptibility to only 22 of the isolated 
phages. As a result, the six most effective phages were selected for all further screening. 
Selection criteria were primarily based on time to reach optimal titre and ability to lyse all four 
bacterial hosts, within a 12hr incubation period.  
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Coupled to the phage host range assay, an antibiotic resistance assay was carried out 
where the same four bacterial strains were screened against the major chemotherapeutic agents 
used in vivo. These bacterial strains were found to be resistant to the most commonly applied 
antibiotics used in the dairy industry (Table 2.1). However, all four bacterial strains showed 
susceptibility towards antibiotics in the tetracycline group, i.e., tetracycline and oxytetracycline.   
 
Table 2.1 Antibiotic resistance screening of S. aureus strains, SaB1, SaB2, SaB3 and SaB4. 
Antibiotics   Average zone of inhibition (mm) 
Group Antibiotic Abbr. SaB1 SaB2 SaB3 SaB4 
β-lactamase ampicillin AMP5 nz nz nz nz 
 penicillin G P10 nz nz nz nz 
 methicillin Met10 nz nz nz nz 
 amoxycillin/flucloxacillin A/F nz nz nz nz 
Macrolides erythromycin E5 nz nz nz nz 
Aminoglycosides streptomycin S25 nz nz nz nz 
Tetracyclines Tetracycline
* 
TE10 11.6 16.7 11.4 6.7 
 Oxytetracycline
** 
OB 25 13 6.7 7.6 
Glycopeptides vancomycin Vc nz nz nz nz 
Non- β-lactamase trimethoprim Tr nz nz nz nz 
 nz = no zone of inhibition;*Standard deviation SaB1=0.29, SaB2=0.29; SaB3=0.29; SaB4=0.29; **Standard deviation SaB1=0.5, 
SaB2=0.61, SaB3=0.21, SaB4=0.25.  
 
2.3.5 Single step growth curve 
The single step growth curve for phages, Sabp-P1 to Sabp-P6, is presented in Figure 2.1 (Table 
1, Appendix 1); SaB1 was used as the host bacterium. ANOVA showed highly significant 
(p<0.001) differences between the activity of each phage over the duration of the growth cycle. 
Sabp-P1 to Sabp-P3 showed a significant (p<0.001) increase in phage multiplication and entered 
the exponential phase of growth after 40-50min of incubation. Sabp-P4, Sabp-P5 and Sabp-P6 do 
not exhibit a clear exponential phase throughout their growth cycle. Phage counts at the 
exponential phase (40-50min) for Sabp-P1, Sabp-P2 and Sabp-P3 were not statistically different 







































six phages entered a  phase with limited replication from 50min onwards. In general, Sabp-P4, 
















Figure 2.1 Infection curve for S. aureus phages. Data points are the means of three independent 
experiments. The vertical bar represents the LSD (0.05) when comparing any phage count x time 
combination.  
2.3.6 Lethal dose assay  
The lethal dose assay was carried out to investigate phage efficacy in reducing live bacterial cell 
counts after incubation for 12hr. Phages Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and 
Sabp-P6 were tested against S. aureus strain, SaB1. ANOVA showed highly significant 
(p<0.001) differences in bacterial cell counts when SaB1 was inoculated with phages in 
comparison to un-inoculated SaB1. Live cell counts decreased significantly upon introduction of 
phages into the bacterial culture (Figure 2.2; Table 2 in Appendix 1). No significant differences 


































difference was noted between lytic activity of Sabp-P4, Sabp-P5 and Sabp-P6. However, 
significant (p<0.001) differences were apparent in lytic activity between the two groups of 
phages, i.e., Sabp-P1, Sabp-P2 and Sabp-P3 compared to Sabp-P4, Sabp-P5 and Sabp-P6. 
Phages Sabp-P1, Sabp-P2 and Sabp-P3 were able to reduce live bacterial cell count up to 95.32% 
(Table 2.2). Phages Sabp-P4, Sabp-P5 and Sabp-P6 performed poorly, with reductions ranging 



















Figure 2.2 Lethal dose assay showing S. aureus (SaB1) growth with and without addition of 
phages. Each bar represents the means of three independent experiments. The vertical bar represents the LSD (0.05) 













Table 2.2 Reduction in live bacterial cell count after addition of phages to bacterial cultures 














2.3.7 Farm survey 
Results of the farm survey differed significantly in terms of bacterial species and number of 
phages that were isolated between each sampling (Table 2.3). Although the cows SCC values 
were high (>400,000 cells.ml
-1
), a great percentage of samples showed zero bacterial growth 
(Table 2.3) even after 24hr incubation at 37ºC. In Sampling 1, 80% of the samples tested positive 
for presence of phage. In Sampling 2, 71% of the samples tested positive for presence of phage. 
S. aureus was only present in 13.33% and 17.31% of the milk samples in Sampling 1 and 
Sampling 2, respectively.  
Phage activity of Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6 was also 
tested against the S. aureus strains isolated from both samplings. Of the two S. aureus strains 
isolated from Sampling 1, only one showed susceptibility to all six phages; the other showed 
susceptibility to only Sabp-P1, Sabp-P2, Sabp-P4, and Sabp-P5. From Sampling 2, where 21 S. 
aureus strains were isolated, 18 showed susceptibility to all six phages. Three strains showed 
resistance to all six phages.  
 
 













Table 2.3 Prevalence of bacterial species in raw milk, drawn from cows with a high (>400,000 
cells.ml
-1
) somatic cell count.  
 Prevalence of bacteria 
Bacterial species Sampling 1 (%) Sampling 2 (%) 
Staphylococcous aureus 13.33 17.31 
Streptococcus agalactiae 6.67 5.77 
Coliform bacteria 20.00 1.92 
Micrococcus spp. 26.67 13.46 
Bacilliform bacteria 0 1.92 
Zero bacteria 33.33 59.62 
% of samples that contained phages 80 71 
 
2.4 Discussion 
Phages have potential as biological control agents of S. aureus. The ubiquity of phages in any 
environment, their ability to replicate exponentially within their hosts and their specificity, make 
them ideal candidates for more sustainable mastitis control. In particular, the results of the 
current study demonstrate the potential of South African phage isolates for biological control of 
bovine mastitis. The six phages that were screened showed pathogenicity towards 18 S. aureus 
strains that were isolated from different milk-producing regions. Additionally, phages were 
readily isolated from raw milk from different geographical locations. It is this ubiquity that 
distinguishes phage potential for disease control from other measures.  
Farmers today are frequently faced with the problem of antibiotic resistance, which 
essentially breeds a ―super-parasite‖ that cannot be controlled using conventional antibiotics. 
This resistance can be attributed to several factors. S. aureus has the ability to form abscesses 
within the udder that are surrounded by thick fibrous tissue (Almeida et al. 1996; Villar et al. 
2011). This fibrous layer inhibits translocation of antibiotics into the abscess, thereby preventing 
destruction of bacterial cells.  In addition, some strains of S. aureus can survive within animal 
cells as macrophages (Herbert et al. 2000; Villar et al. 2011). Most antibiotics do not have the 
ability to penetrate within cells themselves, hence these staphylococci remain protected and 
infectious. Many strains of S. aureus produce beta-lactamase which confers resistance to certain 
formulations of penicillin, in addition to other antibiotics that have been deemed more effective 
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(such as certain aminoglycosides, cephalosporins and tetracyclines) (Herbert et al. 2000; Blowey 
and Edmondson, 2010; Cabrera et al. 2011).  Some strains of S. aureus can persist in a state of 
bacterial dormancy with a mucoid capsule and completely cease all replication (Blowey and 
Edmondson, 2010; Cabrera et al. 2011). In this state, they are not killed by antibiotics and are 
able to reactivate once favourable conditions prevail.  
The current study also identified a significant drawback in the application of SCC to 
identify mastitic cows. While SCC is an accurate estimate of the white blood cell count in raw 
milk, it does not necessarily imply that that milk has a high bacterial cell count, or that the cow 
requires antibiotic treatment. When faced with a high SCC, farmers are encouraged to treat those 
affected animals with antibiotics. Over time, this misuse could potentially lead to selection for 
resistance in bacteria that occur within the dairy system.    
 Antibiotic resistance is however, not exclusive to S. aureus. In the past three decades, we 
have witnessed a rise in bacteria carrying extended spectrum β-lactamases, which are mutants of 
enzymes that previously could only inactivate penicillins but now have gained activity against 
many cephalosporins too (Wright, 2010); plasmid-mediated (and hence horizontally transmitted) 
resistance to fluoroquinolone antibiotics (Silver, 1993); the rise of multi-drug resistant Neisseria 
gonorrhoeae (Tapsall, 2009); the emergence and global dissemination of multi-drug resistant 
Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae and 
Enterobacteriaceae (Kumarasamy et al. 2010; Wright, 2010); and the spread of extensively 
drug-resistant Mycobacterium tuberculosis (Wright, 2010). This being said however, the 
development of new antibiotics is ongoing. Tigecycline, a third-generation, semi-synthetic 
tetracycline antibiotic approved in 2005, has been shown to have activity against MRSA when 
used in conjunction with rifampin (Raad et al. 2007). In addition, ceftobiprole, a fifth-generation 
cephalosporin, has shown in clinical trials to provide significant control over MRSA (Zhanel et 
al. 2008). The core problem is that the rate of development of new antibiotics is unable to keep 
up with the pace of microbial evolution for antibiotic resistance. As a result, the newest 
antibiotics being used are themselves the source of the evolutionary pressure that will render 
them obsolete.  
Development of phages as a biocontrol option could obviate this problem. Their ubiquity 
implies a readily available source of control agents should bacterial hosts overcome the control 
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provided by already developed phages. Their mode of attachment and replication (Kutter and 
Sulakvelidze, 2005) means that they need not permeate the bacterial cell wall in the way that an 
antibiotic would. As a result, they are able to readily inject their DNA into bacterial hosts. 
Furthermore, the exponential rate at which phages are able to multiply within a bacterial cell, 
while simultaneously killing the target host, is an added benefit. Phage specificity is also a 
significant advantage. Target bacteria are lysed by their appropriate phages, while other 
commensal (or non-target) organisms remain unaffected. Studies have shown that production 
costs for commercial phages are significantly lower than those associated with development of 
new antibiotics or vaccines (Gill et al. 2007; Veiga-Crespo et al. 2010).   
 
2.5 Conclusion 
Of the six phages screened in this study, three have shown significant potential for further 
development. It is essential that these phages undergo further screening in order to classify them 
into appropriate taxonomic groups. Lytic ability must also be evaluated when the phages are 
exposed to elements that will be involved in their mass production, formulation and final in vivo 
application. With the onset of antibiotic resistance amongst South African dairy cattle, it is also 
essential that diagnostic methods evolve in order to include accurate bacterial cell counts in raw 
milk, and not just white blood cells. These results have shown that phages are already abundant 
in the dairy environment. The next step that remains is to develop this resource and make it 
readily available as a supplementary treatment for affected dairy cattle.  
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Stress sensitivity assays of bacteriophages associated with Staphylococcus aureus, causal 
organism of bovine mastitis 
Abstract 
Bacteriophages can provide an alternative measure for the control of Staphylococcus aureus, the 
major causal agent for bovine mastitis. This study looked at the sensitivity of six phages towards 
simulated environmental and formulation stresses. Phages Sabp-P1, Sabp-P2 and Sabp-P3 
showed the most stable replication rates at increasing temperatures (45-70ºC), in comparison to 
phages Sabp-P4, Sabp-P5 and Sabp-P6. The effect of temperature on storage of phages showed 
that 4ºC was the minimum temperature at which phages could be stored without a significant 
reduction in their lytic and replication abilities. Furthermore, all phages showed varying levels of 
sensitivity to chloroform exposure, with Sabp-P5 exhibiting the highest level of reduction in 
activity (74.23%) in comparison to the other phages. All six phages showed optimal lytic ability 
at pH 6-7 and reduced activity at any pH above or below pH 6-7. Exposure of phages to varying 
glycerol concentrations (5-100%) produced variable results. All six phages were most stable at a 
glycerol concentration between 10-15%. Three of the six isolated phages, Sabp-P1, Sabp-P2 and 
Sabp-P3, performed optimally during the in vitro assays and have considerable potential for in 
vivo applications to treat mastitis-infected dairy cattle.  
 
3.1 Introduction 
Staphylococcus aureus-induced bovine mastitis in dairy herds is one of the most widespread and 
destructive diseases of dairy cows. It has far reaching consequences that affect milk quality and 
yield, health of the dairy cow, and the economics associated with the processing of milk and milk 
products. Under optimal conditions, the natural defence mechanisms of the cow itself, in 
conjunction with cultural control measures, may prove adequate in curbing disease onset and 
severity. However, the real problem arises when these intrinsic defences and cultural measures 
are compromised by infection. Antibiotic therapy has traditionally served as the next option to 
achieve effective control of the disease. Overall benefits of antibiotic therapy include a more 
rapid elimination of bacterial pathogens than self-cure, a reduced probability of chronic recurrent 
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infections, a reduced depression in milk yield and a more rapid return to an acceptable somatic 
cell count and hence to saleable milk (Barkema et al. 2006; Nickerson, 2009).  
 Despite the documented success associated with antibiotic usage, it remains debatable as 
to whether this therapy is indeed positive in the long term. There are several conflicting views on 
this (Murchan et al. 2004; Borm et al. 2006; Sandgren et al. 2008; Nickerson, 2009; Blowey and 
Edmondson, 2010; Vanderhaeghen et al. 2010), many of which revolve around S. aureus and its 
ability to develop antibiotic resistance. In the long term, the cure rate of antibiotic treatments 
against this pathogen is low and, therefore, the disease cannot be effectively eliminated and/or 
controlled in infected herds by using antibiotics alone (Sutra et al. 1993; Carter et al. 2003; 
Murchan et al. 2004; Shi et al. 2010). 
Antibiotic resistance can be attributed to several factors, ranging from structural features 
that protect the bacterium, to production of chemicals that can neutralise antibiotics (Almeida et 
al. 1996; Herbert et al. 2000; Blowey and Edmondson, 2010; Cabrera et al. 2011; Villar et al. 
2011). The spread of virulent methicillin-resistant S. aureus (MRSA) (Goñi et al. 2004; Murchan 
et al. 2004; Nickerson, 2009; Shi et al. 2010; Vanderhaeghen et al. 2010), coupled with the 
development of resistance to two new antibiotics (daptomycin and linezolid) recently approved 
for clinical use against Gram-positive bacteria (Mangili et al. 2005), has shown that S. aureus is 
indeed a formidable pathogen. 
Due to these treatment limitations, research focus into the control of bovine mastitis has 
shifted to alternative therapies, such as the development of vaccines (Sutra, 1993; Herbert et al. 
2000; Pereira et al. 2011) and biological control options, such as the use of botanical extracts 
(Akinyemi et al. 2005; Fawole, 2009) or phage therapy (O‘Flaherty et al. 2005b; Sulakvelidze 
and Barrow, 2005; Gill et al. 2006a; García et al. 2007; Jones et al. 2007; García et al. 2008; 
Synott et al. 2009). Considering the wealth of information at our disposal, phage therapy appears 
to be one of the most sustainable measures for control of bovine mastitis. Several studies have 
identified various phages with lytic capabilities towards S. aureus (O‘Flaherty et al. 2005a; Gill 
et al. 2006a; García et al. 2007; García et al. 2008; Synott et al. 2009). While each study did 
present noteworthy results, it must be noted that there are limitations which must be overcome. 
Phage inactivation  can be triggered by milk proteins and fats (O‘Flaherty et al. 2005b; Gill et al. 
2006b), aggregation of S. aureus cells within milk (O‘Flaherty et al. 2005b), and intrinsic 
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immune factors within the cow itself (O‘Flaherty et al. 2005a).  While these limitations do exist, 
the solutions to these problems are merely a product of time. Further studies into the detailed 
effects of whey proteins on bacterial activity and aggregation, proper delivery of phage cocktails 
into animal tissues, and the development of phage formulations to facilitate optimal delivery and 
activity within intramammary tissues, are ongoing. 
The primary focus of the current study was to investigate phage sensitivity, in vitro, 
towards simulated environmental and chemical stresses. This study aimed to contribute to phage 
formulations for in vivo application.  
 
3.2 Materials and Methods 
3.2.1 Bacterial host strains and their isolation 
Strain SaB1 of S. aureus was used for phage isolation and propagation. This strain was isolated 
from raw bovine milk collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa). SaB1 was initially isolated on blood agar. Cultures required for 
phage propagation were maintained on tryptone soy agar (TSA) or typtone soy broth (TSB). 
  
3.2.2 Phage isolation, propagation and purification 
Raw bovine milk samples collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa) served as the initial material from which to isolate phages. These 
milk samples were stored at 4ºC. Phages were isolated using the spot-plate method on double-





) were incorporated into 7% top agar that was supplemented with 1M CaCl2. Raw milk 
samples were filtered through a 0.45μm syringe filter. Filtered samples were then spotted onto 
the surface of the solidified top agar at 10μl per spot. Plates were allowed to dry for 2hr, 
followed by incubation for 12hr at 37ºC. Zones of clearing (plaques) were indicative of phage 
activity. Plaques were removed from top agar and soaked in phage buffer (Appendix 1) for 12hr 
with gentle agitation (150rpm) at 4ºC. The resulting suspension was centrifuged using an Avanti 
J-26 XPI (www.beckmancoulter.com) at 10,000g x 10min at 4ºC. The supernatant was filtered 
using a 0.45μm syringe filter and stored as phage stock at 4ºC. Subsequent phage was grown 
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from this stock in liquid broth culture or using the double-layer agar method (Sambrook et al. 
1989).   
Isolated phages were purified through a modification of standard methods (Sambrook et 
al. 1989; Harley and Prescott, 1993). Filter-sterilised phage stock isolated from either liquid 
broth culture or double-layer agar method, were subjected to centrifugation using the Avanti J-26 
XPI (Beckman-Coulter) at 75,600g x 3hrs x 10ºC. The resulting phage pellets were re-suspended 
in fresh phage buffer and a second centrifugation was conducted (Avanti J-26 XPI (Beckman-
Coulter) at 75,600g x 3hrs x 10ºC). The phage pellets were then re-suspended in fresh phage 
buffer at 1/10 of the original volume that was processed. All stocks were stored at 4ºC. Six 
phages were isolated and named Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6. 
Multiplicity of infection (MOI) was calculated for each phage. Phage MOI was determined for 
each phage: Sabp-P1=3, Sabp-P2=3, Sabp-P3=3, Sabp-P4=0.2, Sabp-P5=0.1 and Sabp-P6=0.2. 
 
3.2.3 Temperature sensitivity 
a. Heat sensitivity 





 were prepared for each phage for this assay. Phage dilutions were 
carried out in phage buffer. Diluted phages, Sabp-P1 to Sabp-P6, were placed into a water-bath 
at 45°C. 100µl aliquots were removed at each of the following time intervals: 0min (control), 
5min, 10min, 20min, 30min, 40min, 50min and 60min. Each aliquot was plated using the 
double-layer plating technique (Sambrook et al. 1989), with an overnight culture of SaB1 as the 
host bacterium. The experiment was repeated for temperatures 50°C, 55°C, 60°C, 65°C and 
70°C. Phage diluted in phage buffer was used as a control. All plates were incubated at 37°C for 
12hr. After 12hr, the number of plaques was counted and phage titre was calculated for each time 
and its associated temperature. All assays were carried out in duplicate.     
 
b. Cold sensitivity (storage feasibility of phages) 
This assay was conducted in order to see the opposite effects of heat treatment on phages and to 




 were prepared for 
each phage. Phage dilutions were carried out in phage buffer. This experiment was ongoing over 
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a period of 6mo. Overnight SaB1 was used as the host bacterium. Phages Sabp-P1 to Sabp-P6 
were screened for stability at various storage temperatures, i.e., 4°C, -20°C and -80°C, with 
different durations at each temperature, i.e., 1hr, 8hr, 12hr, 1wk, 2wk, 3mo and 6mo. All phages 
were stored in sterile phage buffer (supplemented with 5% glycerol) for the duration of the 
experiment. At the end of each storage duration, at each temperature, a 100µl aliquot of phage 
was removed and immediately plated using the double-layer plating technique. An overnight 
culture of SaB1 was used as the host bacterium, hence final reaction contained 100µl phage + 
100µl SaB1 (+ 1M CaCl2). This was followed by double-layer plating as previously described 
(Sambrook et al. 1989).  Fresh phage diluted in phage buffer was used as a control. Plates were 
incubated for 12hr at 37°C. The total number of plaques was counted and phage titre was 
calculated for each phage, at each time and at each associated temperature. The same phage 
sample was stored and screened for the entire duration of the experiment (6mo). All assays were 
carried out in triplicate.     
 
3.2.4 pH sensitivity  
This method is a modification of that described by Harley and Prescott (1993). TSB was 
calibrated according to the following pH range: 2, 4, 6, 8, 10, 12 and 14, and 900µl of each was 
aliquoted into 2ml Eppendorf vials. Phage stock was added to the calibrated TSB to bring the 
































P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6 respectively. The vials were gently inverted in 
order to mix the phage within the TSB medium. All vials were left to stand at room temperature 
(22°C) for 60min. At 60min, 100µl of phage suspension was removed and mixed with 100µl of 
an overnight SaB1 culture (+ 1M CaCl2). This was followed by double-layer plating as 
previously described (Sambrook et al. 1989). Phage diluted in phage buffer was used as a 
control.  All plates were incubated at 37°C for 12hr. After 12hr, the number of plaques was 
counted and phage titre was calculated for each pH.  All assays were carried out in triplicate.     
 
3.2.5 Chloroform sensitivity 
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This method is a modification of that described by Harley and Prescott (1993). Optimal phage 
dilutions of 10
-5
 pfu/ml were prepared for each phage. Phage dilutions were carried out in phage 
buffer (Appendix 1). Overnight SaB1 was used as the host bacterium. 1ml each, of phages Sabp-
P1 to Sabp-P6, were treated with 5% (v/v) chloroform. This suspension was gently shaken 
(100rpm) at room temperature (22°C) for 15min, followed by centrifugation at 10,000g x 10min 
at 4°C. The aqueous phase was withdrawn and phages were titred using standard double-layer 
plating. Phage diluted in phage buffer was used as the control. All plates were incubated at 37°C 
for 12hr. After 12hr, the number of plaques was counted and phage titre was calculated. All 
assays were carried out in triplicate.     
 
3.2.6 Glycerol sensitivity  





prepared for each phage. Phage dilutions were carried out in phage buffer. Overnight SaB1 was 
used as the host bacterium. Glycerol was made up in sterile distilled water at the following 
concentrations (v/v): 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% and 100%.  Phage 
stock was added to the 900µl of each glycerol solution to bring the final phage dilution to10
-5 
pfu/ml. This was left at room temperature (22°C) for 1hr. Incubation was followed by standard 
double-plating and incubation of all plates at 37°C for 12hr. After incubation, the number of 
plaques was counted and phage titre was calculated. Phage diluted in phage buffer was used as a 
control. All assays were carried out in triplicate.     
 
3.2.7 Statistical analyses 
Differences between treatments were determined by analysis of variance (ANOVA) using 
Genstat 14
th
 Edition.  
 
3.3 Results 
3.3.1 Heat assay 
ANOVA of the phage titres showed highly significant (p<0.001) differences for phage titers at 
different temperatures, and a highly significant phage x temperature x exposure time interaction. 
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It was found that an increase in temperature, coupled with increased exposure time to that 
temperature, reduced phage reproductive activity (Figure 3.1; Table 1 in Appendix 3).  
Phage counts dropped significantly from 0min exposure to high temperature, to 10min 
exposure to the same temperature (across the complete temperature range of 45-70ºC). After 
10min, phage reproductive activity stabilised across all temperature ranges, but remained low 
(Figure 3.1). Significant differences were noted between phage activity at each temperature and 
exposure time (<0.001), as well as between each phage itself (<0.001). In general, Sabp-P1, 
Sabp-P2 and Sabp-P3 were more stable, and titers remained higher than those for Sabp-P4, Sabp-
P5 and Sabp-P6.  Exposure to 70°C was the most damaging with a 92-96% reduction in phage 
titers. Overall results show that propagation of these phages is negatively affected by increased 
exposure to high temperatures.   
 
3.3.2 Cold assay (storage feasibility of phages)  
Storage temperature played an important role in influencing phage titre. ANOVA showed highly 
significant differences (p<0.001) in phage counts when the phages were stored at different 
temperatures for different durations (Figure 3.2; Table 2 in Appendix 3). Storage of phages at 
temperatures below 4°C reduced phage activity significantly. Sabp-P1, Sabp-P2 and Sabp-P3 
displayed more stability at all three temperature ranges (4°C, -20°C, -80°C), although phage titre 
did decrease significantly at -80°C. The titres for the other three phages Sabp-P4, Sabp-P5 and 
Sabp-P6, were generally low throughout these studies. However, these three phages showed 
stability during storage at all durations and temperatures. While the study did not proceed 
beyond a screening period of 6mo, it appears that the optimal storage temperature for the isolated 































































































































Figure 3.1 Heat assay screening the titres of six phages over a range of different temperatures.  SaB1 was 
used as the host bacterium for phage propagation; Data points are the means of two independent experiments. 


































































































































































































































Figure 3.2 Screening the storage ability of six phages over a range of low temperatures. SaB1 was used as 
the host bacterium for phage propagation.Each bar represents the means of three independent experiments. The 




































3.3.3 Chloroform Assay 
Chloroform exposure imposed negative effects on phage titers (Figure 3.3). ANOVA showed 
that significant (p<0.001) differences occurred between the titers of Sabp-P1, Sabp-P2 and Sabp-
P3 in comparison to phages Sabp-P4, Sabp-P5 and Sabp-P6. Sabp-P1, Sabp-P2 and Sabp-P3 
appeared more stable and titres did not reduce as significantly upon exposure to chloroform, as 
they did for Sabp-P4 and Sabp-P5. Sabp-P6 showed the most stability over time upon exposure 














Figure 3.3 Effect of chloroform on phage titers. SaB1 was used as the host bacterium for phage 
propagation.  
Each bar represents the means of three independent experiments. The vertical bar represents the LSD (0.05)=9.5E+07 
























3.3.4 pH assay 
All of the screened phages (Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5, Sabp-P6) showed 
sensitivity to changes in the pH of the surrounding growth media (Figure 3.4). ANOVA showed 
significant differences (p<0.001) in activity between phages as pH increased, as well as 
significant difference in interactions between the phages themselves. Sabp-P1, Sabp-P2 and 
Sabp-P3 showed the highest increase in phage titer between pH 6-7. Thereafter, a sharp decline 
in phage titre was noted from pH 7.2-12. Phages, Sabp-P4, Sabp-P5 and Sabp-P6, showed a 
similar pattern.. However, titres were significantly lower from those of Sabp-P1, Sabp-P2 and 
Sabp-P3. There was no significant difference in activity between Sabp-P1, Sabp-P2 and Sabp-
P3, or, between activity of Sabp-P4, Sabp-P5 and Sabp-P6. However, each group differed 


































































Figure 3.4 Effect of increasing pH on the titers of six phages. SaB1 was used as the host bacterium for 
phage propagation. Data points are the means of three independent experiments. The vertical bar represents the 
LSD (0.05) when comparing any phage x pH combination.  
 
3.3.5 Glycerol Assay 
A general trend of reduced phage activity was observed with an increasing concentration of 
glycerol (Figure 3.5). ANOVA showed significant differences (p<0.001) in activity between 
phages as glycerol concentrations increased from 5-100%. Phages Sabp-P2 and Sabp-P3 are 
stable and able to replicate up to a glycerol concentration of 25%. Thereafter, titres dropped 
significantly and no further increase was noted. Phages Sabp-P1, Sabp-P4, Sabp-P5 and Sabp-P6 
showed a dramatic decline in titre as glycerol concentration increased from 10% upwards. This 
differed significantly from the activity of Sabp-P2 and Sabp-P3 (<0.001). Exposure of the 
selected phages to high concentrations of glycerol resulted in a dramatic decrease in titre that 
















































Figure 3.5 Effects of increasing glycerol concentration on phage titers. SaB1 was used as the host 
bacterium for phage propagation. Data points are the means of three independent experiments. The vertical bar 
represents the LSD (0.05) when comparing any phage x glycerol % combination.  
 











Reduction in phage activity 
(%) 
Range of increase in glycerol 
concentration that limits phage growth 
Sabp-P1 89.94 10-100% 
Sabp-P2 71.36 25-100% 
Sabp-P3 52.68 25-100% 
Sabp-P4 87.05 10-100% 
Sabp-P5 87.5 10-100% 
Sabp-P6 94.69 10-100% 
Mean 80.54  
LSD 7.01  




The onset of antibiotic resistance in S. aureus and its implications for the treatment of bovine 
mastitis have raised awareness of the need for alternative control therapies. Phages provide such 
an alternative. However, associated with this therapy are several challenges, particularly in terms 
of developing stable formulations and optimizing storage and in vivo application of phage 
products. The primary objective of the current study was to evaluate phage titers upon exposure 
to simulated stresses that might be encountered during the formulation of the phage or during in 
vivo application of the formulated phages.  
Phage activity was assessed in vitro, in a heat assay to determine the temperature at 
which the selected phages are most stable, for the longest duration. In vivo application of phages 
requires resistance (or tolerance) to high temperatures. Temperature fluctuations in an in vivo 
system could possibly arise from changes in weather patterns, physiological changes in the body 
of the cow itself, or even changes in the storage conditions of the phage. All six phages that were 
screened showed reduced lytic ability from as early as 10min exposure to 45ºC. This is 
significant, especially in terms of formulation of phages into commercial products. Certain 
formulation procedures may require high temperatures during the manufacturing process. This 
has to be undertaken with caution in order to minimize any reduction in the replication ability of 
the phages. Phages are primarily composed of protein (Kutter and Sulakvelidze, 2005). Any 
prolonged exposure to high temperature may cause denaturation of phage proteins responsible 
for infection of a bacterial host. Compromised physical structure of an otherwise infective phage, 
then reduces the control potential that that phage could have imposed on a target host. These 
results correlate with previous studies where phage lytic ability was shown to be reduced by 
prolonged exposure to high temperatures (Da Silva and Janes, 2005; Bryant et al. 2007; Chandra 
et al. 2011).  
The selected phages also showed reduced lytic ability after exposure to temperatures 
below 4ºC. This reduced pathogenicity could be attributed to the effect that freezing/thawing 
may have on phage ultrastructure. This is particularly relevant for tailed phages from the 
Myoviridae family. Delicate tail and tail fibres could become dissociated from the virus head due 
to changes in osmotic pressure (Jończyk et al. 2011). This sort of dissociation renders the phage 
ineffective as a control agent. The results of this study contradict those of Hsieh et al. (2011), 
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where phages were found to have maintained stability even after one year of storage at -85ºC. 
Hsieh et al. (2011) stored all phages in 7% dimethyl sulfoxide, in comparison to phage buffer (+ 
glycerol) in the current study. The choice of storage medium might therefore influence phage 
stability over time. For the purposes of an in vivo study, long- and short-term storage of phage 
products at 4ºC, in a more protective medium (such as glycerol) seems the most likely way 
forward.  
When phages are grown in large-scale liquid broth cultures, either for laboratory or in 
vivo assays, chloroform is usually added to the growing medium to kill any live bacterial cells 
that remained un-lysed (Sambrook et al. 1989). The isolated phages from this study showed 
extreme sensitivity to chloroform treatments. While phages Sabp-P1, Sabp-P2 and Sabp-P3 
demonstrated significant tolerance to chloroform treatment, their lytic ability was still 
compromised. In light of this, an alternative method has to be employed in order to remove host 
cells from a culture suspension. Micro-filtration serves as one of the least-damaging methods to 
apply, as phage simply pass directly through the filter while un-lysed bacterial cells as well as 
large bacterial debris, are retained. The use of micro-filters was implemented throughout the 
current study.  
The pH of the medium in which a phage is propagated is also an area of importance. 
Depending on where a phage has been isolated from, the pH of its growth medium should ideally 
mimic that of its natural environment in order to promote optimal phage replication. The pH of 
milk is between pH 6.6-6.7 (Blowey and Edmondson, 2010). Optimal phage replication occurred 
at pH 6-7, followed by a sharp decline at higher pH. This was also noted in a study by Da Silva 
and Janes (2005), where phages specific to Vibrio spp. (infective on oysters) were screened at 
various pH ranges. The Vibrio phages were most stable at that pH range which best mimicked 
the pH of the oyster system (pH 7-8).     
The formulation of phage/s into a product that can be applied in an in vivo system 
requires storage of the phages in a medium that maintains phage stability, is itself stable over 
time, and does not damage the teat upon application. Dairy farmers implement both pre- and 
post-dipping disinfectants during the milking process (Blowey and Edmondson, 2010). Teat skin 
has relatively few sebaceous glands, and continual washing and drying of the teats can remove 
the limited amount of fatty acids that maintain the skin barrier (Blowey and Edmondson, 2010). 
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This can result in severe cracking/breaking of the teat skin, leaving the teat exposed to entry of 
pathogens. In an attempt to maintain healthy teat skin, additives are used in post-dipping 
formulations. Emollients (such as lanolin) and humectants (such as glycerin) are the most 
commonly applied additives (Blowey and Edmondson, 2010). The current study investigated the 
effect of glycerol concentrations on phage activity. Phage lytic ability was optimal in a 
suspension of up to 15% glycerol, but dropped thereafter. Phage suspension in a 10% glycerol 
solution could be applied as an in vivo treatment for the treatment of bovine mastitis. Such an 
application could have a two-fold benefit: (1) the protective effect of phages against S. aureus on 
teat surfaces; (2) the moisturizing effect of glycerol on sensitive teat skin. Note that phages have 
not been shown to have any negative effects on either the actual health of the cow (O‘Flaherty et 
al. 2005b;  Gill et al. 2006a) or the quality of milk produced (Hudson et al. 2005; García et al. 
2008).  
3.5 Conclusion 
This study showed the optimum storage and growth conditions necessary in order to maintain 
high tire phage cultures. Slight deviations from the standard growth requirements (37°C for 
optimal growth; storage at 4°C, culture medium pH of 6-7) for the selected phages resulted in 
dramatic reductions in phage activity. Phages Sabp-P1, Sabp-P2 and Sabp-P3 showed more 
vigour and were more robust than Sabp-P4, Sabp-P5 or Sabp-P6. Sabp-P1, Sabp-P2 and Sabp-P3 
would be preferred candidates when investigating in vivo applications of the phages as a control 
treatment against staphylococcal bovine mastitis.   
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Morphological classification of three novel South African bacteriophages infective 
against Staphylococcus aureus, causal agent of bovine mastitis 
 
Abstract 
Morphological classification of unknown biological entities forms an integral step in their proper 
nomenclature and grouping. Bacteriophages can usually be placed into a group based on their 
physical structure. The aim of the current study was to morphologically characterise three novel 
South African phages and to investigate their infection cycle within the bacterial host, using 
transmission electron microscopy. The phages were isolated from raw milk drawn off dairy cows 
that had tested positive for Staphylococcus aureus-induced bovine mastitis. Results showed that 
all three phages appeared structurally similar. Each possessed an icosahedral head separated 
from a striated, contractile tail region by a constricted neck region. The head capsules ranged in 
diameter between 90-110nm with the tail length ranging from 150-200nm in the non-contractile 
state and 100-130nm in the contractile state. Rigid tail fibres were also visible below the striated 
tail. The major steps in the virus replicative cycle were also documented. Ultra-thin sections 
through phage plaques were prepared through a modification of traditional methods, with no 
negative effects on sample integrity. The major steps that were reported in the phage replicative 
cycle were (1) attachment to host cells, (2) replication within host cells, and, (3) release from 
cells. Overall results suggested that the three phages are strains from the order Caudovirales and 
are part of the Myoviridae family.  
 
4.1 Introduction 
Phages have been found to infect more than 140 bacterial genera including (1) aerobes and 
anaerobes; (2) exospore and endospore formers; (3) cyanobacteria, spirochetes, mycoplasmas, 
chlamydias; (4) budding, gliding, ramified, stalked and sheathed bacteria; (5) extreme halophiles 
and methanogens; and, (6) hyperthermophilic Archaea (Ackermann, 2005). Phages have been 
found to be extremely heterogeneous in their structural, physicochemical and biological 
properties, which could suggest that they are polyphyletic in nature (Ackermann, 2005). 
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However, their primary mode of action is similar. Virions differ significantly as well, occurring 
as tailed, polyhedral, filamentous or pleomorphic, with heterogenous genomes ranging from 
dsDNA, ssDNA, dsRNA and ssRNA (Ackermann, 2005; 2007). By 2007, at least 5568 phages 
had been examined through electron microscopy (Ackermann, 2007). Results derived from 
genomic and morphological studies have been used to categorise phages into one order, 13 
families and 31 genera (Ackermann, 2005; 2007).  
Tailed phages of the order Caudovirales constitute the most extensive group of bacterial 
viruses comprising 96% of phages identified so far (Ackermann, 2007; Gutiérrez et al. 2011). 
These phages consist of a protein shell and linear dsDNA and lack any type of envelope 
(Ackermann, 2005; 2007). Phage heads are icosahedral and tails are true helices that consist of 
stacked discs. These tails usually possess terminal adsorption structures such as base plates, 
spikes or tail fibres (Ackermann, 2005). Although these phages constitute a monophyletic group 
possessing related properties (morphological, physicochemical, physiological) and have been 
classified into as a single order, Caudovirales, their individual properties are rather varied. 
Typically, they differ in terms of dimension and fine structure, DNA content and composition, 
nature of constitutive proteins, serology and host range (Ackermann, 2005). Ackermann (2005) 
has devised criteria to distinguish between these phages: Myoviridae, with contractile tails 
consisting of a sheath and central tube, approximately 25% of tailed phages; Siphoviridae, with 
long, non-contractile tails, approximately 61% of tailed phages; and, Podoviridae, with short, 
non-contractile tails, approximately 14% of tailed phages.  
While tailed phages do comprise the majority of bacterial viruses, tailless phages also 
occur. These include only about 190 known viruses, corresponding to less than 4% of the 
currently recognised bacterial viruses (Ackermann, 2005). They have been classified into 10 
small families, occur enveloped or non-enveloped, and are of three types: (1) polyhedral phages 
that are icosahedral with cubic symmetry and either DNA or RNA constituted; (2) filamentous 
phages with helical symmetry that are DNA constituted; and, (3) a few pleomorphic types 
without obvious symmetry axes that are also DNA constituted (Ackermann, 2005). 
The current study involved the morphological classification of three phages with specific 
lytic activity against Staphylococcus aureus, the causal organism of bovine mastitis. Bovine 
mastitis is an infectious inflammation or irritation of the mammary glands that interferes with the 
97 
 
normal flow and quality of milk (Blowey and Edmondson, 2010). Although a range of control 
measures are used, this disease remains a major cause of economic losses in the dairy industry 
both within South Africa and worldwide. In recent years, the use of integrated control measures 
has become paramount, due to the onset of resistance against the antibiotics commonly used to 
treat the disease. Phages provide an alternative control measure because antibiotic resistance is 
particularly relevant to S. aureus-induced bovine mastitis.  
Against this background, three phages with activity against South African strains of S. 
aureus, were characterised according to their morphology and replicative cycle, using 
transmission electron microscopy. Other than genomic analysis, electron microscopy is often the 
fastest method for phage identification. It can be used to assign an unknown phage to a specific 
family, based on head and tail morphology, and to differentiate between different phage types.  
 
4.2 Materials and Methods 
4.2.1 Bacterial strains 
Four S. aureus strains were used for phage isolation, i.e., SaB1, SaB2, SaB3 and SaB4. These 
strains were isolated from raw bovine milk collected from dairy farms in the province of 
KwaZulu-Natal, RSA (Republic of South Africa). S. aureus was initially isolated on blood agar. 
Thereafter, cultures were maintained on tryptone soy agar (TSA). S. aureus cultures used for 
phage propagation were grown on TSA for 12hr at 37ºC.  
 
4.2.2 Phage isolation 
Raw bovine milk samples collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa) served as the initial material from which to isolate phages. These 
milk samples were stored at 4ºC. Phages were isolated using the spot-plate method on double-





incorporated into 7% top agar that was supplemented with 1M CaCl2. Raw milk samples were 
filtered through a 0.45μm syringe filter. Filtered samples were then spotted onto the surface of 
the solidified top agar at 10μl per spot. Plates were allowed to dry for 2hr, followed by 
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incubation for 12hr at 37ºC. Zones of clearing (plaques) were indicative of phage activity. 
Plaques were removed from top agar and soaked in phage buffer for 12hr with gentle agitation 
(150rpm) at 4ºC. The resulting suspension was centrifuged using the Avanti J-26 XPI 
(www.beckmancoulter.com) at 10,000g x 10min at 4ºC. The supernatant was filtered using a 
0.45μm syringe filter and stored as phage stock at 4ºC.  
 
4.2.3 Phage preparation for microscopy 
Two different phage preparations were used during the study. Phage was propagated via standard 
double-plate technique (Sambrook et al. 1989). Resulting plaques that developed on the top agar 
were cut into quarters along the margin between the clear zone and the bacterial lawn. These 
quarters were processed further for microscopy. Phage was also propagated using enrichment 
procedures described previously (Gill et al. 2006). Enrichment protocols involved inoculation of 
an overnight broth culture of SaB1 with phage eluted directly from plaques. Thereafter, phages 
were concentrated through centrifugation at 75,600g using Avanti J-26 XPI (Beckman-Coulter) 
for 3hrs at 10ºC. The resulting virus pellet was resuspended in phage buffer (Appendix 1) and 
stored at 4ºC.   
 
4.2.4 Microscopy    
a. Embedding and sectioning 
Agar quarters containing both phage and bacterial cells were prepared for transmission electron 
microscopy analysis over a 4d period (Table 4.1). The methodology described in Table 4.1 
represents a modification of methods of Hajibagheri and Trenton (1999). Resin embedded 
samples were sectioned using the Reichert-Jung Ultracut ultramicrotome (www.reichert.com). 
These sections were collected on formvar coated copper mesh grids and stained with 2% uranyl 
acetate (10min), followed by 2% lead citrate (10min). The grids were viewed using the JEOL 
JEM-1400 (www.jeol.com) at an operating voltage of 100kV. Images were captured using the 
Orius Camera (SC600A) (www.gatan.com) operating off Gatan Digital Micrograph (version 
2.02.800.0) software (www.gatan.com). 
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b. Negative staining 
Phages incubated with live bacterial cells were viewed using a negative staining 
technique. Bacterial cultures were grown for 12hr at 37ºC in liquid broth medium. The bacterial 
suspension was centrifuged at 10,000g x 10min at 4ºC. The supernatant was discarded and the 
bacterial pellet was re-suspended in 1M MgSO4 amended with 1M CaCl2. Previously isolated 
phage was then added to the bacterial suspension and incubated at 37ºC. Composite samples 
were negatively stained at 20min, 8hr and 12hr, post incubation. Formvar coated copper mesh 
grids (both 200 mesh) were inverted, for 1min each, onto 20μl sample droplets representative of 
an incubation period. Excess sample was wicked off and grids were stained with either uranyl 
acetate (2%) or phosphotungstic acid (2%) for 30sec. All stains were freshly prepared and used 
within 2wk. Grids were left to air-dry, followed by viewing using the JEOL JEM-1400 at an 
operating voltage of 100kV. Images were captured using the Orius Camera (SC600A) operating 
off Gatan Digital Micrograph (Version 2.02.800.0) software. 
 
4.3 Results 
Transmission electron microscopy proved to be a useful tool for the identification of key features 
of the isolated phages. Negative staining of the viral wet mounts using phosphotungstic acid 
provided more clarity than staining with uranyl acetate. However, staining of ultra-thin sections 
using uranyl acetate plus lead citrate provided optimal resolution of samples. The three phages 
were named Sabp-P1, Sabp-P2 and Sabp-P3.  
Figures 4.1a-f shows that each of the three phages possesses an icosahedral head that is 
separated from a rigid, striated, contractile tail region by a constricted neck region. The head 
capsule ranged in diameter from 90-110nm, with the tail ranging in length from 150-200nm in 
the non-contractile state and 100-130nm in the contractile state. 
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Table 4.1 Amended protocol for transmission electron microscopy preparation of phage plaques 
at room temperature (unless otherwise stated).  
Day Procedure Time 
1 Fixation of agar plugs in 3% buffered glutaraldehyde 2hr  
 Washing in 0.05M sodium cacodylate buffer 2 x 30min  
 Post-fixation in 2% osmium tetroxide 2hr  
 Washing in 0.05M sodium cacodylate buffer 1 x 30min (sample left overnight in fresh 
buffer) 
2 Alcohol dehydration series: 30%, 70%, 100% 10min per alcohol solution for 30% and 
70% 
3 x 10min for 100% 
 Removal of residual alcohol using propylene oxide 1 x 10min  
 Embedding in epon/araldite and propylene oxide 
(+DMP):  
25% epon: 75% propylene oxide 
50% epon: 50% propylene oxide 




2hr (in Eppendorf tube) 
2hr (in Eppendorf tube) 
2hr (in Eppendorf tube) 
overnight (in Eppendorf tube) 
3 Polymerization using 100% epon + DMP 14hr in oven at 70ºC (open tube) 
4 Trim, section, stain, view  
 
 
Rigid tail fibres were also visible below the striated tail. Head capsules manifested in two 
different states – a collapsed state and an intact state (Figure 4.1e). The hexagonal shape of the 
head capsule is clearly distinguishable in the intact state, as are the tail components, whereas the 
virus particle in the collapsed state appears circular and has a contracted tail. Figure 4.2a shows 
the distinctive icosahedral virus head, but with a contracted tail. An anomaly that was noted was 
the presence of viral proteins that ranged in length from 150-450nm (Figure 4.2b). These viral 
polyrods were found associated with virus stock that had been stored in phage buffer, at 4ºC, for 
more than 2wk.  
Two methods were employed in order to gain information on the key stages of the virus 
replication cycle after inoculation of S. aureus: (1) embedding and sectioning of a phage plaque 
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12hr post inoculation (Figure 4.3); and (2) wet mount analysis of phage activity at 20min, 8hr 
and 12hr post inoculation (Figure 4.4). The observations reported below are for phage Sabp-P3 
only. Modification of the traditional embedding protocol proved efficient as sample processing 
was reduced from 7 days to 4 days, with no compromise in sample integrity.  
Staining of the ultra-thin sections using uranyl acetate and lead citrate provided optimal 
resolution (Figures 4.3a-d). Typical signs of phage activity included the presence of bacterial cell 
wall debris, and cells with indistinct internal structures that appeared to have collapsed. Figures 
4.3a-d shows sections through the marginal region of a phage plaque. In Figure 4.3a, residual 
intercellular annuli can be seen. Cells with swollen protoplasts and partially digested membranes 
are also visible. Figure 4.3b shows extrusion of a bubble of cytoplasm from a bacterial cell 
shortly after rupture of the cell wall. Figures 4.3c and 4.3d show lysed cells and cells that are 
packed with newly formed phages. In addition, a single phage particle can be seen attached to the 
outer membrane of a bacterial cell that is already at an advanced stage of infection.  
Figures 4.4a-f show the various stages of virus replication, using the wet mount and 
negative staining technique. Figures 4.4a and 4.4b show attachment of virus particles to the 
surface of bacterial cell walls 20min post inoculation. Figures 4.4c and 4.4d show virus infection 
at a more advanced stage 8hr post inoculation. Bacterial cells have begun to lose cell wall 
integrity and the cell cytoplasm has begun to ooze from areas of the cell wall that have already 
ruptured (Figure 4.4c). Virus particles are also packed within bacterial cells and are ready for 
release. Figure 4.4d shows the presence of thin fibrils among the virus particles. Figures 4.4e-f 
show virus replication at 12hr post inoculation.   
At this stage, virions are packaged in an ordered fashion within bacterial cells that are on 
the verge of rupture. Bacterial cells have lost cell wall integrity and appear disorganized. 
Bacterial cell wall debris and annuli are also present as a by-product of those cells that have 
already ruptured. Virions leaving the ruptured bacterial cells seem to carry with them strands of 
bacterial cytoplasm (Figure 4.4f). An interesting observation during the release of the virions 
from lysed bacterial cells was that the virions themselves appeared to aggregate towards each 
other and create a network of viruses, even if they had been released from neighboring cells that 
































Figure 4.1 Electron micrographs of three different phages derived from Staphylococcus aureus. 
a-b. Sabp-P1; c-d. Sabp-P2; e-f. Sabp-P3. Note the distinctive head and tail regions as well the tail fibres 















Figure 4.2 Electron micrographs of distinguishing phage structures.  
a. Typical hexagonal shape of phage head characteristic to Sabp-P1, Sabp-P2 and Sabp-P3; b. Virus 



























Figure 4.3 Ultra-thin sections through a plaque of phage Sabp-P3 at 12hr post inoculation. 
a. Bacterial debris and residual intercellular annulus (A) as well as swollen protoplasts (*); b. Bacterial 
cell at an advanced stage of phage infection indicated showing extrusion of bubbles of cytoplasm 
(indicated by arrow); c. Newly formed phage particles packed within bacterial cells (indicated by arrow); 
d. Phage attached to the outer wall of an infected bacterial cell. All samples were stained using uranyl 






























Figure 4.4 Representation of the phage life cycle at 20min, 8hr and 12hr post inoculation onto 
Staphylococcus aureus. 
a-b. Phage attachment to bacterial cell wall surface, 20min post inoculation. Note the circular intact form of the 
cells; c-d. S. aureus cells with virus particles packaged within them, 8hr post inoculation, where cell walls have 
begun to lose integrity and cell cytoplasm (c) can be seen oozing from walls; d. Bacterial cell with virus particles 
packaged within as well as the presence of viral protein chains/viral polyrods (indicated by arrow); e. Bacterial 
infection at an advanced stage 12hr post inoculation, where all cell wall integrity has been lost and cell debris from 
already ruptured cells can be seen; f. Release of virions (v) from ruptured bacterial cells where the virions carry with 
them a cytoplasm trail as they leave the ruptured cells (indicated by arrow). All samples were stained using 




Morphological studies conducted on the unknown phages using transmission electron 
microscopy revealed their size, shape and basic replication cycle. The length of phage particles 
including both the head and tail components was between 150-250nm. The presence of a distinct 
constricted neck region between the head capsule and the tail provided further evidence 
regarding the placement of the phages into a specific family. The morphological characteristics 
of the phages reported in this study correlated with those from previous studies. Average phage 
dimensions were reported in a range between 150-300nm, head capsules were icosahedral, tail 
structures appeared to end in a base plate, and tail fibers were present in all three phages 
(Coetzee, 1987; Ackermann, 2005; Hseih, et al. 2011). Furthermore, the presence of anomalous 
viral polyrods were noted. These structures were previously reported by Tikhonenko (1970), who 
hypothesized that these structures were actually an aggregation of viral tail proteins. This 
aggregation was reported to have occurred upon phage exposure to high pH (10-11) or prolonged 
exposure to fluctuating temperatures. In terms of the current study, the latter exposure could have 
accounted for the development of tail protein aggregation and hence the viral polyrods. These 
structures were common among all three phages that were examined. Based on these results, the 
isolated phages can be assigned to the order Caudovirales, family Myoviridae. 
Tailed phages of the order Caudovirales constitute the largest and most widespread group 
of phages, with more than 5000 tailed phages having been identified through electron 
microscopy (Ackermann, 2005). This order of viruses may be the oldest, dating back to 3.5 
billion years (Ackermann, 2005). Caudovirales seem to constitute a monophyletic evolutionary 
group that possesses clearly related morphological, physicochemical and physiological properties 
(Ackermann, 2005). However, in depth studies have shown that they are actually diverse in their 
properties, e.g., particle dimensions and fine structure, DNA content and composition, nature of 
constitutive proteins, serology, host range and physiology (Ackermann, 2005; Abedon, 2008). 
Ackermann (2005) has proposed a useful criterion based on phage tail structures that can be 
easily determined via electron microscopy and that is suggestive of virus assembly pathways. 
Based on this criterion, tailed phages are divided into three families: Myoviridae, with long 
contractile tails consisting of a sheath and a central tube; Siphoviridae with long non-contractile 
tails; and Podoviridae with short, non-contractile tails. However, these three families show 
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extensive overlap in terms of their physicochemical properties and cannot be differentiated solely 
based on morphology (Ackermann, 2005).  
In addition to classification of the newly isolated phages, an image-based representation 
of the major steps of the virus replication cycle was also documented. Phages can be seen 
attached to bacterial cells, followed by replication and production of virus protein (fibrils) within 
cells, and subsequent release from these cells. Tailed phages recognize their host cells through 
the interaction between attachment sites on their tails and host surface molecules (Kutter et al. 
2005). Some phages use a single, central fibre as their receptor recognition element (or adhesin), 
while others use a cluster of 3, 6 or 12 fibres that are associated with the tail structure (Kutter et 
al. 2005). Adsorption to host cells may involve multiple steps, which are quite different for both 
Gram-positive and Gram-negative bacteria. Little is known about the specific adhesins of phages 
that are able to infect Gram-positive bacteria such as S. aureus, or about the bacterial receptors to 
which these phages bind. However, studies have been undertaken in an attempt to characterize 
phage genes involved in this process (Duplessis and Moineau, 2001). Appropriate placement of 
the phage tail on the cell surface triggers irreversible events that lead to delivery of phage DNA 
into the host cell. In the case of Myoviruses, although they possess contractile tails, it appears 
that their tail tubes do not pierce the inner host membrane and that a potential gradient is actually 
required for DNA entry into the host cell (Molineux, 2001; Letellier et al. 2004; Kutter et al. 
2005). Once phage DNA has entered the host cells, a complex sequence of events follows where 
phage DNA is replicated, repaired and recombined by using a combination of host and phage 
mechanisms (Kutter et al. 2005). Transcription then follows (Kutter et al. 2005), at which stage 
most of the regulation of phage development takes place. Phage morphogenesis and DNA 
packaging takes place subsequently.  
The Myoviridae build some of the most complex virus particles known (Ackermann, 
2005; Kutter et al. 2005). The well studied phage, T4, devotes more than 40% of its genetic 
information to the synthesis and assembly of its icosahedral heads, tails with contractile sheaths 
and tail fibres (Kutter et al. 2005). Twenty-five T4 proteins are involved in head morphogenesis, 
22 in tail morphogenesis and 7 for tail fibres; in addition, 5 of the 54 proteins are actually 
assembly catalysts rather than components of final phage structure (Kutter et al. 2005). Tail 
morphogenesis is an intricate step involved in the phage life cycle. For the Myoviridae, the many 
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components of the contractile tail are assembled in a highly ordered fashion. Using T4 as a type 
example, the baseplate is formed through the associations of six ―wedges‖, each of which consist 
of seven types of protein, around a ―hub‖ to form a dome-shaped base plate (Kutter et al. 2005). 
Trimeric short tail fibres are located beneath the baseplate with the head of each fibre associating 
with the tail of the next fibre. These tail fibers serve to irreversibly bind a phage structure to a 
bacterial cell during infection (Kutter et al. 2005).  
The last stage in the replication cycle is the release of progeny phage particles from the 
host cells. Initial assumptions on phage release were that the host cells become packed tightly 
with virus progeny and then burst as a result of intracellular pressure. However, more recent 
theories are based on the production of virus lysozymes that facilitate cell rupture and virus 
release (Kutter et al. 2005; Donovan et al. 2006). The two major proteins involved are endolysin 
(to attack the host peptidoglycan layer) and holin (to let the endolysin move from the cell 
cytoplasm into the periplasmic space in a carefully timed fashion). Kutter et al. (2005) discussed 
how the holin-endolysin combinations facilitated the evolution of several key properties that 
affect the ability of the phage to compete by regulating the onset of lysis and the speed at which 
infectious progeny are released.  
In addition to morphological classification of phages, molecular analysis of genomic 
material has been used by others to confirm the identity of specific phages. Fifteen genera have 
been defined among the tailed phages, based on molecular criteria (Ackermann, 2005). These 
molecular criteria include the presence/absence of cos or pac sites, terminal redundancy and 
circular permutation, DNA or RNA polymerases, and nucleotide sequences (Ackermann, 2005; 
Abedon, 2008). To date, approximately 260 phage species have been recognized, mostly on the 
basis of morphology, nucleotide sequencing, protein analysis, serology and DNA-DNA 
hybridisation (Ackermann, 2005). The results of the current study allow for the preliminary 
classification of the three phages into a specific order (Caudovirales) and family (Myoviridae). 
Further research is needed to generate the nucleotide sequencing and protein analysis that is 
required in order to accurately classify the phage to the strain level, as per internationally 




This electron microscopy study identified the morphology and parts of the replicative cycle of 
three novel South African phages infective against S. aureus strains responsible for bovine 
mastitis. In addition, this is the first study involving phages specific against bovine mastitis-
causing S. aureus that has been undertaken in South Africa. This can serve as a preliminary step 
in a long-term biocontrol plan to apply these phages as biocontrol agents against S. aureus-
induced bovine mastitis.  
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 CHAPTER 5 
Protein profile analysis of selected bacteriophages, infective against Staphylococcus aureus 
subsp. aureus Rosenbach 1884, causal agent of bovine mastitis 
 
Abstract 
A wealth of information can be derived about an organism based on analysis of its proteomic 
data, and different diagnostic techniques can be employed to derive proteomic data from an 
organism. The aim of this study was to use one-dimensional electrophoretic methods 
specifically, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and ultra-
thin layer isoelectric focusing (UTLIEF), to analyse the proteins of three strains of 
staphylococcal bacteriophages, Sabp-P1, Sabp-P2 and Sabp-P3, in order to determine whether 
these strains differed from each other. SDS-PAGE analysis produced unique protein profiles for 
each phage, with band fragments ranging in size from 8.86-171.66kDa. Combined similarity 
matrices showed an 84.62% similarity between Sabp-P1 and Sabp-P2 and a 73.33% similarity 
between Sabp-P1 and Sabp-P3. Sabp-P2 showed a 69.23% similarity to Sabp-P3. UTLIEF 
analysis showed protein isoelectric charges in the range of pI 4.21-8.13, for all three phages. The 
isoelectric profiles for each phage were distinct from each other. A combined similarity matrix of 
both SDS-PAGE and UTLIEF data showed an 80.00% similarity between phages Sabp-P1 and 
Sabp-P2, and a 68.29% similarity between Sabp-P1 and Sabp-P3. Sabp-P2 showed a 70.59% 
similarity to Sabp-P3. Although the current results are based on putative protein fragments 
analysis, it can be confirmed that phages Sabp-P1, Sabp-P2 and Sabp-P3 are three distinct phage. 
Complete sequencing of viral genomes is necessary in order to specifically characterize how 
each phage differs, based on protein chain composition.  
 
5.1 Introduction 
Bovine mastitis refers to an infectious inflammation of the mammary glands that interferes with 
the normal flow and quality of milk (Blowey and Edmondson, 2010). Traditionally, this disease 
has been managed through the application of chemotherapeutic agents. However, the primary 
causal organism of the disease, Staphylococcus aureus subsp. aureus Rosenbach 1884, has with 
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time, developed resistance towards those antibiotics most commonly applied against it. As a 
result, interest has shifted to other avenues for control of the disease.  
Polyvalent staphylococcal phages of the Myoviridae family have received renewed 
interest with respect to their practical application for the treatment of bovine mastitis. However, 
due to their ubiquity and associated abundance in an environment, it is paramount to be able to 
accurately distinguish between each phage, in order to fully exploit its control potential. Analysis 
of viral proteins serves as one such method of characterisation.  
Viral protein analysis can provide further insight into those mechanisms involved in the 
infection cycle, from attachment of the phage to the host cell wall, to final expulsion of newly-
formed phage particles from a lysed host cell. Phages are highly host specific (Kutter and 
Sulakvelidze, 2005; Tan et al. 2008). This specificity is dependant upon the evolution of 
recognition systems of the viruses, based on the ―lock-and-key‖ theory, where receptors on the 
host bacterium are recognized by proteins of the phage (Kutter and Sulakvelidae, 2005; Tan et 
al. 2008). To initiate successful infection, an incoming phage must first cross the barrier 
presented by the bacterial cell wall (Rashel et al. 2008). Several studies have identified the 
proteins associated with initiation of infection associated with Gram-negative bacteria (Kao and 
McClain, 1980; Caldentey and Bamford, 1992; Sandmeier, 1994).  
However, studies into the lytic proteins responsible for initiation of infection of Gram-
positive bacteria are rather limited. Kenny et al. (2004) showed that a phage specific to 
Lactococcus lactis Lister 1873, Tuc2009, encodes for a tail-associated protein (tal2009) that might 
be involved in localized cell wall degradation. Eyer et al. (2008) reported characterization of a 
phage (Phage 812) proteome as well the identification of phage virion proteins. It was found that 
identified proteins of phage 812 showed 99-100% similarity with corresponding proteins of the 
phage G1, and, approximately 60% similarity with proteins of the phage Twort, all of which are 
staphylococcal phages. Lood and Collin (2011) also carried out protein analysis on phages of 
Propionibacterium acnes Gilchrist 1900. This study identified major head and tail proteins, as 
well as three other low molecular weight minor proteins. Monod et al. (1997) conducted a study 
on phages that exhibit T-even morphology but are only distantly related to the T-even phages; 
these phages were termed ―pseudo-T-even‖. Protein analyses revealed that pseudo-T-even 
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phages could be a distant source of viral sequences that might be exchanged with the T-even 
phages, and that each group does in fact differ from the other.  
Considering the wealth of information that can be derived from analysis of phage 
proteins, the primary objective of the current study was to carry out protein characterisation of 
three novel South African phages isolated from the dairy environment. These phages have shown 
specific activity towards pathogenic strains of S. aureus, associated with bovine mastitis. It is 
envisaged that these phages will be used in an integrated control program for the control of 
bovine mastitis in dairy cattle.  
 
5.2 Materials and Methods 
 
5.2.1 Bacterial host strains and their isolation 
Staphylococcus aureus strain, SaB1, was used for phage isolation and propagation. This strain 
was isolated from raw bovine milk collected from dairy farms in the province of KwaZulu-Natal, 
RSA (Republic of South Africa). SaB1 was initially isolated on blood agar. Cultures required for 
phage propagation were maintained on tryptone soy agar (TSA) or typtone soy broth (TSB). 
  
5.2.2 Phage isolation, propagation and purification 
Raw bovine milk samples collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa) served as the initial material from which to isolate phages. These 
milk samples were stored at 4ºC. Phages were isolated using the spot-plate method on double-





) were incorporated into 7% top agar that was supplemented with 1M CaCl2. Raw milk 
samples were filtered through a 0.45μm syringe filter. Filtered samples were then spotted onto 
the surface of the solidified top agar at 10μl per spot. Plates were allowed to dry for 2hr, 
followed by incubation for 12hr at 37ºC. Zones of clearing (plaques) were indicative of phage 
activity. Plaques were removed from top agar and soaked in phage buffer (Appendix 1) for 12hr 
with moderate agitation (150rpm) at 4ºC. The resulting suspension was centrifuged using the 
Avanti J-26 XP1 (www.beckmancoulter.com) at 10,000g x 10min at 4ºC. The supernatant was 
filtered using a 0.45μm syringe filter and stored as phage stock at 4ºC. Subsequent phage was 
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grown from this stock in liquid broth culture or using the double-layer agar method (Sambrook et 
al. 1989).   
Isolated phages were purified through a modification of standard methods (Sambrook et 
al. 1989; Harley and Prescott, 1993). Filter-sterilised phage stock isolated from either liquid 
broth culture or double-layer agar method, were subjected to centrifugation using the Avanti J-26 
XPI (Beckman-Coulter) at 75,600g x 3hrs x 10ºC. Resulting phage pellets were re-suspended in 
fresh phage buffer and a second centrifugation was conducted (Avanti J-26 XPI (Beckman-
Coulter) at 75,600g x 3hrs x 10ºC). The phage pellets were then re-suspended in fresh phage 
buffer at 1/10 of the original volume that was processed. All stocks were stored at 4ºC. Six 
phages were isolated and named Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6. 
However, only phages Sabp-P1, Sabp-P2 and Sabp-P3, were used in this study. The results of 
previous screening eliminated the need to characterise all six phages, as only Sabp-P1, Sabp-P2 
and Sabp-P3, are intended for use in in vivo trials.   
 
5.2.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
a. Sample preparation 
Purified phage stock previously prepared through centrifugation was used as the starting 
material. The protein concentration of each sample was determined using the Nanodrop ND-100 
spectrophotometer (www.nanodrop.com). An equal volume of phage sample was mixed with an 
equal volume of SDS sample reducing buffer (4% (m/v) SDS, 10% (v/v) β-mercaptoethanol, 
20% (v/v) glycerol, 125mM Tris-HCl). This suspension was incubated at 55°C for 30min, in 
order to slowly denature phage proteins. After 30min, all samples were transferred to ice.  A 
marker dye, bromophenol blue (5µl), which migrates with the buffer front, was added to each 
sample prior to loading onto the gel.  
 
b. Electrophoresis 
The proteins were electrophoresed on a standard SDS-PAGE gel (Laemmli, 1970).  A 4% 
stacking gel and a 12.5% separating gel were used to separate the proteins. A total volume of 
20 l of each phage was loaded onto the gel; 10 l of protein marker as added to gel (PageRuler™ 
Prestained Protein Ladder, Thermo Scientific) (www.thermoscientific.com). The gel unit was 
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connected to a power-pack and the run at 18mA, 100V until the bromophenol blue marker was 
0.5cm from the bottom of the gel (~2hr). The gel was removed and stained for 4h using the 
Coomassie Blue R-250 staining solution (0.125% (m/v) Coomassie R-250 dissolved in 50% 
(v/v) methanol, 10% (v/v) acetic acid). The gel was then placed overnight in de-stain I (50% 
(v/v) methanol, 10% (v/v) acetic acid), and thereafter into de-stain II (7% (v/v) methanol, 5% 
(v/v) methanol). Gels were all shaken at room temperature at 100rpm using a MRC Orbital 
Shaker (www.mrclab.com). Gels were stored in de-stain II (7% (v/v) methanol, 5% (v/v) 
methanol), in polyethylene air-tight bags, at 4°C. Gels were photographed using the VersaDoc 
Gel Imaging System 4000 (www.exetersoftware.com).  
5.2.4 Ultra-thin layer isoelectric focussing 
a. Sample preparation 
Purified phage stock previously prepared through centrifugation was used as the starting 
material. The protein concentration of each sample was determined using the Nanodrop ND-100 
spectrophotometer. An equal volume of phage sample was mixed with an equal volume of 
isoelectric focussing lysis buffer (Appendix 3) (Berkelman and Stenstedt, 1998). Phage and 
buffer suspension were incubated at 50°C for 30min. After 30min, all samples were transferred 
to ice until loaded onto gel. No dye marker was added to any sample.   
 
b. Electrophoresis 
All phages samples were applied to ultra-thin iso-electric focusing gels with a wide pI range 
using large application strips. The gels were supplied by Incotec Proteios South Africa 
(www.incotech.com). Electrophoresis was performed on a flatbed focuser (Multiphor II 
electrophoresis system, Pharmacia Biotech) (www.gelifesciences.com) at a pre-cooled 
temperature of 10ºC.  The anodal buffer consisted of 25.5mM L
-1
 aspartic acid and 24.5mM L
-1 
glutamic acid in distilled water. The cathodal buffer used was 25.2mM L
-1
 arginine, 24.6 mM L
-1
 
lysine and 12% ethylenediamine in distilled water.  The gels were run using a single cathode and 
a single anode, in single direction electrophoresis. The gel was pre-focussed at 200V, 58mA, 
12W and 100 volt hours (VH), using a VH integrated electrophoresis power supply, 
Electrophoresis Power Supply EPS-3501XL (www.gehealthcare.com). 20µl of each phage 
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sample was loaded into sample wells; 3µl of IEF marker (IEF Markers 3-10, SERVA Liquid 
Mix) (www.invitrogen.com) was loaded onto each gel. Electrophoresis was carried out using the 
following run settings: Step 1 = 160V, 46mA, 9.6W, 80VH; Step 2 = 400V, 46mA, 9.6W, 
160VH; Step 3 = 1000V, 46mA, 9.6W, 500VH; total run time = ~1hr 20min. After completion 
of protein focussing, the gels were fixed at room temperature using 20% trichloracetic acid 
(15min standing, 15min shaking at 50rpm). The gels were rinsed twice in sterile distilled water, 
and then stained at room temperature for 2hr, using a colloidal Coomassie blue stain (Neuhoff et 
al. 1988; Kang et al. 2002) (Appendix 3). After 2hr, the gel was de-stained in sterile distilled 
water for 8hr, shaking (50rpm) at room temperature using a MRC Orbital Shaker. Each gel was 
dried in a gel-dryer (Bio-Rad GelAir Dryer; www.bio-rad.com) and then photographed using the 
VersaDoc Gel Imaging System 4000.  
 
5.2.5 Gel scoring and interpretation 
Similarity matrices and dendrograms were generated for each protein profile obtained from SDS-
PAGE and UTLIEF. For the similarity matrices construction, bands were scored as present (1) or 
absent (0). The fragment data was converted to binary data by generating a binary matrix (0, 1) 
using the banding patterns of each individual. The NTSYS v2.1 software programme (Numerical 
Taxonomy and Multivariate Analysis for personal computers, Exeter Software, Setauket, NY, 
U.S.A.) was used to evaluate the similarities between the protein banding patterns for each 
phage. Pair-wise comparisons were made between phage protein profiles based on DICE (Dice 
1945) similarity coefficient; a statistic used for comparison of similarities between two samples. 
The resultant distance matrix data was used to construct a dendrogram using the agglomerative 
hierarchical un-weighted pair-group method with an arithmetic average (UPGMA) sub-
programme of NYSTS (Rohlf, 1998). Additionally, banding data was used to create standard 
curves and logarithmic and linear equations were used to extrapolate unknown molecular 




5.3.1 SDS-PAGE  
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Results derived from SDS-PAGE (Figure 5.1) were used to determine approximate molecular 
weights (kDa) for phage proteins. In addition, results were subjected to phylogenetic analysis to 
determine whether phages Sabp-P1, Sabp-P2 and Sabp-P3 differed from each other in terms of 
their protein content.   





revealed that each phage is comprised of several different sized proteins (Figure 5.1). Phages, 
Sabp-P1 and Sabp-P3, produced profiles comprising of 17 proteins while Sabp-P2 produced a 
profile comprising of 15 proteins.  While all three phages appear to have several similar sized 
proteins in common, distinctive differences were also apparent between each phage profile 


















Figure 5.1 SDS-polyacrylamide gel electrophoresis of proteins of phages Sabp-P1, Sabp-P2 and 
Sabp-P3. Lane identity:  1 = Protein marker; 2 & 5 = Sabp-P1; 3 & 6 = Sabp-P2; 4 & 7 = Sabp-P3; 8 = 
Positive control (Tobacco mosaic virus).  
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Table 5.1 Approximate molecular weights for proteins of phages Sabp-P1, Sabp-P2 and Sabp-P3 
that were separated during SDS-PAGE. 
 
Protein marker Approximate MW (kDa) of phage proteins 
Band no. MW (kDa) Sabp-P1 Sabp-P2 Sabp-P3 
1 170 171.66 171.66 171.66 
2 130 143.81 124.94 124.94 
3 100 124.94 115.04 115.04 
4 70 95.76 92.55 102.74 
5 55 81.23 78.71 89.51 
6 40 71.73 71.73 78.71 
7 35 65.49 65.49 71.73 
8 25 53.06 53.06 54.68 
9 15 49.94 49.94 51.48 
10 10 45.55 46.97 44.15 
  42.79 44.15 40.15 
  37.63 40.15 36.41 
  34.04 36.41 29.57 
  30.65 29.57 25.41 
  24.41 20.58 19.67 
  19.67  15.27 
  15.27  8.86 
 
 
The data of relative mobility and molecular weight of the protein marker were used to plot a 
standard curve of mobility versus molecular weight (Figure 5.2). The logarithmic equation 
derived from the standard curve was used to determine approximate molecular weights of 
proteins of Sabp-P1, Sabp-P2 and Sabp-P3 (Table 5.1). Proteins ranged in size from 15.27-



























































Figure 5.2 Standard curve for proteins separated during SDS-PAGE. 
(x) actual molecular weights for protein marker; (—) fitted logarithmic trendline; (*) logarithmic equation 
and regression coefficient for extrapolation of unknown protein molecular weights. 
 
 
Band fragment data (Figure 5.1) was used to construct a dendogram using the UPGMA sub-
program on NTSYS (Figure 5.3). Phages Sabp-P1 and Sabp-P2 were clearly distinguishable 
from Sabp-P3, based on the combined data presented in the dendogram (r
2
=96.63%). Combined 
similarity matrices (Appendix 3) showed an 84.62% similarity between Sabp-P1 and Sabp-P2 
















Figure 5.3 Phylogenetic tree comparing SDS-PAGE protein profiles for phages Sabp-P1, Sabp-
P2 and Sabp-P3.  
5.3.2 UTLIEF 





revealed that proteins of each phage displayed varying isoelectric points along the pH range of 
the gel. While all three phages appeared to have proteins with similar isoelectric points in 

































Figure 5.4 UTLIEF of phage proteins. Lane identity: 1 &14 = Markers; 2, 3, 8, 9 = Sabp-P3; 4, 5, 10, 
11 = Sabp-P2; 6, 7, 12, 13 = Sabp-P1. 
 
Table 5.2 Approximate isoelectric points (pI) for proteins of phages Sabp-P1, Sabp-P2 and 
Sabp-P3 that were separated during UTLIEF. 
Isoelectric marker Approximate isoelectric point (pI) of phage proteins 
Band no. Isoelectric point (kDa) Sabp-P1 Sabp-P2 Sabp-P3 
1 1 6.60 6.26 4.21 
2 2 6.94 6.77 4.55 
3 3 7.79 7.11 6.26 
4 4a
* 
  6.60 
5 4c
** 
  7.11 
6 5   8.13 
7 6a
* 
   
8 6c    
9 7a
*
    
10 7m
*** 
   
11 7c
**
    
12 8    
13 9    
*
Migration towards anode; 
**
Migration towards cathode; 
***
Migration midway between anode 
and cathode 
1 












































The data of relative mobility and isoelectric point of the protein marker were used to plot a 
standard curve of mobility versus isoelectric point (Figure 5.5). The linear equation derived from 
the standard curve was used to determine approximate isoelectric point of proteins of Sabp-P1, 
Sabp-P2 and Sabp-P3 (Table 5.2). Approximate isoelectric point for all three phages ranged from 





















Figure 5.5 Standard curve for migration of proteins according to isoelectric points during ultra-
thin isoelectric focusing.  
(x) actual molecular weights for protein marker; (—) fitted linear trendline; (*) linear equation and 
regression coefficient for extrapolation of unknown protein molecular weights. 
 
Band fragment data from Figure 5.4 was used to construct a dendogram using the UPGMA sub-
program on NTSYS (Figure 5.6). Contrary to the results from SDS-PAGE, where phages Sabp-
P1 and Sabp-P2 were clearly distinguishable from Sabp-P3, based on relative size of protein 
fragments, combined analysis of UTLIEF data presented in the dendogram (r
2
=80.80%) showed 
that, based on the isoelectric point of proteins, phages Sabp-P2 and Sabp-P3 showed similarity to 
each other and were different from Sabp-P1 (Figure 5.6). Combined similarity matrices 
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(Appendix 3) showed a 66.67% similarity between phages Sabp-P1 and Sabp-P2 and a 54.55% 












Figure 5.6 Phylogenetic tree comparing relative isoelectric focussing profiles of different phages 
proteins.  
 
5.3.3 Comparison of SDS-PAGE and UTLIEF  
A comparison of all data obtained during both SDS-PAGE and UTLIEF were compared to each 
other to determine any relatedness between phages Sabp-P1, Sabp-P2 and Sabp-P3. Combined 
analysis presented in the dendogram (r
2
= 98.27%) revealed that Sabp-P1 and Sabp-P2 were more 
related to each other, than either to Sabp-P3 (Figure 5.7). Combined similarity matrices 
(Appendix 3) showed an 80.00% similarity between phages Sabp-P1 and Sabp-P2, and a 68.29% 

























Figure 5.7 Phylogenetic tree comparing combined data from SDS-PAGE and UTLIEF to 
determine differences between phage strains, Sabp-P1, Sabp-P2 and Sabp-P3.  
 
5.4 Discussion 
Characterisation of phages through analysis of their proteomes is a dynamic field of research. 
This form of characterisation serves as a supplementary technology to genomic analysis and can 
aid in the characterisation of newly discovered phages. Typical methods of analysis include one-
dimensional (SDS-PAGE, IEF) and two-dimensional electrophoresis, spectrophotometric 
methods (matrix assisted laser desorption/ionization, mass spectrometry), immunoblotting 
(Western blot) or chromatographic methods (Berkelman and Stenstedt, 1998). Each of these 
methods characterizes phage proteins, based on different factors ranging from molecular weight, 
to isoelectric charge, to mass-to-charge ratios (Berkelman and Stenstedt, 1998). The current 
study investigated one-dimensional electrophoretic analysis of proteins from three different 
strains of staphylococcal phages, in order to determine whether the phages differed from each 
other.  
Although a majority of proteins encoded by phages with larger genomes have no matches 
in current sequence databases, and hence have undiscovered functions, there is a core set of 
Dice Coefficient










genes that encode for common proteins mainly involved in morphogenesis and nucleotide 
processing (Eyer et al. 2007; Carvalho et al. 2012). The most abundant proteins that appear in 
any electrophoretic profile for phages are the major capsid proteins and the major tail sheath 
proteins (Lee and Stewart, 1965; Eyer et al. 2007; Lood and Collin, 2011). Analysis of phage 
proteins using SDS-PAGE showed that phages Sabp-P1, Sabp-P2 and Sabp-P3 comprised of 
proteins that ranged in size from 8.86kDa to 171.66kDa. From the identified protein sizes, nine 
sizes were common amongst all three phage, with the largest being 171.66kDa. It has been 
postulated that high molecular weight proteins, in the range from 160kDa up to 500kDa, 
represent a major head protein, and is probably a complex of 6-8 monomers (Lood and Collins, 
2011). Additionally, it appears that this protein complex is not easily disrupted into smaller 
components, even during lysis by boiling in SDS reducing buffer (Lood and Collin, 2011). 
Similar results have been reported by Popa et al. (1991) with Enterobacteria phage HK97, which 
has complexes of covalently linked major head proteins, instead of a single major head protein 
that exists as a monomer.     
Lood and Collin (2011) also identified several other proteins that showed correlation to 
phages Sabp-P1, Sabp-P2 and Sabp-P3 (in terms of relative molecular weight). Protein Gp14 
(tape measure protein) was estimated to have a molecular weight of approximately 65kDa. This 
was similar to Sabp-P1 and Sabp-P2 which showed presence of similar sized proteins. Sabp-P1 
seemed to lack this protein completely. Additionally, protein Gp3 (~48kDa), or portal protein, 
showed molecular weight similarity to Sabp-P1 (~49kDa) and Sabp-P2 (~49kDa). Müller et al. 
(1994) identified phage tail tube proteins with molecular weights (~20kDa) that were similar to 
all three phages. Protein fragments in the range of 70-109kDa have been associated with major 
tail proteins of phages (Miller et al. 2003; Lood and Collin, 2011). Sabp-P1, Sabp-P2 and Sabp-
P3 showed both major and minor band fragments in this region. These proteins could be 
associated with the synthesis of the phage tail and associated structures (tail sheath, tail fibres). 
Although SDS-PAGE was able to resolve the proteins of each phage and produce a distinctive 
protein profile for each, proteomic sequence analysis is required in order to fully characterize 
each derived protein. For the purposes of the current study, SDS-PAGE analysis adequately 
revealed that, based on protein profiling, each phage represented a unique strain.  
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The differences between strains were further corroborated through UTLIEF analysis of 
phage proteins. Sample treatment conditions differed between SDS-PAGE and UTLIEF. 
Generally, during two-dimensional analysis, where IEF is followed by SDS-PAGE, a single band 
derived from IEF can yield more than one band when resolved during SDS-PAGE (Brown et al. 
1980). In the current study, the number of protein fragments generated, differed between the 
methods, and subsequently, so did the results of UTLIEF phylogenetic analysis. Phage Sabp-P1 
differed significantly in terms of relative protein charge, from both Sabp-P2 and Sabp-P3. 
However, overall similarity matrices showed that although there was a degree of homology 
between each phage, they were still clearly different from each other. The application of 
isoelectric focusing for protein resolution is a well documented method (Berkelman and 
Stenstedt, 1998). However, the use of ultra-thin isoelectric focusing is a new method that has not 
been previously applied to separate phage proteins. The current study presents novelty in this 
respect, as it adds a further technique to the spectrum of phage analysis methodology. Although 
much optimization was required before positive results were obtained, the method was able to 
produce a unique isoelectric profile for each phage, with good resolution of bands.  
 
5.5 Conclusion 
Two different methods of protein profile analysis were successfully applied to differentiate 
between three strains of staphylococcal phages. Both techniques confirmed that phages Sabp-P1, 
Sabp-P2 and Sabp-P3 were three different strains of phage. While current results are based on 
putative protein fragments analysis, complete protein sequencing would be necessary in order to 
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Preliminary genomic characterization of bacteriophages with specific lytic activity against 
Staphylococcus aureus, associated with bovine mastitis 
Abstract 
Staphylococcus aureus subsp. aureus Rosenbach 1884 is the primary causal agent of bovine 
mastitis. Phages were selected for use in a biological control program aimed at reducing 
staphylococcal-associated infections in dairy cattle. The aim of the current study was to 
genomically characterize three staphylococcal phages, Sabp-P1, Sabp-P2 and Sabp-P3, using 
restriction fragment length analysis and whole genome sequencing. Results showed that the 
genomes of phages Sabp-P1, Sabp-P2 and Sabp-P3 were all different from each other. Phages 
Sabp-P1 and Sabp-P3 showed sequence homology to a form of Pseudomonas phages labelled 
―giant‖ phages. Phage Sabp-P3 showed sequence homology to a Clostridium perfringens phage. 
The major functional proteins of phages (tail tape measure protein, virion structural proteins, 
head morphogenesis proteins, and capsid proteins) were identified in all three phages. However, 
although the level of sequence similarity between the screened phages and those already found 
on the databases enabled preliminary classification of the phages into the order Caudovirales, 
family Myoviridae, the level of homology was not sufficient to assign each phage to a particular 
type species. Results suggest that phage Sabp-P1 especially, might be a new species of phage 
within the Myoviridae family. The long-term objective of the sequencing study is to carry out 
complete assembly and annotation of all the contigs for each phage. This will provide definitive 
conclusions in terms of phage relatedness and classification. 
6.1 Introduction 
Genomic characterization serves as one of the most accurate means of distinction between 
organisms. There are approximately 500 phage genome sequences available in the NCBI phage 
database with genomes ranging from 15-500kbp in size (Gutiérrez et al. 2011). Tailed phages of 
the order Caudovirales constitute the most extensive group of bacterial viruses, comprising up to 
96% of phages identified so far (Ackermann, 2007; Gutiérrez et al.2011). These phages consist 
of a protein shell, linear dsDNA, and lack any type of envelope (Ackermann, 2005; 2007). Phage 
heads are icosahedral and tails are true helices that consist of stacked discs. These tails usually 
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possess terminal adsorption structures such as base plates, spikes or tail fibres (Ackermann, 
2005). Although these phages constitute a monophyletic group possessing related properties 
(morphological, physicochemical, physiological), and have been classified into a single order, 
Caudovirales, their individual properties are rather varied. Typically, they differ in terms of 
dimension and fine structure, DNA content and composition, nature of constitutive proteins, 
serology and host range (Ackermann, 2005). Ackermann (2005) has devised a criterion to 
distinguish between these phages: (1) Myoviridae, with contractile tails consisting of a sheath 
and central tube, approximately 25% of tailed phages; (2) Siphoviridae, with long, non-
contractile tails, approximately 61% of tailed phages; and, (3) Podoviridae, with short, non-
contractile tails, approximately 14% of tailed phages.  
Phage genomes are large and complex, and they are usually organized into 
interchangeable modules, with genes for related functions clustered together (Ackermann, 2005; 
2007). Replicating DNA tends to form large, branched concatemers, which are then cut into unit 
lengths and inserted into preformed capsids (Ackermann, 2005). Virion assembly of individual 
components (heads, tails, tail fibres) takes places via separate pathways which forms the last 
stage of the maturation process (Ackermann, 2005). Newly assembled phage particles are then 
liberated into the surrounding environment via lysis of the host bacterium (Ackermann, 2005).  
While tailed phages do comprise the majority of bacterial viruses, tailless phages also 
occur (Ackermann, 2005). These include only about 190 known viruses corresponding to less 
than 4% of the currently recognised bacterial viruses (Ackermann, 2005). They are classified 
into 10 small families, occur enveloped or non-enveloped, and are of three types: polyhedral 
phages that are icosahedral with cubic symmetry and either DNA or RNA constituted, 
filamentous phages with helical symmetry that are DNA constituted, and a few pleomorphic 
types without obvious symmetric axes that are also DNA constituted (Ackermann, 2005). 
Several phages specific to mastitis-causing Staphylococcus aureus subsp. aureus 
Rosenbach 1884, have been sequenced, either completely or partially (Bon et al.1997; 
O‘Flaherty et al, 2004; Kwan et al.2005; Garcia et al.2009; Lavigne et al.2009; Hsieh et al.2011; 
Vandersteegen et al.2011). These studies have contributed significantly to understanding the 
diversity of the phage genome, as well mechanisms such as lateral gene transfer and illegitimate 
recombination that drive bacterial genetic diversity (Kwan et al.2005). The number of known, 
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strictly lytic phages is limited to the close-knit Myoviridae genus of the SPO1-like viruses which 
also contains phages K, Twort and G1 (O‘Flaherty et al. 2004; García et al. 2009). Apart from 
this group, a large number of genomes from unclassified Siphoviridae in lysogenic S. aureus 
strains are available (Kwan et al. 2005). Some lysogenic phages may play an important role in 
the pathogenicity of S. aureus by carrying virulence factors, mediating lateral gene transfer and 
possibly facilitating adaptation of the pathogen during infection (Górski et al. 2009). Kwan et al. 
(2005) sequenced the complete genomes and proteomes of 27 S. aureus phages. Comparative 
nucleotide and protein sequence analysis was used to group these phages into three classes: 
<20kbp, ~40kbp and >125kbp. García et al. (2009) also presented a detailed genomic and 
molecular characterisation of two S. aureus lytic phages. Other studies conducted by various 
researchers also on sequence analysis of S. aureus phages (O‘Flaherty et al. 2004; Rashel et al. 
2008; Vandersteegen et al. 2011; Gu et al. 2012; Kwiatek et al. 2012) have provided a solid 
background for future comparative studies.  
While studies into phage genomics, particularly of S. aureus phages, have taken place in 
other parts of the world, within a South African perspective, this remains an area of significant 
novelty. There are currently no other known staphylococcal phage studies underway, either in 
terms of genomics or practical application of phages against bovine mastitis in South Africa.  
This study served to characterize staphylococcal phages that were isolated from dairy 
cows diagnosed with bovine mastitis. Through morphological analyses of phage structure and 
infection cycle, these phages were preliminarily classified into the order Caudovirales, family 
Myoviridae. Preliminary genomic characterization was undertaken in order to derive further 
information on the relatedness of each phage towards each other and to those phages that have 
already been sequenced worldwide.  
  
6.2 Materials and Methods 
6.2.1 Bacterial host strains and their isolation 
The S. aureus strain, SaB1, was used for phage isolation and propagation. This strain was 
isolated from raw bovine milk collected from dairy farms in the province of KwaZulu-Natal, 
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RSA (Republic of South Africa). SaB1 was initially isolated on blood agar. Cultures required for 
phage propagation were maintained on tryptone soy agar (TSA) or typtone soy broth (TSB). 
 
6.2.2 Phage isolation, propagation and purification 
Raw bovine milk samples collected from dairy farms in the province of KwaZulu-Natal, RSA 
(Republic of South Africa) served as the initial material from which to isolate phages. These 
milk samples were chosen at random and included milk with both high (>400,000cells ml
-1
) and 
low somatic cell counts (SCC). All milk samples were stored on ice during transit, or at 4ºC in 
the laboratory.  
Phages were isolated using the spot-test method on double-layer agar (Sambrook et 




, was incorporated into 7% top 
agar that was supplemented with 1M CaCl2. Raw milk samples were filtered through a 0.45μm 
syringe filter. Filtered samples were then spotted onto the surface of solidified top agar at 10μl 
per spot. Plates were allowed to dry for 2hr, followed by incubation for 12hr at 37ºC. Zones of 
clearing (plaques) were indicative of phage activity. Plaques were removed from top agar and 
soaked in phage buffer (Appendix 1) for 12hr with gentle agitation (150rpm) at 4ºC. The 
resulting suspension was centrifuged using the Avanti J-26 XPI (www.beckmancoulter.com) at 
10,000g x 10min at 4ºC. The supernatant was filtered using a 0.45μm syringe filter and stored as 
phage stock at 4ºC. Subsequent phage was grown from this stock in liquid broth culture or using 
the double-layer agar method (Sambrook et al.1989). 
Isolated phages were purified through a modification of standard methods (Sambrook et 
al.1989; Harley and Prescott, 1993). Filter-sterilised phage stock isolated from either liquid broth 
culture or double-layer agar method, were subjected to centrifugation using the Avanti J-26 XPI 
(Beckman-Coulter, www.beckmancoulter.com) at 75,600g x 3hr at 10ºC. Resulting phage pellets 
were re-suspended in fresh phage buffer and a second centrifugation was conducted (Avanti J-26 
XPI at 75,600g x 3hrs x 10ºC). The phage pellets were then re-suspended in fresh phage buffer at 
1/10 of the original volume that was processed. All stocks were stored at 4ºC.  
A total of 28 phages were isolated. However, only three showed consistency with regard 
to host cell lysis and growth requirements. These three phages were used for subsequent 
screening and were named Sabp-P1, Sabp-P2 and Sabp-P3.  
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6.2.3 DNA extraction  
Phage DNA was extracted using a modification of methods by Sambrook et al. (1989). Purified 









. The phage suspension was centrifuged at 75,600g x 3hr at 10ºC using the Avanti  J-26 XPI 
(Beckman-Coulter) centrifuge. Phage pellets were re-suspended in 400µl SDS buffer (20%) and 
incubated at 80ºC x 30min. Thereafter, 400µl cetyltrimethyl ammonium bromide (CTAB) was 
added and tube was gently shaken. 400µl chloroform: isoamyl alcohol (24:1) with 5% phenol, 
was added to the tube. The tube was centrifuged at 14,000g x 10min at 4ºC. 600µl of the clear 
aqueous phase was drawn off, taking care to avoid the impurity-laden organic phase. An equal 
volume (600µl) of isopropanol was added to the tube, followed by incubation for 1hr at 4ºC. 
After 1hr, the tube was centrifuged at 14,000g x 10mins at 4ºC. The DNA pellet was washed 
twice in cold (4ºC) 70% ethanol, air-dried in a laminar flow unit for 30min, followed by final re-
suspension in 500µl 1x Tris-EDTA (Appendix 4). All isolated DNA was stored at -20ºC. A 
Nanodrop-100
1
 was used to quantify the concentration and quality of phage DNA. Phage DNA 
was also analysed using standard agarose gel electrophoresis to check for presence and quality 
(Appendix 4).   
6.2.4 Restriction endonuclease digestion and agarose gel electrophoresis 
Phage DNA was treated with the following restriction endonucleases: EcoR1 (Fast Digest) 
(www.fermentas.com), EcoRV (Fast Digest) (www.fermentas.com), HindIII (www.neb.com), 
BamH1 (www.neb.com), and PvuII (Fast Digest) ( www.fermentas.com). Samples preparations 
were according to manufacturer instructions. The only amendment that was made for each 
enzyme was incubation time: all digests, including those using fast-digest enzymes, were left to 
proceed for 1hr at 37ºC. The O‘Gene Ruler 1kb Plus DNA Ladder (www.fermentas.com) was 
used as the marker.  
 Restriction products were analysed on a horizontal 1% (w/v) agarose gel with 1xTAE 
buffer (Appendix 4) (Sambrook and Russell, 2010). All digests were run at 100V for 60min (or 
until loading dye was 1cm from bottom of gel), using the Labnet Electrophoresis Sub System 70 
(Model E-0310) (www.labnetinternational.com) powered off a Bio-Rad Power Pack 300 
(www.bio-rad.com). Gels were post-stained in 1x TAE buffer (augmented with 0.01% ethidium 
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bromide) for 30min. Gels were viewed and photographed using the VersaDoc Gel Imaging 
System 4000
 
(www.bio-rad.com).   
6.2.5 Gel scoring and intepretation 
Quantitative analysis of gel banding patterns was carried out using NtSys 
(www.exetersoftware.com). Regression coefficients were calculated for data using the Mantel 
(1967) method. Matrix comparison tests were carried out to quantify differences between 
banding patterns of each phage. Standard curves were created and logarithmic equations were 
used to extrapolate unknown molecular weights for each band.  
 
6.2.6 Genome sequencing 
a. Sequencing  
Approximately 2ug of phage DNA of each sample was sequenced using 454 pyrosequencing 
technology for a Roche genome sequencer GS FLX system (www.454.com). The Roche 454 
technology allowed for sample multiplexing combined with average to long read lengths of each 
library. The complete sequencing workflow of the GS FLX system comprised of four major 
steps, leading from purified DNA to analysed results: (1) generation of a single-stranded 
amplicon DNA library using Ampure (www.454.com) (a high sensitivity QC chip), a qPCR 
quantitation (www.454.com), and equimolar pooling; (2) emulsion-based clonal amplification of 
the library where libraries were attached to DNA Capture Beads (www.454.com), with each bead 
carrying a unique, single-stranded library fragment. Beads were emulsified with amplification 
reagents in a water-in-oil mixture to trap individual beads in amplification microreactors. The 
entire emulsion was amplified in parallel to create millions of clonal copies of each library 
fragment on each bead. Amplified fragments remained bound to their specific beads even after 
breaking of the emulsion; (3) Data generation via sequencing-by-synthesis, where beads were 
loaded onto the PicoTiterPlate (www.454.com) (PTP) device which allows only one bead per 
well. This was followed by a FLX Titanium sequence run on the PTP. Individual nucleotides 
were flowed in sequence across the wells. Each incorporation of a nucleotide complementary to 
the template strands on the beads resulted in a chemiluminescent light signal recorded by a 
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camera; (4) data processing with software that used the signal intensity of each incorporation 
event at each well position to determine the sequence of all reads in parallel.  
b. Analysis of phage genome 
Phage genome sequences were analysed using Artemis Release 14.0.0 (www.sanger.ac.uk) 
program. Genome mapping was then carried out using pDraw 32 (www.acalone.com).  
6.3 Results 
6.3.1 Restriction fragment length analysis 
Analysis of agarose gels post-restriction, revealed that the DNA from all three phages appeared 
resistant to digestion by the following enzymes: EcoRv (Fast Digest), BamHI, HindIII, and PvuII 
(Fast Digest). The phage DNA was successfully digested using only EcoRI.  Results derived 
from restriction digestion of phage DNA (Fig. 6.1) were used to determine approximate 
molecular weights (kbp) for the genome of each phage. In addition, results were subjected to 
phylogenetic analysis to determine whether phages Sabp-P1, Sabp-P2 and Sabp-P3 differed from 
each other in terms of the relative sizes of their genomes.   





revealed that each phage possessed a different sized genome (Fig. 6.1, Table 6.1). The data of 
relative mobility and molecular weight of the DNA marker were used to plot a standard curve of 
mobility versus molecular weight (Fig. 6.2). The logarithmic equation derived from the standard 
curve was used to determine approximate molecular weights for individual DNA fragments of 
Sabp-P1, Sabp-P2 and Sabp-P3 (Table 6.1).  Combined sums of each of the range of fragments 
for each phage showed that Sabp-P1 contained a genome measuring approximately 107kbp, 
Sabp-P2 contained a genome measuring approximately 70kbp, and Sabp-P3 contained a genome 






















Figure 6.1 Restriction fragments of phage DNA that was digested using the restriction enzyme, 
EcoRI. Lane identity:  1 = 1kb Plus DNA Ladder; 2 = Sabp-P1 undigested; 3 = Sabp-P1 restriction 
digest; 4 = Sabp-P2 undigested; 5 = Sabp-P2 restriction digest; 6 = Sabp-P3 undigested; 7 = Sabp-P3 
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Table 6.1 Approximate molecular weights (kbp) of phage DNA digested with restriction 
enzymes 
DNA ladder (1kb Plus) Approximate MW (kbp) of phage genomes 
Band no. MW (bp) Sabp-P1 Sabp-P2 Sabp-P3 
1 20,000 11,581 12,046 12,555 
2 10,000 10,388 10,757 10,757 
3 7,000 9,719 7,876 10,043 
4 5,000 9,125 7,053 9,414 
5 4,000 7,877 6,339 8,851 
6 3,000 6,865 5,860 8,341 
7 2,000 6,175 5,563 7,876 
8 1,500 5,710 5,282 7,247 
9 1,000 5,282 4,886 6,684 
10 700 5,015 4,400 6,339 
11 500 4,673  5,860 
12 400 4,400  5,563 
13 300 4,172  5,147 
14 200 3,954  4,637 
15 75 3,745  4,400 
  3,161  3,954 
  2,805  2,980 
  2,470  2,552 
 
 
Band fragment data (Fig. 6.1) was used to construct a dendogram using the UPGMA sub-
program on NTSYS (Fig. 6.3). Phages Sabp-P1 and Sabp-P3 were clearly distinguishable from 
Sabp-P2 based on combined data presented in the dendogram (r
2
=96.82%). Combined similarity 
matrices (Appendix 4) showed a 70.97% similarity between Sabp-P1 and Sabp-P2 and an 
















































Figure 6.2 Standard curve for molecular weight of DNA for analysis of phage DNA fragments.   
(x) actual molecular weights for protein marker; (—) fitted logarithmic trendline; (*) logarithmic equation 











Figure 6.3 Phylogenetic tree comparing relative DNA banding patterns for three different strains 
of phage, Sabp-P1, Sabp-P2 and Sabp-P3.  
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6.3.2 Combined analysis of DNA and protein profiling  
A comparison of all data obtained during both protein profiling (Chapter 5) and restriction 
fragment length analysis were compared to each other to determine relatedness between phages 
Sabp-P1, Sabp-P2 and Sabp-P3. Combined analysis presented in the dendogram (r
2
= 71.46%) 
revealed that Sabp-P1 and Sabp-P3 were more related to each other, than either to Sabp-P2 (Fig. 
6.4). Combined similarity matrices (Appendix 4) showed a 75.76% similarity between phages 
Sabp-P1 and Sabp-P2, and a 76.92% similarity between Sabp-P1 and Sabp-P3. Sabp-P2 showed 
a 72.73% similarity to Sabp-P3.  
Dice Coefficient






Figure 6.4 Phylogenetic tree comparing combined data from DNA and protein profiling (SDS-
PAGE and UTLIEF) to determine differences between phage strains, Sabp-P1, Sabp-P2 and 
Sabp-P3. 
 
6.3.4 Genome sequencing  
Whole-genome shotgun sequencing of the genetic material of phage Sabp-P1 generated 3.8Mb 
of data that was assembled into 172 contigs with a total size of 367854bp (Table 6.2). Mean 
contig length was 2138bp, and average G+C content was 47%. With Sabp-P2, a total of 10.47Mb 
of data was generated that was assembled into 116 contigs with a total size of 425240bp (Table 
6.2). Mean contig length was 3665bp, and average G+C content was 38%. The genome of phage 
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Sabp-P3 measured 333889bp and comprised of 49 contigs with a mean contig size of 6814bp 
(Table 6.2). The average G+C content for Sabp-P3 was 39%. 
Preliminary comparison of open reading frames (ORFs) of all three phages showed that 
Sabp-P1 had zero sequence similarity to either Sabp-P2 or Sabp-P3. Phages Sabp-P2 and Sabp-
P3 showed genetic relatedness as demonstrated by commonly shared ORFs, but each also 
possessed divergent ORFs.  
 
Table 6.2 Sequence results from whole genome sequencing of phages Sabp-P1, Sabp-P2 and 
Sabp-P3.  
Data description Phage 
 Sabp-P1 Sabp-P2 Sabp-P3 
Total number of reads 10597 29188 12412 
Total genome size (bp) 367854 425240 333889 
Number of contigs 172 116 49 
Average contig size (bp) 2138 3665 6814 
N50 contig size
* 
4990 241493 25278 
Largest contig size (bp) 48928 241493 102301 
Q40 Plus bases
** 
354908, 96.48% 418478,98.41% 330325, 98.93% 
G+C content (%) 47 38 39 
Amount of data generated 
(Mb) 
3.8 10.47 4.49 
*N50 contig size = >50% of total bases have contigs of 4990 for Sabp-P1, 241493 for Sabp-P2, and 25728 for Sabp-
P3 bases or more; **Q40 Plus bases = quality metric where for every 93.48% (Sabp-P1), 98.41% (Sabp-P2) and 
98.93% (Sabp-P3) of reads, the error rate was 1 in 10000.  
The largest contig for phage Sabp-P1 was analysed against known sequences in genomic 
databases
1
. Artemis Release 14.0.0
8
 was used to predict coding sequences (CDS) on the Sabp-P1 
contig. The CDSs were compared to other known sequences using BLASTp
8
 analysis. Analysis 
showed the presence of several key diagnostic proteins that are associated with phage biology 
and replication. Genes encoding for major proteins associated with head and tail assembly as 
well several other putative proteins with unknown functions were identified (Table 6.3). Genes 




encoding for replicative proteins, such as endonucleases and DNA replicase, were also found. It 
was also found that Sabp-P1 showed sequence similarity to two pseudomonad phages, isolated 
from Pseudomonas fluorescens Migula, 1895 and P. aeruginosa  Migula, 1900 (Cornelissen et 
al.2012). Sequence identity, however, was not higher than 51% for any given gene.  A 
noteworthy finding was that Sabp-P1 showed no sequence homology to any other staphylococcal 
phage that was listed on the genomic database. Sequence homology to key diagnostic proteins, 
especially the tail tape measure protein, can confirm that this phage is of the order Caudovirales, 
and part of the Myoviridae family. 
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Table 6.3 List of identified proteins and their predicted functions for phage Sabp-P1.  
Protein  No. of 
bases 




Predicted protein function BLASTp best match Accession 
reference 
1 1221 406 51 Putative virion-associated RNA polymerase beta‘ 
subunit 
Pseudomonas phage OBP YP_004958184.1 
2 1512 503 50 Hypothetical protein PPEV_gp173 Pseudomonas phage EL YP_418206.1 
3 453 151 50 Hypothetical protein PAJU2_gp19 Pseudomonas phage PAJU2 YP_002284353.1 
4 1194 397 49 Putative virion-associated RNA polymerase beta‘ 
subunit 
Pseudomonas phage OBP YP_004958185.1 
5 816 272 49 Hypothetical protein SDSG_00020 Silicibacter phage DSS3-P1 AET42286.1 
6 687 228 48 Putative virion structural protein Pseudomonas phage OBP YP_004958175.1 
7 1935 645 48 Hypothetical protein BPPAW11_00710 Pseudomonas phage 
YMC/01/01/P52_PAE-BP 
AFQ22096.1 
8 957 319 48 Putative head morphogenesis protein Pseudomonas phage phi297 YP_005098071.1 
9 1077 359 47 Putative coat protein Pseudomonas phage phi297 YP_005098074.1 
10 465 155 47 Deoxyuridine 5‘-triphosphate nucleotidohydrolase Erwinia phage vB_EamM-Y2 YP_007004707.1 
11 2661 887 47 Hypothetical protein PAJU2_gp22 Pseudomonas phage PAJU2 YP_002284356.1 
12 489 163 46 Hypothetical protein PAJU2_gp20 Pseudomonas phage PAJU2 YP_002284354.1 
13 1398 466 45 Replicative DNA helicase Pseudomonas phage phi297 YP_005098095.1 
14 912 303 45 Hypothetical protein PPEV_gp005 Pseudomonas phage EL YP_418038.1 
15 2214 737 45 Hypothetical protein PPEV_gp182 Pseudomonas phage EL YP_418215.1 
16 459 152 44 Hypothetical protein PPEV_gp180 Pseudomonas phage EL YP_418213.1 
17 519 172 43 Hypothetical protein PPEV_gp194 Pseudomonas phage EL YP_418227.1 
18 1842 613 43 Putative virion-associated SNF2-domain 
containing helicase 
Pseudomonas phage OBP YP_004958170.1 
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Table 6.3 continued     
Protein  No. of 
bases 




Predicted protein function BLASTp best match Accession 
reference 
19 906 301 43 Virion structural protein Pseudomonas phage 201phi2-
1 
YP_001956953.1 
20 1515 504 42 Hypothetical protein PPEV_gp171 Pseudomonas phage EL YP_418204.1 
21 1326 441 42 Hypothetical protein PPEV_gp169 Pseudomonas phage EL YP_418202.1 
22 729 243 42 hypothetical protein PMI34_01895 Pseudomonas sp. GM74 ZP_10626697.1 
23 804 268 42 IstB domain protein ATP-binding protein Pseudomonas syringae pv. 
maculicola str. ES4326 
EGH59120.1 
24 1542 514 42 Putative T5 A1-like protein Caulobacter phage phiCbK YP_006988022.1 
25 3408 1136 41 Tail tape measure protein  Pseudomonas phage phi297 YP_005098093.1 
26 492 163 41 Hypothetical protein PPEV_gp178 Pseudomonas phage EL YP_418211.1 
27 744 248 41 Hypothetical protein phi297_00054 Pseudomonas phage phi297 YP_005098081.1 
28 1425 475 41 Hypothetical protein SPN3UB_0003 Salmonella phage SPN3UB YP_007010973.1 
29 1029 342 40 Putative endonuclease Pseudomonas phage PhiPA3 AEH03633.1 
30 879 292 40 Hypothetical protein PPEV_gp188 Pseudomonas phage EL YP_418221.1 
31 738 245 40 Hypothetical protein PPEV_gp191 Pseudomonas phage EL YP_418224.1 
32 795 265 39 C-5 cytosine-specific DNA methylase Mycobacterium phage SG4 AER49474.1 
33 639 212 38 Putative virion structural protein Pseudomonas phage OBP YP_004958165.1 
34 606 201 38 Dihydrofolate reductase Listeria marthii FSL S4-120 ZP_07871197.1 
35 903 300 38 Hypothetical protein PPEV_gp192 Pseudomonas phage EL YP_418225.1 
36 3204 1067 38 Hypothetical protein PPEV_gp186 Pseudomonas phage EL YP_418219.1 
37 585 195 38 Hypothetical protein Rhodococcus phage REQ2 YP_005087102.1 





Table 6.3 continued     
Protein  No. of 
bases 




Predicted protein function BLASTp best match Accession 
reference 
39 2667 888 37 Hypothetical protein PPEV_gp008 Pseudomonas phage EL YP_418041.1 
40 2163 720 37 Hypothetical protein PPEV_gp006 Pseudomonas phage EL YP_418039.1 
41 7785 2594 37 Putative phage-related lysozyme domain Pseudomonas phage EL YP_418216.1 
42 738 245 37 Thymidine kinase Aeromonas phage Aes508 YP_007010778.1 
43 1203 400 36 Putative thymidylate synthase  Pseudomonas phage OBP YP_004958141.1 
44 558 186 36 Hypothetical protein ORF003 Pseudomonas phage PA11 YP_001294596.1 
45 459 153 36 Possible small terminase subunit Enterobacteria phage ES18 YP_224139.1 
46 486 162 36 Possible endopeptidase Burkholderia phage DC1 YP_006590002.1 
47 843 281 35 Phage-related exonuclease Arsenophonus nasoniae CBA74387.1 
48 882 293 33 Hypothetical protein PPEV_gp007 Pseudomonas phage EL YP_418040.1 
49 831 276 32 Putative metal-dependent phosphohydrolase  Pseudomonas phage OBP YP_004958214.1 
50 795 265 31 Phage regulatory protein Anaerostipes sp. 3_2_56FAA ZP_07932474.1 
51 1341 447 31 Hypothetical protein Cronobacter phage ES2 AEM24695.1 
52 1581 526 30 Putative Gro-EL-like chaperonine protein Pseudomonas phage EL YP_418179.1 
53 543 181 30 Hypothetical protein Pseudomonas phage KPP10 BAK78949.1 
54 645 214 29 DNA-binding protein Niastella koreensis GR20-10 YP_005012592.1 
55 819 272 29 Hypothetical protein PPEV_gp172 Pseudomonas phage EL YP_418205.1 
56 4089 1362 28 Hypothetical protein Pseudomonas phage OBP YP_004958159.1 
57 717 238 27 Hypothetical protein PPEV_gp177 Pseudomonas phage EL YP_418210.1 
58 1167 388 27 Putative virion structural protein Pseudomonas phage OBP YP_004958181.1 
59 1566 521 20 Hypothetical protein PPEV_gp190 Pseudomonas phage EL YP_418223.1 
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The data generated from analysis of the contig for Sabp-P1 using Artemis Release 14.0.0, was used to 
generate a genome map using pDRAW32 (Figure 6.5). A linear map was created because the whole 
genome for Sabp-P1 has not yet been annotated. This diagrammatic representation of the ORFs within the 
contig shows those proteins with highest sequence identity to already sequenced proteins within the 
BLASTp database. In addition, during the initial stages of the study, the DNA of phage Sabp-P1 was 
digested using the restriction enzyme, EcoR1, in order to break it into constituent fragments. EcoR1 
digests were  also used for the construction of the genome map, firstly, to maintain consistency within 
results, and secondly because initial studies showed that Sabp-P1 remained undigested by restriction 
enzymes other than EcoR1.  A computerized representation of EcoR1 digestion showed 20 restriction 
sites on the Sabp-P1 contig. This differed from results of the initial studies on restriction fragment length 
analysis on whole Sabp-P1 DNA, where 18 restriction fragments were identified.   
With regard to genomic analysis of Sabp-P2 and Sabp-P3, the contigs of these phages were not 
analysed in the same detail as Sabp-P1. However, preliminary analysis did provide significant 
information on the genetic make-up of Sabp-P2 and Sabp-P3. It was found that Sabp-P2 was closely 
related to a phage of Clostridium perfringens Hauduroy et al. 1937 (Oakley et al. 2011), while Sabp-
P3 was closely related to a phage of Pseudomonas fluorescens (Cornelissen et al.2012). However, as with 
Sabp-P1, Sabp-P2 and Sabp-P3 showed no sequence homology to any other staphylococcal phages within 
the genomic databases. Genes encoding for the presence of several different virion associated 
polymerases and helicases, and DNA polymerase were also noted for both Sabp-P2 and Sabp-P3. Phages 
Sabp-P2 and Sabp-P3 also showed presence of the tail tape measure protein, which served to confirm 
their placement in the order Caudovirales, and the family Myoviridae.  
 
6.4 Discussion  
Genomic characterization of three phages specific to S. aureus was carried out. However, the 
results produced, deviated from what was originally expected. Firstly, preliminary analysis of the 
DNA of phages Sabp-P1, Sabp-P2 and Sabp-P3 using restriction fragment length analysis 
revealed approximate genome sizes of 107kbp, 70kbp and 126kbp, respectively. This differed 
significantly from the results obtained after whole genome sequencing using 454 pyrosequencing 
technology. Phages Sabp-P1, Sabp-P2 and Sabp-P3 were found to contain unusually large 















Figure 6.5 Genome map for largest contig of phage Sabp-P1, showing restriction sites using EcoR1 restriction enzyme. Arrows are 
shown in presumed direction of transcription. The arrows below the GC% block represent the following: 
 
 
 BLASTp sequence identity of >50%  BLASTp sequence identity 40-50% 
 BLASTp sequence identity 30-40%  BLASTp sequence identity of <30% 
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Furthermore, during restriction fragment length analysis, it was observed that all three phages 
were resistant to restriction by the most commonly applied restriction enzymes (EcoRv, BamHI, 
HindIII, PvuII), and were only digested by EcoRI. It is possible that these three phages lacked 
the appropriate restriction sites for the respective enzymes. This phenomenon has been 
previously reported (O‘Flaherty et al.2004). O‘Flaherty et al. (2004) found that the genome of 
staphylococcal Phage K showed little sequence homology to any DNA methylases and that it 
completely lacked GATC sites which were normally restricted by Sau3AI, BamHI, PvuI and 
DpnI. A paucity of restriction sites has also been observed in phages that infect lactococci 
(Moineau et al.1993).  
Next-generation sequencing technology, particularly pyrosequencing, involves highly 
precise and sensitive methodologies which allow little chance for error (Henn et al.2010). In the 
current study, results showed high quality metrics for the genomes of all three phages, where for 
every 93.48% (Sabp-P1), 98.41% (Sabp-P2) and 98.93% (Sabp-P3) of reads, the error rate was 1 
in 10000. Although the genome sizes generated from restriction fragment length analysis did not 
correlate with the results from whole genome sequencing, restriction fragment length analysis 
can still serve as a good method for the visualization of the relative quality of prepared DNA. 
Impurities present in a phage DNA preparation can manifest as blotches at the bottom of the gel, 
indicative of contaminating ribosomal material, as bright smears between individual fragments 
implying bacterial DNA contamination, or as a thick band band just below the loading well, 
which is also indicative of bacterial contamination (Sambrook et al.1989; Alphey, 1997). The 
current study showed no manifestation of DNA contamination.  
The second set of divergent results pertains to the lack of homologies between the 
sequence data of the test phages and those already on the genomic databases. It was expected 
that the phages Sabp-P1, Sabp-P2 and Sabp-P3 would show significant homology to other 
staphylococcal genomes already sequenced. However, all three phages showed zero homology to 
any other staphylococcal phage. Instead, phages Sabp-P1 and Sabp-P3 have shown homology to 
different forms of ―giant‖ phages, particularly those affecting the Pseudomonas spp. Phage Sabp-
P1 showed 51% sequence identity to the Pseudomonas phage OBP (Shaburova et al.2006) and 
phage Sabp-P3 showed 36% sequence identity to Pseudomonas phage EL (Krylov et al.2004; 
Adriaenssens et al.2012). These ―giant‖ forms of phage have been previously described 
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(Shaburova et al.2006; Adriaenssens et al.2012). In a report by Adriaenssen et al. (2012), a giant 
phage pathogenic towards Ps. putida was identified and called Pseudomonas Phage Lu11. This 
phage is related to both Pseudomonas phage OBP and Pseudomonas phage EL that was 
previously described by Shaburova et al. (2006), is part of the Myoviridae family. It has an 
icosahedral head (~124nm), and a contractile tail (~200nm in length). These particle dimensions 
correlate with the dimensions of all three test phages as demonstrated in earlier studies (Chapter 
4). However, with similarity values of only 51% and 36% for Sabp-P1 and Sabp-P3, 
respectively, it is likely that these phages are only peripherally related to Pseudomonas phages 
OBP and EL. Phage Sabp-P2 showed only 32% sequence homology to a Clostridium perfringens 
phage that was described by Oakley et al. (2011). These results could suggest that phages Sabp-
P1, Sabp-P2 and Sabp-P3 are separate species within the Myoviridae family. However, only 
preliminary analysis of the largest contigs of each phage was carried out. Complete assembly of 
all contigs for all three phages is necessary in order to unequivocally group them. 
Although complete annotation and assembly was not within the scope of the current 
study, preliminary analysis of the functional assignments of proteins making up the largest contig 
for phage Sabp-P1 was carried out. Analysis revealed the presence of several core proteins 
involved in phage replication and assembly. Of particular importance were the putative head 
morphogenesis protein, and the capsid protein. The product of ORF 29 of the Sabp-P1 contig 
showed 48% similarity to the major head protein of the Pseudomonas phage phi297 
(Burkal‘tseva et al.2011). The putative coat protein from ORF 21 of the Sabp-P1 contig, showed 
47% similarity, also to the major coat protein of the Pseudomonas phage phi297 (Burkal‘tseva et 
al.2011). Of the 109 ORFs comprising the Sabp-P1 contig, only 59 showed sequence homology 
to other known sequences. The percentage similarity between genes encoded by the 59 ORFs 
and those on the genomic databases are not significantly high enough to deduce that Sabp-P1 
may be a specific relative of any given group within the Myoviridae family. This further supports 
the theory that Sabp-P1 could be a new member of the Myoviridae family with only distant 
relatives having been identified already.  
 Although this study produced unexpected results in terms of genetic relatedness of the 
test phages to already sequenced phages, the results are still of considerable significance. It was 
concluded that phages Sabp-P1, Sabp-P2 and Sabp-P3 are of the order Caudovirales, and the 
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family Myoviridae. The type species for each of these phages currently appears to be different 
from anything within the genomic databases. This is particularly relevant from a South African 
perspective, because this constitutes a first study into characterization of phages pathogenic on 
mastitis-causing S. aureus. 
Phages Sabp-P1, Sabp-P2 and Sabp-P3 encoded all of the major functional components 
expected for a phage, but they still remained significantly divergent from their closest matches. It 
is acknowledged that much analysis remains in terms of completion of assemblies of all the 
contigs for all the phages before definitive conclusions can be derived. However, within the 
scope of the current study, the results were able to meet the objectives such that distinct 
differences were noted between each of the test phages, and these proved sufficient to distinguish 
between them.  
 
6.5 Conclusions 
Phages Sabp-P1, Sabp-P2 and Sabp-P3 appear to be of the order Caudovirales, and the family 
Myoviridae. A particular point of interest is that phages Sabp-P1 and Sabp-P3 appear to be 
related to a group of already identified ―giant‖ phages. Furthermore, none of the three phages 
showed sequence homology to any staphylococcal phages already on the database. Only full 
genome assembly of all phage contigs can definitely address these anomalies.  
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Technical Note: An improved embedding technique for transmission electron microscopy 
of bacteriophages propagated on solid growth media 
 
Abstract 
An improved technique was developed for the embedding of bacteriophages for transmission 
electron microscopy (TEM). Studies were conducted on phages and their host bacterium, 
Staphylococcus aureus. Phage particles and bacteria were propagated using the standard 
―double-layer‖ method. Plaque sections from the top agar were prepared for TEM analysis using 
both the traditional and an amended embedding method. The amended protocol improved both 
sample integrity and picture quality. In addition, preparation time which reduced from six days  
to three days. 
7.1 Technical Note 
High quality sample preparation for transmission electron microscopy (TEM) is paramount in 
order to acquire the most amount of information from a given sample. Current methods for 
studies on phage morphology and infection using TEM include a fixation and embedding 
protocol over six days (Hajibagheri and Trenton, 1999). The following report presents an 
amended protocol where sample processing is carried out in half the time, and concurrently, 
improved sample integrity (Table 7.1).  
Standard phage amplification on solid double-layer media was carried out using 
Staphylococcus aureus as the host bacterium (Sambrook et al. 1989). Phage plaques that 
developed on top agar (0.7% w/v) were divided into quarters along the margin between the clear 
zone and the bacterial lawn. These quarters were processed in two ways, as described in Table 
7.1. Resin embedded samples were sectioned using the Reichert-Jung Ultracut ultramicrotome. 
Sections were collected on formvar-coated copper mesh grids (200 mesh) and stained with 2% 
uranyl acetate (10min) followed by 2% lead citrate (10min). Grids were viewed using a JEOL 
JEM-1400
1
 at an operating voltage of 100kV. Images were captured using an Orius Camera 
(SC600A) operating off Gatan Digital Micrograph (version 2.02.800.0) software.  




Table 7.1 Comparison of methods for preparation of phage plaques for transmission electron 
microscopy analysis. 
 Previous protocol* Amended protocol 
Procedure Time Day Time Day 






Washing in 0.05M sodium cacodylate 
buffer 




2 x 30min 
 
 
     1 
Post-fixation in 2% osmium tetroxide 4hr 
 
2hr  
Washing in 0.05M sodium cacodylate 
buffer. Sample left o/n in fresh buffer. 
2 x 30min  1 x 30min  




for 30%, 70% 




   
10min/alcohol 
solution 
for 30%,  70% 
3 x 10min for 100% 
 
Removal of residual alcohol using 
propylene oxide 
1 x 10min        3  1 x 10min  
Embedding in epon/araldite and propylene 
oxide (+DMP):  
25% epon: 75% propylene oxide 
50% epon: 50% propylene oxide 











      
2 
100% epon overnight  4 
 
overnight  
Polymerization using 100% epon + DMP 48hr   5-6 14hr in oven at 
70ºC 
 3 
Trim, section, stain, view     
*as described by  (Tikhonenko, 1970; Hajibagheri and Trenton, 1999) 
 
Sample clarity was enhanced in those agar sections prepared using the amended protocol (Figure 


























Figure 7.1 Ultra-thin sections through the plaque of a staphylococcal phage, 12hr post 
inoculation, using an amended embedding protocol for transmission electron microscopy. 
a. Bacterial debris and residual intercellular annulus (A) as well as swollen protoplasts (*); b. Bacterial 
cell at an advanced stage of phage infection indicated showing extrusion of bubbles of cytoplasm 
(indicated by arrow); c. Newly formed phage particles packed within bacterial cells (indicated by arrow); 
d. Phage attached to the outer wall of an infected bacterial cell. All samples were stained using uranyl 






















Figure 7.2 Ultra-thin sections through the plaque of a staphylococcal phage, 12hr post 
inoculation, using traditional methods for sample embedding and fixation for transmission 
electron microscopy analysis.  
a-c. Obscured background and uneven staining in ultra-thin sections. From these images, it is not possible 
to accurately viral components from bacterial cells; d. Ultra-thin section showing shattering and cracking. 
All samples were stained using uranyl acetate and lead citrate. 
 
This could be attributed to the porous nature of top agar (0.7% w/v) which may facilitate easier 
translocation of reactive agents within it. As a result, biological material within the porous 
medium may be over-exposed to these reactive agents, with the result that visibility becomes 
obscured. It is also postulated that porosity combined with prolonged periods of exposure results 
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in samples/sections that are more prone to cracking and shattering, due to over-imbibition of 
reagents in the embedding procedure (Figure 7.2d).   
It is evident from these results that reduced exposure time of agar plaques to reactive 
agents during the TEM embedding protocol not only maintains superior cell and virus integrity 
and hence final picture quality, but also adds a valuable time-saving factor. While the amended 
protocol is specific for phages propagated on soft media, it could also be used on other studies 
where soft or porous material forms the basic material of the study. Typical examples could 
include studies in plant and animal tissue culture, or hyperparasitism studies associated with 
fungi and bacteria.      
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Bovine mastitis and its associated ramifications have long plagued dairy cattle. Control measures 
based on antibiotics provide only temporary relief before they are rendered obsolete by 
resistance (Du Preez, 2000; Petrovski et al., 2006; Petzer et al., 2009; Schmidt, 2010). The wide 
range of organisms that are able to cause the disease, coupled to the ubiquity of these organisms, 
makes disease management a complex process. Antibiotics, integrated with cultural control 
measures, formed the traditional basis for control of the disease. Global losses associated with 
bovine mastitis can reach up to 35 billion USD annually (Jones and Bailey, 2009; Van Den 
Borne, 2010; Mubarack et al., 2011).  
Amongst the wide array of microbes that are able to cause bovine mastitis, 
Staphylococcus aureus subsp. aureus Rosenbach 1884 remains the major causal agent. Many 
strains of S. aureus has developed antibiotic resistance against those antibiotics most commonly 
applied to treat bovine mastitis: penicillin, methicillin, and recently vancomycin (Vanderhaeghen 
et al., 2010). From a South African perspective, penicillin or penicillin+dihydrostreptomycin, 
make up 97% of the intramammary preparations used within the dairy industry, with the 
remaining 3% of preparations containing tetracyclines or cephalosporins (Schmidt, 2010). 
Subsequently, interest has shifted to alternative therapies for the control of bovine mastitis. The 
application of lytic phages could provide disease control in a far more sustainable manner than 
either antibiotics or cultural control measures alone. Phage therapy has been applied in several 
different disciplines ranging from human and veterinary medicine to agricultural settings 
(Soothill, 1994; Hagens and Offerhaus, 2008; Omnilytics, 2012). In our view, there is a clear 
niche for the application of phages against S. aureus-induced bovine mastitis. 
With this in mind, the long-term objective of the current study was to develop phages as a 
marketable product for use against bovine mastitis, with S. aureus being the first target organism. 
The research presented in this thesis represents in vitro screening and characterisation of isolated 
phages, prior to their development and formulation into commercial bactericides. Such a study is 
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essential in order to understand the intricacy of phage dynamics relative to its host organism, 
before application of a phage-based product to infected animals. 
       
8.2 Major findings and their implications  
The isolation, screening and characterization of potential phages against S. aureus, formed the 
backbone of this study. Twenty-eight phages were isolated from the dairy environment and raw 
milk, and screened against four strains of antibiotic-resistant S. aureus. However, only six 
phages showed potential for further screening, based on their wide host range, high titres and 









dilution of phage stock), these phages were able to reduce live bacterial cell counts by 64-95%. 
Additionally, these six phages showed pathogenicity towards a further 18 S. aureus strains that 
were isolated from a different milk-producing region during a farm survey. Phage ubiquity and 
abundance was also demonstrated during the farm survey, where up to 80% of raw milk samples 
tested positive for the presence of phages that were specific to the S. aureus test strain used 
throughout the study. 
A major finding of the farm survey was that the standard assay of somatic cell count (SCC) of 
infected milk was not an accurate representation of active infection and the state of mastitis 
disease. It provided a delayed measurement of an immune response to prior events. However, 
milk samples with a high SCC (>400,000 cells.ml
-1
) were not necessarily contaminated with 
bacteria, and many milk samples with a high SCC were complete free of mastitic bacteria. This 
finding contradicts the traditional expectation of what a high SCC represents, and may invalidate 
the course of treatment events that usually follow the discovery of a high SCC, such as the 
injection with antibiotics of all cows with a high SCC. This suggests that a different technique of 
disease quantitation is essential in order to accurately align treatment protocols with actual 
mastitis events, in time. 
Analysis of phage activity towards simulated environmental and formulation stresses 
showed that only three of the six screened phages performed well enough to be considered for in 
vivo applications, possibly as a cocktail treatment against mixed S. aureus strains. The risk of 
development of resistance by target bacteria towards their respective phages is ever-present.  
However, the abundance of phages that are active against S. aureus makes the problem of 
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resistance easier to overcome, both in terms of the time it takes to find new phages, and to 
incorporate these phages into established formulations. Antibiotic research, on the other hand, 
requires huge amounts of funding, and years of development research, prior to release of a novel 
antibiotic product to the consumer market. Coupled with the low economic return on antibiotic 
usage due to its short treatment duration, most pharmaceutical companies prefer to invest in the 
sustainability that is associated with production of chronic illness medication (Braine, 2011). 
This drives the demand for alternative therapies such as the use of phages or phage by-products 
to treat bacterial illnesses.  
Phages demonstrate a unique system of infection and replication within their target 
bacteria. This intricate network of events is so specific that all other microbes in that 
environment (pathogenic or commensal) remain unaffected. This, coupled with their ability to 
multiply between 50-1000 fold within a host bacterium, makes phages an ideal candidate for 
bacterial disease therapy. This study identified the morphology and the major steps in the 
replicative cycle of three novel South African phages infective against S. aureus strains causing 
bovine mastitis. These three phages were found to be of the order Caudovirales, family 
Myoviridae. The Myoviridae comprise approximately 25% of all tailed phages (Ackermann, 
2005).  
Protein profile analysis of the three phages revealed that proteins ranged in size from 
8.86-171.66kDa. Combined similarity matrices based on putative fragment analysis was able to 
confirm that all three phages were indeed different from each other.  
This was further confirmed through analysis of phage genomes. Preliminary sequence 
data analysis confirmed that the phages Sabp-P1, Sabp-P2 and Sabp-P3 are of the order 
Caudovirales, and the family Myoviridae. The type species for each phage currently appears 
unique from DNA sequences currently found in genomic databases. This is particularly relevant 
from a South African perspective because this research constitutes a first study into the 
characterization of phages specifically pathogenic towards mastitic S. aureus. Phages Sabp-P1, 
Sabp-P2 and Sabp-P3 encoded all of the major functional components expected for a phage, but 
they still remained significantly divergent from their closest matches. A particular point of 
interest is that phages Sabp-P1 and Sabp-P3 appear related to ―giant‖ phages, and Sabp-P1 
appears related to a Clostridium perfringens giant phage. None of the three phages showed 
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sequence homology to any staphylococcal phages already on the database. It is acknowledged 
that much analysis remains in terms of completion of assemblies of all the contigs for all the 
phages before definitive conclusions can be derived and these anomalies can be addressed. 
However, within the scope of the current study, the results were able to meet the objectives such 
that distinctive differences were noted between each of the test phages, and these proved 
sufficient to distinguish between them. 
 
8.3 Conclusions and way forward  
This study has demonstrated the need for a paradigm shift in the diagnosis and treatment 
of bovine mastitis, both within South Africa and worldwide. Dairy production in South Africa is 
faced with the serious problem of antibiotic resistance, with very few treatment alternatives 
outside of this sphere. The first step in the revolution must be focused on a more precise method 
for disease diagnosis. Diagnosis of bovine mastitis based on the SCC of raw milk alone, was 
shown to be an inaccurate method. Alternative methods, such as near-infrared 
spectrophotometric analysis (NIRA), must be explored. NIRA possesses the ability to detect 
even trace amounts of target compounds. The effect of mastitis on milk composition is a 
measurable factor. Another approach could be based on the changes in the lactose content of 
milk, affecting sodium and chloride levels. Measurement of the electrical conductance of milk 
may reflect the mastitis status of the cow. Excessive production of certain enzymes (lipase and 
plasmin) as a result of infection could also be measured. These measurements would supplement 
the SCC, in order to accurately diagnose the infection status of an animal.  
Further studies into the proteomic and genomic make-up of the three test phages should 
also be undertaken in order to identify specific phage proteins (and/or enzymes) that could be 
exploited for their control potential.  
Finally, in vivo application of the isolated phages is the pivotal next step envisaged for the 
study. These phages have shown stability under variable conditions and when grown in a 
glycerol-based medium. The application of a phage cocktail infused in a glycerol base, shows 
promise as a post-milking treatment. These studies all form part of the long-term objective for 
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Appendix 1  




1M Tris-HCl (pH 7.5) 50ml 
2% (w/v) gelatin solution 5ml 
Distilled water Up to 1l 
Aliquot buffer into 100ml vials. Sterilize buffer by autoclaving for 20min at 15psi  
(1.05kg.cm
-2












Figure 1. Staphylococcus aureus identification tests; a. Typical hemolysis reaction of S. aureus on blood 
agar; b. Gram reaction and coccal arrangement of S. aureus; c. Catalase reaction of S. aureus with 5% 






Table 1. Single step growth curve data for Sabp-P1, Sabp-P2, Sabp-P3, Sabp-P4, Sabp-P5 and Sabp-P6. 
Time (min) Log phage count (pfu.ml
-1
) 
 Sabp-P1 Sabp-P2 Sabp-P3 Sabp-P4 Sabp-P5 Sabp-P6 






 3.50 x 10
7
 6.2 x 10
7
 3.4 x 10
7
 
25 1.03 x 10
8
 1.25 x 10
8
 1.53 x 10
8
 7.80 x 10
7
 1.44 x 10
8
 8.10 x 10
7
 
30 1.61 x 10
8
 1.71 x 10
8
 1.99 x 10
8
 1.03 x 10
8
 1.46 x 10
8
 8.70 x 10
7
 
35 1.67 x 10
8
 1.96 x 10
8
 2.45 x 10
8
 9.10 x 10
7
 1.17 x 10
8
 1.00 x 10
8
 
40 2.30 x 10
8
 2.57 x 10
8
 2.91 x 10
8
 1.67 x 10
8
 1.07 x 10
8
 7.50 x 10
7
 
45 4.18 x 10
8
 4.09 x 10
8
 4.76 x 10
8
 2.12 x 10
8
 8.51 x 10
8
 1.62 x 10
8
 
50 5.73 x 10
8
 4.60 x 10
8
 7.16 x 10
8
 2.95 x 10
8
 1.97 x 10
8
 1.49 x 10
8
 
55 6.24 x 10
8
 5.28 x 10
8
 7.13 x 10
8
 2.92 x 10
8
 2.22 x 10
8
 1.41 x 10
8
 
60 6.11 x 10
8
 4.43 x 10
8
 7.07 x 10
8
 2.33 x 10
8
 2.14 x 10
8
 1.33 x 10
8
 
65 5.57 x 10
8
 4.35 x 10
8
 6.54 x 10
8
 2.53 x 10
8
 2.56 x 10
8
 1.65 x 10
8
 
70 5.03 x 10
8
 3.17 x 10
8
 6.12 x 10
8
 2.25 x 10
8
 2.15 x 10
8
 1.35 x 10
8
 
Mean 3.64 x 10
8
 3.11 x 10
8
 4.41 x 10
8
 1.80 x 10
8
 2.30 x 10
8
 1.15 x 10
8
 
F-value <0.001      
LSD(0.05) 1.22E+08      
CV% 5.6      
  


















Phage SaB1 only SaB1+ phage 
Sabp-P1 3.50 x 10
8
 1.63 x 10
7
 
Sabp-P2 3.83 x 10
8
 2.57  x 10
7
 
Sabp-P3 3.65 x 10
8
 1.87  x 10
7
 
Sabp-P4 3.56  x 10
8
 1.14 x 10
8
 
Sabp-P5 3.38 x 10
8
 1.10 x 10
8
 
Sabp-P6 3.22 x 10
8
 1.16 x 10
8
 
Mean 3.52 x 10
8




 LSD(0.05) 9.67 x 10
6
 1.55 x 10
7
 
















Figure 2. Typical ―webbing‖ or adjoining of neighbouring plaques at high concentrations. This is Sabp-
P1 at 1x10
-4









Table 1. Heat assay data of average phage counts at varied exposure times to different temperatures. 
  Temperature (°C) 
  45 50 55 60 65 70 
Phage Time 
(min) 
Log phage count (plaque forming unit.ml-1) 
Sabp-P1 0 2.88E+08 2.88E+08 2.88E+08 2.88E+08 2.88E+08 2.88E+08 
 10 1.79E+08 8.75E+07 9.00E+07 1.14E+08 4.05E+07 2.20E+07 
 20 1.39E+08 9.20E+07 3.05E+07 6.85E+07 5.85E+07 1.05E+07 
 30 1.20E+08 1.04E+08 1.55E+07 4.60E+07 2.50E+07 4.00E+07 
 40 1.18E+08 1.12E+08 1.70E+07 1.45E+07 3.25E+07 9.00E+06 
 50 1.25E+08 7.70E+07 2.05E+07 2.65E+07 3.70E+07 2.50E+06 
 60 1.08E+08 4.80E+07 4.20E+07 1.70E+07 2.55E+07 1.50E+06 
Sabp-P2 0 2.64E+08 2.64E+08 2.64E+08 2.64E+08 2.64E+08 2.64E+08 
 10 1.42E+08 1.88E+08 1.06E+08 6.05E+07 4.45E+07 1.95E+07 
 20 1.78E+08 4.50E+07 4.40E+07 5.45E+07 3.50E+06 3.80E+07 
 30 1.22E+08 3.15E+07 8.50E+06 6.75E+07 3.95E+07 2.50E+07 
 40 1.44E+08 7.55E+07 3.35E+07 1.30E+07 2.05E+07 2.10E+07 
 50 1.32E+08 3.00E+07 2.45E+07 2.75E+07 2.60E+07 1.25E+07 
 60 1.20E+08 8.45E+07 3.10E+07 1.30E+07 3.65E+07 1.15E+07 
Sabp-P3 0 1.87E+08 1.87E+08 1.87E+08 1.87E+08 1.87E+08 1.87E+08 
 10 1.37E+08 1.71E+08 9.50E+07 1.13E+08 4.50E+07 4.20E+07 
 20 1.46E+08 6.40E+07 5.55E+07 6.60E+07 3.85E+07 4.45E+07 
 30 1.18E+08 5.90E+07 8.50E+06 4.95E+07 4.20E+07 8.50E+06 
 40 1.30E+08 1.18E+08 8.50E+06 1.65E+07 4.05E+07 1.65E+07 
 50 1.11E+08 8.05E+07 1.05E+07 9.50E+06 3.90E+07 1.55E+07 
 60 1.11E+08 9.20E+07 5.00E+07 3.20E+07 5.70E+07 4.00E+06 
Sabp-P4 0 1.17E+08 1.17E+08 1.17E+08 1.17E+08 1.17E+08 1.17E+08 
 10 1.04E+08 1.15E+08 9.10E+07 8.95E+07 2.95E+07 1.30E+07 
 20 9.75E+07 1.22E+08 2.70E+07 2.95E+07 2.50E+07 9.50E+06 
 30 1.04E+08 1.19E+08 1.85E+07 2.65E+07 2.55E+07 2.00E+06 
 40 9.70E+07 9.00E+07 2.30E+07 2.25E+07 2.00E+07 5.00E+06 
 50 1.19E+08 1.15E+08 1.35E+07 1.60E+07 1.75E+07 2.50E+06 
 60 1.09E+08 9.95E+07 8.50E+06 8.00E+06 1.65E+07 1.00E+06 
Sabp-P5 0 1.20E+08 1.20E+08 1.20E+08 1.20E+08 1.20E+08 1.20E+08 
 10 1.26E+08 1.22E+08 1.12E+08 4.35E+07 2.20E+07 1.70E+07 
 20 1.30E+08 1.21E+08 5.15E+07 2.25E+07 1.30E+07 1.05E+07 
 30 9.90E+07 1.01E+08 1.55E+07 2.60E+07 1.40E+07 1.20E+07 
 40 1.11E+08 8.85E+07 1.05E+07 1.45E+07 1.50E+07 6.00E+06 
 50 1.05E+08 9.35E+07 1.60E+07 1.45E+07 1.85E+07 6.00E+06 
 60 1.15E+08 1.02E+08 5.50E+06 7.00E+06 1.35E+07 3.50E+06 
Sabp-P6 0 9.10E+07 9.10E+07 9.10E+07 9.10E+07 9.10E+07 9.10E+07 
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Table 1 continued      
 10 9.30E+07 8.70E+07 8.25E+07 4.35E+07 1.85E+07 1.85E+07 
 20 1.01E+08 1.01E+08 1.01E+08 1.01E+08 3.44E+07 6.41E+07 
 30 1.09E+08 9.15E+07 1.55E+07 3.65E+07 2.10E+07 1.00E+07 
 40 1.03E+08 1.10E+08 1.25E+07 2.05E+07 1.30E+07 1.35E+07 
 50 1.18E+08 1.10E+08 3.50E+06 1.00E+07 1.15E+07 5.00E+06 
 60 9.40E+07 9.00E+07 3.50E+06 1.15E+07 8.00E+06 7.00E+06 
LSD(0.05) 3.93E+06       
CV% 5.9       
F-value <0.001       
 
Table 2. Cold assay data of average phage counts at varied exposure times to different temperatures. 
  Time 
  1hr 8hr 12hr 1wk 2wk 3mo 6mo 
Phage Temp 
(°C) 
Log phage count (plaque forming unit.ml
-1
) 
Sabp-P1 4 3.24E+08 3.30E+08 3.21E+08 3.31E+08 3.37E+08 2.93E+08 2.58E+08 
 -20 2.89E+08 2.80E+08 2.45E+08 1.93E+08 1.72E+08 8.90E+07 5.75E+07 
 -80 1.93E+08 1.48E+08 1.53E+08 1.19E+08 8.45E+07 4.95E+07 1.50E+07 
Sabp-P2 4 3.30E+08 3.49E+08 3.36E+08 3.19E+08 3.50E+08 2.93E+08 3.03E+08 
 -20 2.85E+08 2.68E+08 2.48E+08 2.20E+08 1.62E+08 1.15E+08 6.95E+07 
 -80 1.66E+08 1.40E+08 1.17E+08 9.15E+07 6.65E+07 3.20E+07 1.35E+07 
Sabp-P3 4 3.26E+08 3.26E+08 3.23E+08 3.31E+08 3.39E+08 3.11E+08 2.96E+08 
 -20 2.73E+08 2.65E+08 2.57E+08 2.30E+08 2.01E+08 1.70E+08 1.30E+08 
 -80 1.28E+08 9.35E+07 9.75E+07 8.00E+07 5.75E+07 3.50E+07 7.00E+06 
Sabp-P4 4 2.90E+07 3.25E+07 3.45E+07 2.25E+07 2.30E+07 2.20E+07 1.40E+07 
 -20 1.50E+07 1.85E+07 1.45E+07 1.30E+07 1.75E+07 1.05E+07 8.50E+06 
 -80 1.55E+07 1.05E+07 9.50E+06 6.50E+06 3.00E+06 2.00E+06 5.00E+05 
Sabp-P5 4 1.65E+07 2.20E+07 1.75E+07 1.45E+07 1.55E+07 8.50E+06 5.50E+06 
 -20 1.00E+07 1.10E+07 1.35E+07 1.00E+07 1.35E+07 1.00E+07 6.50E+06 
 -80 1.05E+07 8.50E+06 7.50E+06 4.00E+06 6.50E+06 2.50E+06 1.00E+06 
Sabp-P6 4 3.90E+07 2.55E+07 3.35E+07 2.95E+07 3.70E+07 2.25E+07 1.65E+07 
 -20 2.65E+07 3.15E+07 2.55E+07 2.00E+07 2.50E+07 1.50E+07 5.00E+06 
 -80 2.15E+07 1.50E+07 1.35E+07 7.00E+06 6.50E+06 3.50E+06 2.00E+06 
LSD(0.05) 3.93E+06        
CV% 0.1        




Table 3. Effects of chloroform on phage replication. 
Phage Chloroform (+) Chloroform (-) 
Sabp-P1 9.37E+07 1.50E+08 
Sabp-P2 8.87E+07 1.54E+08 
Sabp-P3 8.03E+07 1.45E+08 
Sabp-P4 3.63E+07 9.27E+07 
Sabp-P5 3.07E+07 1.19E+08 
Sabp-P6 6.47E+07 8.73E+07 
Mean 6.57E+07 1.25E+08 
LSD(0.05) 9.47E+06 
 CV% 4.00E-01 
 F-value <0.001 
  
Table 4. Effects of pH on phage replication. 
 pH 
Phage 2 4 6 8 10 12 14 
Sabp-P1 1.05E+08 1.16E+08 2.16E+08 1.79E+08 1.03E+08 4.23E+07 2.83E+07 
Sabp-P2 2.25E+08 1.50E+08 1.73E+08 1.71E+08 2.17E+07 2.13E+07 3.93E+07 
Sabp-P3 1.28E+08 2.24E+08 2.35E+08 2.16E+08 1.17E+08 2.57E+07 2.07E+07 
Sabp-P4 1.01E+08 1.03E+08 9.33E+07 6.00E+07 4.03E+07 2.03E+07 1.33E+07 
Sabp-P5 1.04E+08 9.23E+07 1.09E+08 7.73E+07 4.80E+07 2.00E+07 1.97E+07 
Sabp-P6 1.14E+08 8.60E+07 1.15E+08 5.90E+07 3.13E+07 1.17E+07 1.27E+07 
LSD(0.05) 1.51e+07       
CV% 1.3       










Table 5. Effects of increasing glycerol concentration on phage replication. 
 Phage counts (pfu.ml
-1
) 
Glycerol % Sabp-P1 Sabp-P2 Sabp-P3 Sabp-P4 Sabp-P5 Sabp-P6 
5 4.77E+08 4.05E+08 4.10E+08 2.78E+08 3.04E+08 2.26E+08 
10 3.48E+08 3.82E+08 3.99E+08 2.53E+08 2.68E+08 2.84E+08 
20 2.69E+08 4.18E+08 4.31E+08 1.99E+08 2.20E+08 2.12E+08 
30 1.74E+08 2.79E+08 4.52E+08 1.91E+08 1.86E+08 1.77E+08 
40 2.27E+08 2.56E+08 3.68E+08 1.71E+08 1.72E+08 1.43E+08 
50 2.42E+08 2.65E+08 3.55E+08 1.82E+08 1.05E+08 1.92E+08 
60 1.49E+08 2.53E+08 3.24E+08 1.01E+08 1.09E+08 9.40E+07 
70 1.42E+08 2.02E+08 2.72E+08 5.70E+07 9.90E+07 4.90E+07 
80 9.40E+07 1.72E+08 2.39E+08 5.70E+07 9.30E+07 8.30E+07 
90 1.42E+08 1.35E+08 2.39E+08 6.10E+07 4.00E+07 2.80E+07 
100 4.80E+07 1.16E+08 1.94E+08 3.60E+07 3.80E+07 1.20E+07 
LSD(0.05) 9.50E+07      
CV% 0.4      








1. Colloidal Coomassie blue stain  
Ammonium sulphate (10%) 100g 
Coomassie G-250 20ml of 5% solution 
Ortho-phosphoric acid (3%) 30ml 
Ethanol (100%) 200ml 
Sterile distilled water Up to 1l 
Store in dark, at room temperature, in tightly sealed container.  
 
2. IEF Lysis buffer  
Urea (FW 60.06) 19.2g 
Triton-x-100 4ml 
Tris-base (FW 121.1) 0.194g 
Double distilled water Up to 40ml 




B. Similarity Matrices 
 
1. SDS-PAGE 
=========== Section: 1-SimQual ============ 
SimQual: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:06:13 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein SDS\sds.nts 
Compute by: cols 
Save results in output file: D:\iona\protein SDS\sdssim.nts 
Coefficient: DICE 
Positive:   1.0000 
Negative:   0.0000 
 
Matrix type = 1, size = 19 by 3, missing value code = 99  (rectangular) 
 
Dis/Similarity matrix (3 by 3) saved in file: D:\iona\protein 
SDS\sdssim.nts 
 
Ending date & time: 11/6/2012 11:06:13 AM 
 
=========== Section: 2-SAHN ============ 
SAHN: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:06:37 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein SDS\sdssim.nts 
Save result tree in output file: D:\iona\protein SDS\sdstree.NTS 
Clustering method: UPGMA 
In case of ties: FIND 
Max. no. tied trees:         25 
 
Comments: 
  SIMQUAL: input=D:\iona\protein SDS\sds.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
Results will be stored in file: D:\iona\protein SDS\sdstree.NTS 
Searching for all tied trees 
 
Solution tree number 1 
Sorting tree nodes ... 
 none needed. 
A single tree was found 
 
Ending date & time: 11/6/2012 11:06:37 AM 
 
=========== Section: 3-Tree ============ 
Tree: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 





Read input from file: D:\iona\protein SDS\sdstree.NTS 
 
Comments: 
  SIMQUAL: input=D:\iona\protein SDS\sds.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
  SAHN: input=D:\iona\protein SDS\sdssim.nts, method=UPGMA, tie=FIND 
  Solution tree number 1 
Matrix type = 6, size = 3 by 2, missing value code = "none"  (tree 
(similarity)) 
 
Ending date & time: 11/6/2012 11:07:22 AM 
 
=========== Section: 4-Output ============ 
Output: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:10:35 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein SDS\sdssim.nts 
Format: width=9 decimals=4 
Page width: 80 
Field width: 9 
Decimal places: 4 
Page width: 80 
Comments: 
  SIMQUAL: input=D:\iona\protein SDS\sds.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
 
          Sabp-P1    Sabp-P2    Sabp-P3  
       ---------------------------- 
Sabp-P1 |   1.0000 
Sabp-P2 |   0.8462   1.0000 
Sabp-P3 |   0.7333   0.6923   1.0000 
 




=========== Section: 1-SimQual ============ 
SimQual: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 10:54:29 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein IEF\ief.nts 
Compute by: cols 
Save results in output file: D:\iona\protein IEF\iefsim.nts 
Coefficient: DICE 
Positive:   1.0000 
Negative:   0.0000 
 




Dis/Similarity matrix (3 by 3) saved in file: D:\iona\protein 
IEF\iefsim.nts 
 
Ending date & time: 11/6/2012 10:54:30 AM 
=========== Section: 2-SAHN ============ 
SAHN: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 10:55:12 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein IEF\iefsim.nts 
Save result tree in output file: D:\iona\protein IEF\ieftree.NTS 
Clustering method: UPGMA 
In case of ties: FIND 
Max. no. tied trees:         25 
 
Comments: 
  SIMQUAL: input=D:\iona\protein IEF\ief.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
Results will be stored in file: D:\iona\protein IEF\ieftree.NTS 
Searching for all tied trees 
 
Solution tree number 1 
Sorting tree nodes ... 
 none needed. 
A single tree was found 
 
Ending date & time: 11/6/2012 10:55:12 AM 
=========== Section: 3-Tree ============ 
Tree: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 10:55:55 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein IEF\ieftree.NTS 
 
Comments: 
  SIMQUAL: input=D:\iona\protein IEF\ief.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
  SAHN: input=D:\iona\protein IEF\iefsim.nts, method=UPGMA, tie=FIND 
  Solution tree number 1 
Matrix type = 6, size = 3 by 2, missing value code = "none"  (tree 
(similarity)) 
 
Ending date & time: 11/6/2012 10:55:55 AM 
=========== Section: 4-Output ============ 
Output: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:03:20 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\protein IEF\iefsim.nts 
Format: width=9 decimals=4 
Page width: 80 
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Field width: 9 
Decimal places: 4 
Page width: 80 
Comments: 
  SIMQUAL: input=D:\iona\protein IEF\ief.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
 
          Sabp-P1    Sabp-P2    Sabp-P3  
       ---------------------------- 
Sabp-P1 |   1.0000 
Sabp-P2 |   0.6667   1.0000 
Sabp-P3 |   0.5455   0.7500   1.0000 
 
Ending date & time: 11/6/2012 11:03:20 AM 
 
 
3. Combined SDS-PAGE and UTLIEF matrices 
=========== Section: 1-SimQual ============ 
SimQual: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:33:53 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined protein\combined protein.nts 
Compute by: cols 
Save results in output file: D:\iona\combined protein\combined protein 
sim.NTS 
Coefficient: DICE 
Positive:   1.0000 
Negative:   0.0000 
 
Matrix type = 1, size = 27 by 3, missing value code = 99  (rectangular) 
 
Dis/Similarity matrix (3 by 3) saved in file: D:\iona\combined 
protein\combined protein sim.NTS 
 
Ending date & time: 11/6/2012 11:33:53 AM 
=========== Section: 2-SAHN ============ 
SAHN: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:34:14 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined protein\combined protein sim.NTS 
Save result tree in output file: D:\iona\combined protein\combined protein 
tree.NTS 
Clustering method: UPGMA 
In case of ties: FIND 
Max. no. tied trees:         25 
Comments: 
  SIMQUAL: input=D:\iona\combined protein\combined protein.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
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Results will be stored in file: D:\iona\combined protein\combined protein 
tree.NTS 
Searching for all tied trees 
 
Solution tree number 1 
Sorting tree nodes ... 
 none needed. 
A single tree was found 
 
Ending date & time: 11/6/2012 11:34:14 AM 
=========== Section: 3-Tree ============ 
Tree: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:34:27 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined protein\combined protein tree.NTS 
 
Comments: 
  SIMQUAL: input=D:\iona\combined protein\combined protein.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
  SAHN: input=D:\iona\combined protein\combined protein sim.NTS, 
method=UPGMA, tie=FIND 
  Solution tree number 1 
Matrix type = 6, size = 3 by 2, missing value code = "none"  (tree 
(similarity)) 
 
Ending date & time: 11/6/2012 11:34:27 AM 
=========== Section: 4-Output ============ 
Output: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:36:38 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined protein\combined protein sim.NTS 
Format: width=9 decimals=4 
Page width: 80 
Field width: 9 
Decimal places: 4 
Page width: 80 
Comments: 
  SIMQUAL: input=D:\iona\combined protein\combined protein.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
 
          Sabp-P1    Sabp-P2    Sabp-P3  
       ---------------------------- 
Sabp-P1 |   1.0000 
Sabp-P2 |   0.8000   1.0000 
Sabp-P3 |   0.6829   0.7059   1.0000 
 








1. Tris-EDTA buffer 
1M Tris-HCl (pH 7.4) 
0.5M EDTA (pH 8.0) 
Add 0.5ml 1M Tris-HCl and 0.1ml 0.5M EDTA to a sterile glass bottle and bring volume up to 50ml with 
sterile distilled water. Store buffer at room temperature.  
 
2. TAE buffer (10x stock solution) 
Tris base 48.4g 
Glacial acetic acid 11.4ml 
EDTA, disodium salt 3.7g 
Deionized water Up to 1l 
Dilute buffer to 1x using sterile distilled water. Store 10x stock buffer at room temperature.  
 
 













Figure 1. Agarose gel electrophoresis of phage DNA. Bands from left to right: 1. O‘Gene Ruler 100bp + 
500bp DNA ladder (Fermentas); 2. Sabp-P1 (5µl); 3. Sabp-P2 (5µl); 4. Sabp-P3 (5µl); 5. Sabp-P1 (10µl); 




4. Similarity matrices 
4.1 DNA 
=========== Section: 1-SimQual ============ 
SimQual: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 9/18/2012 11:45:23 AM 
---------------------------------------- 
Input parameters: 
Read input from file: C:\Documents and 
Settings\User\Desktop\iona\ecor1.nts 
Compute by: cols 
Save results in output file: C:\Documents and 
Settings\User\Desktop\iona\ecor1sim.nts 
Coefficient: DICE 
Positive:   1.0000 
Negative:   0.0000 
 
Matrix type = 1, size = 21 by 3, missing value code = "none"  
(rectangular) 
 
Dis/Similarity matrix (3 by 3) saved in file: C:\Documents and 
Settings\User\Desktop\iona\ecor1sim.nts 
 
Ending date & time: 9/18/2012 11:45:23 AM 
 
 
=========== Section: 2-SAHN ============ 
SAHN: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 9/18/2012 11:46:20 AM 
---------------------------------------- 
Input parameters: 
Read input from file: C:\Documents and 
Settings\User\Desktop\iona\ecor1sim.nts 
Save result tree in output file: C:\Documents and 
Settings\User\Desktop\iona\ecor1tree.nts 
Clustering method: UPGMA 
In case of ties: FIND 
Max. no. tied trees:         25 
 
Comments: 
  SIMQUAL: input=C:\Documents and Settings\User\Desktop\iona\ecor1.nts, 
coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
Results will be stored in file: C:\Documents and 
Settings\User\Desktop\iona\ecor1tree.nts 
Searching for all tied trees 
 
Solution tree number 1 
Sorting tree nodes ... 
 none needed. 




Ending date & time: 9/18/2012 11:46:20 AM 
 
 
=========== Section: 3-Tree ============ 
Tree: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 9/18/2012 11:46:42 AM 
---------------------------------------- 
Input parameters: 




  SIMQUAL: input=C:\Documents and Settings\User\Desktop\iona\ecor1.nts, 
coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
  SAHN: input=C:\Documents and Settings\User\Desktop\iona\ecor1sim.nts, 
method=UPGMA, tie=FIND 
  Solution tree number 1 
Matrix type = 6, size = 3 by 2, missing value code = "none"  (tree 
(similarity)) 
 
Ending date & time: 9/18/2012 11:46:42 AM 
 
 
=========== Section: 4-Output ============ 
Output: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 9/18/2012 11:49:15 AM 
---------------------------------------- 
Input parameters: 
Read input from file: C:\Documents and 
Settings\User\Desktop\iona\ecor1sim.nts 
Format: width=9 decimals=4 
Page width: 80 
Field width: 9 
Decimal places: 4 
Page width: 80 
Comments: 
  SIMQUAL: input=C:\Documents and Settings\User\Desktop\iona\ecor1.nts, 
coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
 
         118      119      120   
     ---------------------------- 
Sabp-P1 |   1.0000 
Sabp-P2 |   0.7097   1.0000 
Sabp-P3 |   0.8649   0.7500   1.0000 
 





4.2 Combined matrix: DNA vs Protein 
=========== Section: 1-SimQual ============ 
SimQual: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:26:51 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined\combined data.nts 
Compute by: cols 
Save results in output file: D:\iona\combined\combined data sim.NTS 
Coefficient: DICE 
Positive:   1.0000 
Negative:   0.0000 
 
Matrix type = 1, size = 48 by 3, missing value code = 99  (rectangular) 
 
Dis/Similarity matrix (3 by 3) saved in file: D:\iona\combined\combined 
data sim.NTS 
 
Ending date & time: 11/6/2012 11:26:51 AM 
 
 
=========== Section: 2-SAHN ============ 
SAHN: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:27:22 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined\combined data sim.NTS 
Save result tree in output file: D:\iona\combined\combined data tree.NTS 
Clustering method: UPGMA 
In case of ties: FIND 
Max. no. tied trees:         25 
 
Comments: 
  SIMQUAL: input=D:\iona\combined\combined data.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
Results will be stored in file: D:\iona\combined\combined data tree.NTS 
Searching for all tied trees 
 
Solution tree number 1 
Sorting tree nodes ... 
 none needed. 
A single tree was found 
 
Ending date & time: 11/6/2012 11:27:22 AM 
 
 
=========== Section: 3-Tree ============ 
Tree: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 





Read input from file: D:\iona\combined\combined data tree.NTS 
 
Comments: 
  SIMQUAL: input=D:\iona\combined\combined data.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
  SAHN: input=D:\iona\combined\combined data sim.NTS, method=UPGMA, 
tie=FIND 
  Solution tree number 1 
Matrix type = 6, size = 3 by 2, missing value code = "none"  (tree 
(similarity)) 
 
Ending date & time: 11/6/2012 11:27:44 AM 
 
 
=========== Section: 4-Output ============ 
Output: NTSYSpc 2.11W, (C) 2000-2004, Applied Biostatistics Inc. 
Date & time: 11/6/2012 11:30:37 AM 
---------------------------------------- 
Input parameters: 
Read input from file: D:\iona\combined\combined data sim.NTS 
Format: width=9 decimals=4 
Page width: 80 
Field width: 9 
Decimal places: 4 
Page width: 80 
Comments: 
  SIMQUAL: input=D:\iona\combined\combined data.nts, coeff=DICE 
  by Cols, +=   1.00000, -=   0.00000 
Matrix type = 3, size = 3 by 3, missing value code = "none"  (similarity) 
 
          Sabp-P1    Sabp-P2    Sabp-P3  
       ---------------------------- 
Sabp-P1 |   1.0000 
Sabp-P2 |   0.7576   1.0000 
Sabp-P3 |   0.7692   0.7273   1.0000 
 
Ending date & time: 11/6/2012 11:30:37 AM 
 
 
 
 
